	ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)	CLUSTER	PREPROCESSED_SENTENCE
S18-BMJ_2010_Apr_29_340_c1640	BMJ_2010_Apr_29_340_c1640	4/2010	S18-BMJ_2010_Apr_29_340_c1640	['this EVIDENCE comes from both case-control and cohort studies and INDICATES that age of operation for such a PROTECTIVE EFFECT MIGHT include both childhood and early Adulthood.67891011\nexposure to ultraviolet radiation in early Life has NOT YET been formally examined but MIGHT be LINKED to excess risk of multiple sclerosis at Birth through seasonal deficiency in maternal Vitamin D concentrations.12A study of half siblings with multiple sclerosis has ALSO SHOWN that risk CAN be maternally MEDIATED.13pregnancy is a vulnerable time for Vitamin d deficiency BECAUSE of increased physiological needs and reduced maternal outdoor activity.14experimental data on Animal Fetal Development INDICATE that Cerebral White Matter is responsive to Vitamin D and that Oligodendrocytes in the Brain and Spinal Cord have Vitamin D Receptors.1516furthermore, maternal Vitamin D depletion alters Neurogenesis in the developing Rat Brain,17with subsequent altered Gene Expression in Adult Life.18a RECENT Genetic STUDY in Humans has FURTHER IMPLICATED Vitamin D as a strong environmental CANDIDATE by SHOWING direct functional INTERACTION with the major locus that determines susceptibility to multiple sclerosis.19ALTHOUGH Human EVIDENCE pertaining to fetal development HAS BEEN DIFFICULT to obtain, the body of RELATED EVIDENCE to date has led SOME to RECOMMEND Antenatal supplementation with Vitamin D to prevent multiple sclerosis.14\nAS an indicator of POSSIBLE Perinatal environmental exposures, such as ultraviolet radiation, individual studies in the northern hemisphere have examined month of Birth and risk of multiple sclerosis with VARIED results.2021222324a large RECENT pooled analysis of Births in the northern hemisphere, HOWEVER, SHOWED an excess of multiple sclerosis among People Born in may and a relative deficit among those Born in november; these results were stronger in familial cases and SUGGESTED INTERACTIONS between Genes and environment that are RELATED to climate and that MIGHT act during Gestation or shortly after Birth.12we EXAMINED month of Birth and risk of multiple sclerosis in australia.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 109), ('SUPERFICIAL_RELATIONSHIP', 120), ('INCOMPLETE_EVIDENCE', 127), ('FULL_UNKNOWN', 237), ('INCOMPLETE_EVIDENCE', 272), ('SUPERFICIAL_RELATIONSHIP', 281), ('INCOMPLETE_EVIDENCE', 399), ('INCOMPLETE_EVIDENCE', 454), ('INCOMPLETE_EVIDENCE', 475), ('SUPERFICIAL_RELATIONSHIP', 493), ('PROBABLE_UNDERSTANDING', 560), ('INCOMPLETE_EVIDENCE', 687), ('INCOMPLETE_EVIDENCE', 984), ('INCOMPLETE_EVIDENCE', 1019), ('SUPERFICIAL_RELATIONSHIP', 1027), ('INCOMPLETE_EVIDENCE', 1074), ('INCOMPLETE_EVIDENCE', 1087), ('SUPERFICIAL_RELATIONSHIP', 1113), ('ANOMALY_CURIOUS_FINDING', 1199), ('ANOMALY_CURIOUS_FINDING', 1199), ('INCOMPLETE_EVIDENCE', 1216), ('INCOMPLETE_EVIDENCE', 1257), ('DIFFICULT_TASK', 1266), ('INCOMPLETE_EVIDENCE', 1299), ('SUPERFICIAL_RELATIONSHIP', 1299), ('INCOMPLETE_EVIDENCE', 1332), ('FUTURE_WORK', 1340), ('PROBABLE_UNDERSTANDING', 1424), ('INCOMPLETE_EVIDENCE', 1443), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1629), ('INCOMPLETE_EVIDENCE', 1662), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1723), ('INCOMPLETE_EVIDENCE', 1732), ('INCOMPLETE_EVIDENCE', 1899), ('SUPERFICIAL_RELATIONSHIP', 1909), ('SUPERFICIAL_RELATIONSHIP', 1961), ('INCOMPLETE_EVIDENCE', 1989), ('QUESTION_ANSWERED_BY_THIS_WORK', 2044)]	40	[('UBERON_0000113', 'post-juvenile adult stage', 166, 'adulthood'), ('UBERON_0000104', 'life cycle', 228, 'life'), ('GO_0007567', 'parturition', 328, 'birth'), ('CHEBI_27300', 'vitamin D', 374, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 539, 'vitamin'), ('NCBITaxon_33208', 'Metazoa', 662, 'animal'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 669, 'fetal development'), ('UBERON_0002437', 'cerebral hemisphere white matter', 701, 'cerebral white matter'), ('CHEBI_27300', 'vitamin D', 740, 'vitamin D'), ('CL_0000128', 'oligodendrocyte', 759, 'oligodendrocytes'), ('UBERON_0000955', 'brain', 783, 'brain'), ('UBERON_0002240', 'spinal cord', 793, 'spinal cord'), ('CHEBI_27300', 'vitamin D', 810, 'vitamin D'), ('PR_000001708', 'sphingosine 1-phosphate receptor 3', 810, 'vitamin D receptors'), ('CHEBI_27300', 'vitamin D', 856, 'vitamin D'), ('GO_0022008', 'neurogenesis', 883, 'neurogenesis'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 914, 'rat'), ('UBERON_0000955', 'brain', 918, 'brain'), ('GO_0010467', 'gene expression', 950, 'gene expression'), ('SO_0000704', 'gene', 950, 'gene'), ('UBERON_0000113', 'post-juvenile adult stage', 969, 'adult life'), ('SO_0000704', 'gene', 991, 'genetic'), ('NCBITaxon_9606', 'Homo sapiens', 1008, 'humans'), ('CHEBI_27300', 'vitamin D', 1038, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 1210, 'human'), ('GO_0007567', 'parturition', 1350, 'antenatal'), ('CHEBI_27300', 'vitamin D', 1381, 'vitamin D'), ('GO_0036268', 'swimming', 1452, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1452, 'perinatal'), ('GO_0007567', 'parturition', 1587, 'birth'), ('GO_0007567', 'parturition', 1688, 'births'), ('NCBITaxon_10088', 'Mus <genus>', 1777, 'people'), ('GO_0007567', 'parturition', 1784, 'born'), ('GO_0007567', 'parturition', 1831, 'born'), ('SO_0000704', 'gene', 1930, 'genes'), ('GO_0007565', 'female pregnancy', 2006, 'gestation'), ('GO_0007567', 'parturition', 2033, 'birth'), ('GO_0007567', 'parturition', 2062, 'birth')]	0	['comes case-control age operation childhood adulthood.67891011\nexposure ultraviolet radiation life formally excess sclerosis birth seasonal maternal  concentrations.12a half siblings sclerosis maternally mediated.13pregnancy vitamin physiological maternal outdoor activity.14experimental animal fetal cerebral white responsive  oligodendrocytes brain spinal cord  receptors.1516furthermore, maternal  depletion alters neurogenesis rat brain,17with altered  expression adult life.18a humans  environmental functional locus sclerosis.19although human fetal obtain, antenatal supplementation  sclerosis.14\nas perinatal environmental exposures, ultraviolet radiation, individual northern hemisphere month birth sclerosis results.2021222324a pooled births northern hemisphere, however, excess sclerosis among people born relative among born november; results familial cases  environment climate gestation shortly birth.12we month birth sclerosis australia.']
S74-PMC2290997	PMC2290997	4/2008	S74-PMC2290997	['STILL to be resolved, HOWEVER, is the QUESTION of WHAT levels of Vitamin D are OPTIMAL for preventing the disease—and WHETHER the statistical ASSOCIATIONS REFLECT DIFFERENT Gene pools RATHER than DIFFERENT levels of 25(Oh)D. (INTERESTINGLY, holick REPORTED in the august 1988 issue of the journal of clinical endocrinology & Metabolism that no previtamin d3formed when Human skin was exposed to sunlight on cloudless days in boston, at 42.2°n, from november through february or in edmonton, at 52°n, from october through march.)']	[('IMPORTANT_CONSIDERATION', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('EXPLICIT_QUESTION', 38), ('EXPLICIT_QUESTION', 50), ('IMPORTANT_CONSIDERATION', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 118), ('EXPLICIT_QUESTION', 118), ('SUPERFICIAL_RELATIONSHIP', 142), ('SUPERFICIAL_RELATIONSHIP', 155), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 163), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 184), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 196), ('ANOMALY_CURIOUS_FINDING', 226), ('INCOMPLETE_EVIDENCE', 248)]	14	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('SO_0000704', 'gene', 173, 'gene'), ('CHEBI_71657', 'versiconol acetate', 216, '25(OH)D'), ('GO_0008152', 'metabolic process', 325, 'Metabolism'), ('NCBITaxon_9606', 'Homo sapiens', 369, 'human')]	0	['still resolved, however, levels  disease—and statistical  pools levels 25(oh)d. (interestingly, holick august 1988 journal endocrinology & metabolism previtamin d3formed human skin exposed sunlight cloudless days boston, 42.2°n, november february edmonton, 52°n, october march.)']
S2-PMC2685863	PMC2685863	5/2009	S2-PMC2685863	['a team of canadian and british researchers has now REPORTED EVIDENCE that Vitamin D INTERACTS with a variant form of the Hla-Drb1 Gene, which HAS BEEN ASSOCIATED with ms.\nas REPORTED in the 6 february 2009 issue of the online journal plos genetics , study leader george ebers, a clinical neurologist at the university of oxford, united kingdom, and colleagues examined cells with two copies of the Hla-Drb*15 form of Hla-Drb1 .']	[('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 84), ('INCOMPLETE_EVIDENCE', 142), ('SUPERFICIAL_RELATIONSHIP', 151), ('INCOMPLETE_EVIDENCE', 174)]	6	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('PR_000002011', 'MHC class I histocompatibility antigen C alpha chain', 121, 'HLA-DRB1'), ('SO_0000704', 'gene', 130, 'gene'), ('PR_000002011', 'MHC class I histocompatibility antigen C alpha chain', 398, 'HLA-DRB'), ('PR_000002011', 'MHC class I histocompatibility antigen C alpha chain', 417, 'HLA-DRB1')]	0	['team canadian british  variant form hla-drb1 ms.\nas 6 february 2009 online journal plos genetics leader george ebers, neurologist university oxford, united kingdom, colleagues cells copies hla-drb*15 form hla-drb1 .']
S3-PMC2685863	PMC2685863	5/2009	S3-PMC2685863	['they IDENTIFIED a Vitamin D response element (vdre)—a short stretch of dna that is a signature of Genes Regulated by Vitamin D—next to the Gene.']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('SO_0000704', 'gene', 98, 'genes'), ('GO_0065007', 'biological regulation', 104, 'regulated'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('SO_0000704', 'gene', 139, 'gene')]	0	[' response element (vdre)—a stretch dna  —next .']
S5-PMC2685863	PMC2685863	5/2009	S5-PMC2685863	['the researchers also SHOWED that the vdre sequence FOUND in People with Hla-Drb1*15 could bind to the Vitamin D receptor, and that the hla-Drb1 Gene responded more strongly to Vitamin D in cells with the Hla-Drb1*15 vdre sequence than in cells without it.']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 51)]	2	[('NCBITaxon_10088', 'Mus <genus>', 60, 'people'), ('PR_000002011', 'MHC class I histocompatibility antigen C alpha chain', 72, 'HLA-DRB1'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('PR_000002019', 'MHC class II histocompatibility antigen beta chain DRB1', 139, 'DRB1'), ('SO_0000704', 'gene', 144, 'gene'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D'), ('PR_000002011', 'MHC class I histocompatibility antigen C alpha chain', 204, 'HLA-DRB1')]	0	['vdre sequence people hla-drb1*15 bind  receptor, hla-drb1  responded  cells hla-drb1*15 vdre sequence cells it.']
S6-PMC2685863	PMC2685863	5/2009	S6-PMC2685863	['“this is the FIRST DIRECT EVIDENCE that Vitamin D Regulates the Gene,” says ebers.']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 50)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0065007', 'biological regulation', 50, 'regulates'), ('SO_0000704', 'gene', 64, 'gene')]	0	['“this  ,” says ebers.']
S42-PMC2872349	PMC2872349	4/2010	S42-PMC2872349	['the RELATIONSHIPS REMAINED after adjustment for KNOWN Genetic markers of osteoporosis risk, such as polymorphisms in the Gene for the Vitamin D Receptor (vdr), and after adjustment for lifestyle characteristics in Adulthood that MIGHT have INFLUENCED bone mass (physical activity, dietary calcium intake, cigarette smoking, and alcohol consumption).']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 229), ('SUPERFICIAL_RELATIONSHIP', 240)]	5	[('SO_0000704', 'gene', 54, 'genetic'), ('SO_0000704', 'gene', 121, 'gene'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 134, 'vitamin D receptor'), ('UBERON_0000113', 'post-juvenile adult stage', 214, 'adulthood')]	0	['adjustment  osteoporosis risk, polymorphisms   receptor (vdr), adjustment lifestyle characteristics adulthood bone mass (physical activity, dietary calcium intake, cigarette smoking, alcohol consumption).']
S118-PMC2872349	PMC2872349	4/2010	S118-PMC2872349	['a further example of a dynamic INTERACTION between Genetic and environmental INFLUENCES of bone mass was shown in the analysis of the Vitamin D Receptor (vdr) genotype and Adult bmd in participants of the hertfordshire cohort study.']	[('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 77)]	2	[('SO_0000704', 'gene', 51, 'genetic'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 134, 'vitamin D receptor'), ('UBERON_0007023', 'adult organism', 172, 'adult')]	0	['example dynamic  environmental bone mass  receptor (vdr) genotype adult bmd participants hertfordshire study.']
S128-PMC2873552	PMC2873552	4/2010	S128-PMC2873552	"['[""""caption (table-wrap): table 2\\n\\nfunctions and diseases related to both ceu and yri Signaturesceuyri diabetes 1.70e-172.70e-20 Coronary Artery disease 3.78e-173.12e-13 Genetic disorder 1.09e-144.53e-14 Cardiovascular disease 1.34e-144.78e-11 non-Insulin-dependent diabetes mellitus 1.03e-128.66e-15 Endocrine System disorder 1.91e-121.25e-18 hypertension 2.13e-122.83e-11 Neurological disorder 2.49e-123.27e-12 crohn\'s disease 7.59e-127.25e-09 bipolar affective disease 3.50e-115.24e-09 Metabolic disorder 5.66e-119.83e-16 inflammatory disorder 2.56e-091.08e-08 Digestive System disorder 2.66e-091.31e-07 Skeletal and muscular disorder 1.49e-081.58e-08 progressive motor neuropathy 2.53e-085.59e-12 Autoimmune disease 7.28e-081.09e-12 immunological disorder 2.46e-073.66e-13 rheumatoid arthritis 3.78e-072.54e-07 shape change of Epithelial Cells 8.86e-07 alzheimer\'s disease 3.60e-062.27e-07 parkinson\'s disease 7.24e-065.29e-06 shape change of Dermal Cells 9.33e-06 Insulin-dependent diabetes mellitus 3.76e-15 neuropathy 5.38e-12 amyotrophic lateral sclerosis 1.36e-09 arthritis 1.44e-07\\n\\nVitamin D HYPOTHESIS\\nan INTERESTING HYPOTHESIS HAS BEEN PROPOSED by mcgrace [28] claiming that low Prenatal Vitamin D increases the risk of a wide range of diseases such as multiple sclerosis, diabetes, schizophrenia, Prostate cancer, Breast cancer and Colorectal cancer because of its versatile function in normal development.""""]']"	[('INCOMPLETE_EVIDENCE', 1099), ('ANOMALY_CURIOUS_FINDING', 1113), ('INCOMPLETE_EVIDENCE', 1125), ('INCOMPLETE_EVIDENCE', 1136), ('INCOMPLETE_EVIDENCE', 1145)]	5	[('GO_0036367', 'light adaption', 82, 'signaturesCEUYRI'), ('UBERON_0001621', 'coronary artery', 125, 'Coronary artery'), ('SO_0000704', 'gene', 166, 'Genetic'), ('UBERON_0004535', 'cardiovascular system', 200, 'Cardiovascular'), ('PR_000045358', 'insulin family protein', 244, 'insulin'), ('UBERON_0000949', 'endocrine system', 297, 'Endocrine system'), ('UBERON_0001016', 'nervous system', 370, 'Neurological'), ('GO_0008152', 'metabolic process', 485, 'Metabolic'), ('UBERON_0004854', 'gastrointestinal system mesentery', 560, 'Digestive system'), ('UBERON_0004288', 'skeleton', 603, 'Skeletal'), ('UBERON_0005445', 'segment of pes', 697, 'Autoimmune'), ('CL_0000066', 'epithelial cell', 827, 'epithelial cells'), ('UBERON_0000483', 'epithelium', 827, 'epithelial'), ('CL_0000346', 'hair follicle dermal papilla cell', 943, 'dermal cells'), ('PR_000045358', 'insulin family protein', 965, 'Insulin'), ('CHEBI_28384', 'vitamin K', 1089, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 1188, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1197, 'vitamin D'), ('UBERON_0002367', 'prostate gland', 1307, 'prostate'), ('UBERON_0000310', 'breast', 1324, 'breast'), ('UBERON_0012652', 'colorectum', 1342, 'colorectal')]	0	"['[""""caption (table-wrap): table 2\\n\\nfunctions diseases ceu yri signaturesceuyri diabetes 1.70e-172.70e-20 coronary artery disease 3.78e-173.12netic disorder 1.09e-144.53e-14 cardiovascular disease 1.34e-144.78e-11 non-insulin-dependent diabetes mellitus 1.03e-128.66e-15 endocrine system disorder 1.91e-121.25e-18 hypertension 2.13e-122.83e-11 neurological disorder 2.49e-123.27e-12 crohn*s disease 7.59e-127.25e-09 bipolar disease 3.50e-115.24e-09 metabolic disorder 5.66e-119.83e-16 inflammatory disorder 2.56e-091.08e-08 digestive system disorder 2.66e-091.31e-07 skeletal muscular disorder 1.49e-081.58e-08 progressive motor neuropathy 2.53e-085.59e-12 autoimmune disease 7.28e-081.09e-12 immunological disorder 2.46e-073.66e-13 rheumatoid arthritis 3.78e-072.54e-07 epithelial cells 8.86e-07 alzheimer*s disease 3.60e-062.27e-07 parkinson*s disease 7.24e-065.29e-06 dermal cells 9.33e-06 insulin-dependent diabetes mellitus 3.76e-15 neuropathy 5.38e-12 amyotrophic lateral sclerosis 1.36e-09 arthritis 1.44e-07\\n\\nvitamin hypothesis\\nan mcgrace [28] pitamin diseases sclerosis, diabetes, schizophrenia, prostate cancer, breast cancer colorectal cancer versatile normal development.""""]']"
S133-PMC2873552	PMC2873552	4/2010	S133-PMC2873552	['TO ASSESS this POSSIBILITY, we looked into the entropy of the vdr Gene, a Vitamin D receptor.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 15)]	2	[('SO_0000704', 'gene', 66, 'gene'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]	0	['possibility, entropy vdr  receptor.']
S137-PMC2873552	PMC2873552	4/2010	S137-PMC2873552	['these results are SUGGESTIVE that Vitamin D MIGHT have been INVOLVED in the alteration of risk of disease and abnormal development and CONSEQUENTLY in the Genetic adaptation of modern Humans, BUT validation from FURTHER STUDY IS NECESSARY.']	[('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 60), ('PROBABLE_UNDERSTANDING', 135), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 192), ('FUTURE_WORK', 212), ('FUTURE_WORK', 226), ('FUTURE_WORK', 229)]	8	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('SO_0000704', 'gene', 155, 'genetic'), ('NCBITaxon_9606', 'Homo sapiens', 184, 'humans')]	0	['results  alteration disease abnormal  adaptation modern humans, necessary.']
S1-PMC2913107	PMC2913107	8/2010	S1-PMC2913107	['subsequently, the title of an article in scientific american RECENTLY ASKED, ‘WHAT IF Vitamin D deficiency is a cause of autism?’ (3) since then, an ARTICLE on Vitamin D and autism in acta paediatrica (4) and the accompanying COMMENTARY (5) have added to the ACCELERATING SUSPICION that Vitamin D deficiency – EITHER during Pregnancy OR early childhood – MAY BE an environmental TRIGGER for the Genetic disease of autism.']	[('INCOMPLETE_EVIDENCE', 61), ('EXPLICIT_QUESTION', 70), ('EXPLICIT_QUESTION', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('EXPLICIT_QUESTION', 127), ('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 226), ('IMPORTANT_CONSIDERATION', 259), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 272), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 310), ('INCOMPLETE_EVIDENCE', 355), ('SUPERFICIAL_RELATIONSHIP', 379)]	12	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin D'), ('GO_0007565', 'female pregnancy', 324, 'pregnancy'), ('SO_0000704', 'gene', 395, 'genetic')]	0	['subsequently, title scientific american asked, ‘what  autism?’ (3) then,  autism acta paediatrica (4) (5) added  childhood environmental  disease autism.']
S45-PMC2913107	PMC2913107	8/2010	S45-PMC2913107	['the Vitamin D THEORY of autism DOES NOT DIMINISH Genetic CONTRIBUTIONS to autism occurrence.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 57)]	3	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('SO_0000704', 'gene', 49, 'genetic')]	0	[' autism diminish  autism occurrence.']
S46-PMC2913107	PMC2913107	8/2010	S46-PMC2913107	['indeed, without the Genetic TENDENCY for autism, i SUSPECT that SEVERE maternal or early childhood Vitamin D deficiency MAY cause bone abnormalities, as referenced above, with no evidence autism.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('PROBABLE_UNDERSTANDING', 51), ('IMPORTANT_CONSIDERATION', 64), ('FUTURE_PREDICTION', 120)]	4	[('SO_0000704', 'gene', 20, 'genetic'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]	0	['indeed,  autism, maternal childhood  bone abnormalities, referenced above, autism.']
S47-PMC2913107	PMC2913107	8/2010	S47-PMC2913107	['all that the current EPIDEMIC of maternal and early childhood Vitamin D deficiency does, with its resultant neural deficiency in the pluripotent Neurosteroid Calcitriol, is to ALLOW the Genetic TENDENCY for autism to Express itself.']	[('IMPORTANT_CONSIDERATION', 21), ('FUTURE_PREDICTION', 176), ('SUPERFICIAL_RELATIONSHIP', 194)]	3	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_47838', 'nitrile oxide', 145, 'neurosteroid'), ('CHEBI_17823', 'calcitriol', 158, 'calcitriol'), ('SO_0000704', 'gene', 186, 'genetic'), ('GO_0010467', 'gene expression', 217, 'express')]	0	['maternal childhood  does, resultant neural pluripotent neurosteroid calcitriol,  autism express itself.']
S120-PMC2963768	PMC2963768	10/2010	S120-PMC2963768	['hypothetical mechanisms that MAY CONTRIBUTE to risk of maternal-infant Vitamin D deficiency in south asiageneral mechanismexamples of specific HYPOTHESIZED mechanismsendogenous cutaneous Vitamin D Production\nconservative clothing practices (33)\nlimited time spent outdoors\ndark skin pigmentation (34)\ncloud-cover and outdoor air pollution (12)\ngeographic/Genetic/dietary factors that alter Epidermal 7-Dehydrocholesterol composition or concentrationdietary Vitamin D intake\ninadequate intake of Liver, eggs, fish, or fish oils, or fortified dairy products\ndiminished natural Vitamin d content of farmed fish (35)\nreduction in Vitamin D content of fish due to Cooking (e.g.']	[('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 143)]	3	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 187, 'vitamin D production'), ('PR_000006444', 'diacylglycerol kinase delta', 195, 'D'), ('SO_0000704', 'gene', 355, 'genetic'), ('UBERON_0007376', 'outer epithelium', 390, 'epidermal'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 400, '7-dehydrocholesterol'), ('CHEBI_27300', 'vitamin D', 457, 'vitamin D'), ('UBERON_0002107', 'liver', 495, 'liver'), ('CHEBI_33229', 'vitamin (role)', 575, 'vitamin'), ('CHEBI_27300', 'vitamin D', 626, 'vitamin D'), ('GO_0065007', 'biological regulation', 659, 'cooking')]	0	['hypothetical mechanisms maternal-infant  south asiageneral mechanismexamples mechanismsendogenous cutaneous  production\nconservative clothing practices (33)\nlimited spent outdoors\ndark skin pigmentation (34)\ncloud-cover outdoor air pollution (12)\ngeographic//dietary alter epidermal 7-dehydrocholesterol composition concentrationdietary  intake\ninadequate intake liver, eggs, fish, fish oils, fortified dairy products\ndiminished natural vitamin content farmed fish (35)\nreduction  content fish cooking (e.g.']
S124-PMC2963768	PMC2963768	10/2010	S124-PMC2963768	['Vitamin A (41)\nGenetic polymorphisms in Genes encoding proteins INVOLVED in Vitamin D Metabolism, e.g.']	[('SUPERFICIAL_RELATIONSHIP', 64)]	1	[('CHEBI_27300', 'vitamin D', 0, 'vitamin A'), ('SO_0000704', 'gene', 15, 'Genetic'), ('SO_0000704', 'gene', 40, 'genes'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 76, 'vitamin D metabolism')]	0	[' (41)\n polymorphisms  encoding proteins  metabolism, e.g.']
S137-PMC2963768	PMC2963768	10/2010	S137-PMC2963768	"['[""""a PLAUSIBLE HYPOTHESIS is that Vitamin D deficiency ACTS SYNERGISTICALLY with OTHER causes of INADEQUATE bone mineralization and that an Individual\'s 25(Oh)D concentration below which clinical signs emerge DEPENDS ON the severity and multiplicity of OTHER Genetic and environmental FACTORS.""""]']"	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 52), ('SUPERFICIAL_RELATIONSHIP', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 78), ('IMPORTANT_CONSIDERATION', 94), ('SUPERFICIAL_RELATIONSHIP', 206), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 250), ('SUPERFICIAL_RELATIONSHIP', 282)]	9	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('NCBITaxon_1', 'root', 137, 'individual'), ('CHEBI_71657', 'versiconol acetate', 150, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 150, '25 ... OH ... D'), ('SO_0000704', 'gene', 256, 'genetic')]	0	"['[""""a thn causes bone mineralization individual*s 25(oh)d concentration multiplicity othtic environmental factors.""""]']"
S0-PMC2996405	PMC2996405	11/2010	S0-PMC2996405	['schizophrenia and Vitamin D RELATED Genes COULD have been subject to latitude-driven adaptation\n\nabstract\n\nbackground\nmany natural phenomena are directly OR indirectly RELATED to latitude.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 154), ('SUPERFICIAL_RELATIONSHIP', 168)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('SO_0000704', 'gene', 36, 'genes')]	0	['schizophrenia   subject latitude-driven adaptation\n\nabstract\n\nbackground\nmany natural phenomena latitude.']
S9-PMC2996405	PMC2996405	11/2010	S9-PMC2996405	['in an ATTEMPT to try to EXPLAIN this POSSIBLE LINK between latitude and schizophrenia, we INVESTIGATED their ASSOCIATIONS with Vitamin D. we FOUND in a set of vitamin d related Genes a significant enrichment of both lrgs and of Genes INVOLVED in schizophrenia.']	[('DIFFICULT_TASK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('PROBABLE_UNDERSTANDING', 24), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 46), ('QUESTION_ANSWERED_BY_THIS_WORK', 90), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 141), ('SUPERFICIAL_RELATIONSHIP', 234)]	9	[('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('SO_0000704', 'gene', 177, 'genes'), ('SO_0000704', 'gene', 228, 'genes')]	0	['latitude schizophrenia, . set vitamin  enrichment lrgs  schizophrenia.']
S10-PMC2996405	PMC2996405	11/2010	S10-PMC2996405	['conclusions\nour results SUGGEST a latitude-driven adaptation for both schizophrenia and Vitamin D RELATED Genes.']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 98)]	2	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('SO_0000704', 'gene', 106, 'genes')]	0	['conclusions\nour results latitude-driven adaptation schizophrenia  .']
S103-PMC2996405	PMC2996405	11/2010	S103-PMC2996405	['an IMPORTANT factor HYPOTHESIZED to be both latitude DEPENDENT and Neural Development-RELATED is Vitamin D. we checked for an enrichment of lrgs in Vitamin D related (vdr) Genes by manually creating a list of 943 Genes that broadly comprised the most IMPORTANT processes in which it is INVOLVED, since a comprehensive list is not yet present in the literature (additional file4).']	[('IMPORTANT_CONSIDERATION', 3), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 86), ('IMPORTANT_CONSIDERATION', 251), ('SUPERFICIAL_RELATIONSHIP', 286)]	6	[('GO_0007399', 'nervous system development', 67, 'neural development'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 148, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 148, 'Vitamin'), ('SO_0000704', 'gene', 172, 'genes'), ('SO_0000704', 'gene', 213, 'genes')]	0	['latitude neural development-related . checked enrichment lrgs vitamin (vdr)  manually creating list 943  comprised processes involved, list (additional file4).']
S107-PMC2996405	PMC2996405	11/2010	S107-PMC2996405	"['[""""also the overlap of 70 Genes between vdr and schizophrenia RELATED Genes was significant (p-value 1.4 × 10-6, fisher\'s exact test; figure1and additional file3), CONFIRMING the ROLE of Vitamin D in schizophrenia pathogenesis.""""]']"	[('SUPERFICIAL_RELATIONSHIP', 59), ('PROBABLE_UNDERSTANDING', 161), ('SUPERFICIAL_RELATIONSHIP', 176)]	3	[('SO_0000704', 'gene', 23, 'genes'), ('SO_0000704', 'gene', 67, 'genes'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D')]	0	"['[""""also nes vdr schizophrenia relatnes (p-value 1.4 × 10-6, fisher*s exact test; figure1and file3), n schizophrenia pathogenesis.""""]']"
S108-PMC2996405	PMC2996405	11/2010	S108-PMC2996405	['finally, we found 9 Genes ( Smarca2, Mitf , Dlgap1 , Magi1 , Il4R , Ntrk3 , Runx1 , Ppp3Ca , and Inpp4B ) in common among those ones RELATED to latitude, Vitamin D and schizophrenia (figure1).']	[('SUPERFICIAL_RELATIONSHIP', 133)]	1	[('SO_0000704', 'gene', 20, 'genes'), ('PR_000000364', 'smad2', 28, 'SMARCA2'), ('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 37, 'MITF'), ('PR_000006560', 'dynein heavy chain 14, axonemal', 44, 'DLGAP1'), ('PR_000010068', 'melanoma-associated antigen B3', 53, 'MAGI1'), ('PR_000001470', 'interleukin-28B', 61, 'IL4R'), ('PR_000011459', 'neurotrophin-3', 68, 'NTRK3'), ('PR_000014339', 'radial spoke head 14 homolog', 76, 'RUNX1'), ('PR_000013060', 'peroxisome proliferator-activated receptor gamma coactivator 1-beta', 84, 'PPP3CA'), ('PR_000009020', 'Golgi-resident adenosine 3*,5*-bisphosphate 3*-phosphatase', 97, 'INPP4B'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]	0	['finally, 9  smarca2, mitf dlgap1 magi1 il4r ntrk3 runx1 ppp3ca inpp4b among ones latitude,  schizophrenia (figure1).']
S109-PMC2996405	PMC2996405	11/2010	S109-PMC2996405	['we checked WHETHER OR NOT in these 9 Genes belonged Snps, selected by our procedure, that were PREVIOUSLY studied in RELATIONSHIP to either schizophrenia or Vitamin D RELATED phenotypes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 117), ('SUPERFICIAL_RELATIONSHIP', 167)]	4	[('SO_0000704', 'gene', 37, 'genes'), ('SO_0000694', 'SNP', 52, 'SNPs'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]	0	['checked 9  belonged snps, selected procedure,  phenotypes.']
S153-PMC2996405	PMC2996405	11/2010	S153-PMC2996405	['TO TEST this LINK at a Genomic level, we created a hand-curated list of Genes that, at different levels, are RELATED to Vitamin D (see results; additional file4).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('SUPERFICIAL_RELATIONSHIP', 109)]	3	[('SO_0001026', 'genome', 23, 'genomic'), ('SO_0000704', 'gene', 72, 'genes'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 128, 'D')]	0	['genomic level, created hand-curated list  that, levels,  (see results; file4).']
S155-PMC2996405	PMC2996405	11/2010	S155-PMC2996405	['this result MAY SUGGEST that Vitamin D related Genes COULD have been subject, AT LEAST IN PART, to a latitude-DEPENDENT adaptation, SUPPORTING the HYPOTHESIS that selection also ACTED on OTHER mechanisms different from depigmentation.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 53), ('PROBABLE_UNDERSTANDING', 78), ('SUPERFICIAL_RELATIONSHIP', 110), ('INCOMPLETE_EVIDENCE', 132), ('INCOMPLETE_EVIDENCE', 147), ('SUPERFICIAL_RELATIONSHIP', 178), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 187)]	9	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('SO_0000704', 'gene', 47, 'genes')]	0	['result   subject, part, latitude-dependent adaptation, selection mechanisms depigmentation.']
S164-PMC2996405	PMC2996405	11/2010	S164-PMC2996405	['we FOUND a significant overlap of 70 Genes between schizophrenia and Vitamin D RELATED Genes (figure1and additional file3).']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 79)]	2	[('SO_0000704', 'gene', 37, 'genes'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('SO_0000704', 'gene', 87, 'genes')]	0	['70  schizophrenia   (figure1and file3).']
S167-PMC2996405	PMC2996405	11/2010	S167-PMC2996405	['it is THEREFORE POSSIBLE that the same Genes COULD BE Regulated by Vitamin D levels also in Neurons during Brain Development that, in turn, HAVE BEEN ASSOCIATED to schizophrenia [47].']	[('PROBABLE_UNDERSTANDING', 6), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 150)]	5	[('SO_0000704', 'gene', 39, 'genes'), ('GO_0065007', 'biological regulation', 54, 'regulated'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CL_0000540', 'neuron', 92, 'neurons'), ('GO_0007420', 'brain development', 107, 'brain development'), ('UBERON_0000955', 'brain', 107, 'brain')]	0	['  levels neurons brain that, turn, schizophrenia [47].']
S168-PMC2996405	PMC2996405	11/2010	S168-PMC2996405	['ACCORDING TO our HYPOTHESIS that Vitamin D COULD BE the LINK between latitude and schizophrenia, we FOCUSED on the 9 lrgs present in both the lists of Vitamin D and schizophrenia RELATED Genes (figure1).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 56), ('QUESTION_ANSWERED_BY_THIS_WORK', 100), ('SUPERFICIAL_RELATIONSHIP', 179)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('SO_0000704', 'gene', 187, 'genes')]	0	['according  latitude schizophrenia, 9 lrgs lists  schizophrenia  (figure1).']
S213-PMC2996405	PMC2996405	11/2010	S213-PMC2996405	['for similar REASONS, we expected that also the LINK between latitude and schizophrenia cannot be completely EXPLAINED by Vitamin D. for example, in the intersection between lrgs and Genes RELATED with schizophrenia (additional file3) there is a Gene INVOLVED in the Circadian Rhythms, timeless .']	[('PROBABLE_UNDERSTANDING', 12), ('SUPERFICIAL_RELATIONSHIP', 47), ('PROBABLE_UNDERSTANDING', 108), ('SUPERFICIAL_RELATIONSHIP', 188), ('SUPERFICIAL_RELATIONSHIP', 250)]	5	[('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('SO_0000704', 'gene', 182, 'genes'), ('SO_0000704', 'gene', 245, 'gene'), ('GO_0007623', 'circadian rhythm', 266, 'circadian rhythms')]	0	['reasons, latitude schizophrenia . example, intersection lrgs  schizophrenia (additional file3)  circadian rhythms, timeless .']
S224-PMC2996405	PMC2996405	11/2010	S224-PMC2996405	['the ONLY EXCEPTION is the list of Vitamin D related Genes that we had to build ex novo since no others were present in literature.']	[('ANOMALY_CURIOUS_FINDING', 4), ('ANOMALY_CURIOUS_FINDING', 9)]	2	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('SO_0000704', 'gene', 52, 'genes')]	0	['list   ex novo literature.']
S249-PMC2996405	PMC2996405	11/2010	S249-PMC2996405	['conclusions\nwe FOUND that frequencies of Genetic variants INVOLVED in Brain Development, schizophrenia and Vitamin D-RELATED processes significantly vary with latitude.']	[('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 58), ('SUPERFICIAL_RELATIONSHIP', 117)]	3	[('SO_0000704', 'gene', 41, 'genetic'), ('GO_0007420', 'brain development', 70, 'brain development'), ('UBERON_0000955', 'brain', 70, 'brain'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]	0	['conclusions\nwe frequencies  variants brain development, schizophrenia -related processes latitude.']
S266-PMC2996405	PMC2996405	11/2010	S266-PMC2996405	['the list of Vitamin D related Genes was manually created by merging three different lists of Genes RELATED in different ways to Vitamin D (additional file4).']	[('SUPERFICIAL_RELATIONSHIP', 99)]	1	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('SO_0000704', 'gene', 30, 'genes'), ('SO_0000704', 'gene', 93, 'genes'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]	0	['list   manually created merging three lists   (additional file4).']
S269-PMC2996405	PMC2996405	11/2010	S269-PMC2996405	['finally, CANDIDATE transcriptional target Genes of Vitamin D were obtained from a set of Genes differentially Expressed in scc25 cells treated with 1,25(Oh)2D3By a Genome-wide microarray analysis [56].']	[('INCOMPLETE_EVIDENCE', 9)]	1	[('SO_0000704', 'gene', 42, 'genes'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('SO_0000704', 'gene', 89, 'genes'), ('GO_0010467', 'gene expression', 110, 'expressed'), ('CHEBI_79988', 'Sobetirome', 148, '1,25(OH)2D3by'), ('SO_0001026', 'genome', 164, 'genome')]	0	['finally, transcriptional   set  expressed scc25 cells treated 1,25(oh)2d3by genome-wide microarray [56].']
S10-PMC3075531	PMC3075531	7/2010	S10-PMC3075531	['introduction\nmultiple sclerosis (ms) is a chronic PROBABLY with Autoimmune basis and UNCERTAIN etiology characterized by Demyelinative and inflammatory physiopathology causing Axonal damages.12this disease AFFECTS females more than males with ordinary 10 years Relapsing-remitting course and secondary progressive phase.2on histological basis, T Helper Cells type 1 (th1) is the MOST RESPONSIBLE cause for pathologies SEEN in ms.1–3there are multiple RISK FACTORS for ms in a COMPLEX RELATIONSHIP with each other from Genetic ones to environmental FACTORS BUT exact mechanism leading to ms has REMAINED UNCLEAR yet.45from GUESSED environmental RISK FACTORS for ms, past infection with Ebv, smoking and low Serum level of Vitamin D are more favorable.67the MOST IMPORTANT Vitamin in calcium and Phosphor Homeostasis is Vitamin D. this Vitamin has PROPOSED POTENTIAL power for Modulating Immune System.48this is achieved via enhancing the Phagocytic function of Monocytes9And decreasing the secretion of Il-6, Il-12, Tnf-Α and Pge2 by Monocytes.10also, immature or semi mature Apc’S cannot mature in presence of 1,25 (Oh)2D.8MANY STUDIES SHOWED a ROLE of paracrine function and Nerve Growth Factor Synthesis Of Vitamin D in Cns and also, SHOWED that deficiency of this Vitamin in Pregnancy Period CAN cause Neural System disorder in Animal cases.811–14then, Vitamin D has a near RELATION with ms and the results of DIFFERENT studies can be summarized as follows: first, the EFFECT of latitude via exposure to sun light and Serum level of Vitamin D on ms prevalence, that increases with distance from equator, with ONLY one EXCEPTION in norway.23815second, vander et al.']	[('PROBABLE_UNDERSTANDING', 50), ('FULL_UNKNOWN', 85), ('SUPERFICIAL_RELATIONSHIP', 206), ('PROBABLE_UNDERSTANDING', 379), ('PROBABLE_UNDERSTANDING', 384), ('INCOMPLETE_EVIDENCE', 418), ('SUPERFICIAL_RELATIONSHIP', 451), ('DIFFICULT_TASK', 476), ('SUPERFICIAL_RELATIONSHIP', 484), ('SUPERFICIAL_RELATIONSHIP', 548), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 556), ('INCOMPLETE_EVIDENCE', 594), ('FULL_UNKNOWN', 603), ('INCOMPLETE_EVIDENCE', 622), ('SUPERFICIAL_RELATIONSHIP', 644), ('PROBABLE_UNDERSTANDING', 756), ('IMPORTANT_CONSIDERATION', 761), ('INCOMPLETE_EVIDENCE', 846), ('INCOMPLETE_EVIDENCE', 855), ('INCOMPLETE_EVIDENCE', 1123), ('INCOMPLETE_EVIDENCE', 1136), ('SUPERFICIAL_RELATIONSHIP', 1145), ('INCOMPLETE_EVIDENCE', 1236), ('INCOMPLETE_EVIDENCE', 1295), ('SUPERFICIAL_RELATIONSHIP', 1377), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1413), ('SUPERFICIAL_RELATIONSHIP', 1472), ('ANOMALY_CURIOUS_FINDING', 1612), ('ANOMALY_CURIOUS_FINDING', 1621)]	29	[('UBERON_0001442', 'skeleton of manus', 64, 'autoimmune'), ('GO_0006188', 'IMP biosynthetic process', 121, 'demyelinative'), ('GO_0030424', 'axon', 176, 'axonal'), ('GO_0065007', 'biological regulation', 261, 'relapsing'), ('CL_0000545', 'T-helper 1 cell', 344, 'T helper cells'), ('SO_0000704', 'gene', 518, 'genetic'), ('NCBITaxon_10088', 'Mus <genus>', 685, 'EBV'), ('UBERON_0001977', 'blood serum', 706, 'serum'), ('CHEBI_27300', 'vitamin D', 721, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 771, 'vitamin'), ('CHEBI_30215', 'muonide', 794, 'phosphor'), ('GO_0042592', 'homeostatic process', 803, 'homeostasis'), ('CHEBI_27300', 'vitamin D', 818, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 834, 'vitamin'), ('GO_0065007', 'biological regulation', 875, 'modulating'), ('UBERON_0002405', 'immune system', 886, 'immune system'), ('GO_0006909', 'phagocytosis', 937, 'phagocytic'), ('CL_0002198', 'oncocyte', 960, 'monocytes9and'), ('PR_000001470', 'interleukin-28B', 1002, 'IL-6'), ('PR_000001470', 'interleukin-28B', 1008, 'IL-12'), ('PR_000000134', 'tumor necrosis factor alpha', 1015, 'TNF-α'), ('PR_000012560', 'peroxisomal membrane protein PEX14', 1025, 'PGE2'), ('CL_0000576', 'monocyte', 1033, 'monocytes'), ('PR_000004122', 'adenomatous polyposis coli protein', 1075, 'APC'), ('PR_000011000', 'N-alpha-acetyltransferase 60', 1079, 's'), ('CHEBI_82784', 'PVP38-Ag NP', 1110, '1,25 (OH)2D'), ('UBERON_0001021', 'nerve', 1176, 'nerve'), ('GO_0040007', 'growth', 1182, 'growth factor'), ('GO_0030474', 'spindle pole body duplication', 1196, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 1209, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 1222, 'CNS'), ('CHEBI_33229', 'vitamin (role)', 1267, 'vitamin'), ('GO_0007565', 'female pregnancy', 1278, 'pregnancy'), ('UBERON_0018298', 'stylocone', 1278, 'pregnancy period'), ('UBERON_0023879', 'neural system', 1305, 'neural system'), ('NCBITaxon_33208', 'Metazoa', 1331, 'animal'), ('CHEBI_27300', 'vitamin D', 1356, 'vitamin D'), ('UBERON_0001977', 'blood serum', 1521, 'serum'), ('CHEBI_27300', 'vitamin D', 1536, 'vitamin D')]	0	['introduction\nmultiple sclerosis (ms) chronic autoimmune etiology demyelinative inflammatory physiopathology axonal damages.12this disease females males ordinary 10 relapsing-remitting course secondary progressive phase.2on histological basis, helper cells type (th1) pathologies ms.1–3there ms  ones environmental exact ms yet.45from environmental ms, infection ebv, smoking serum  favorable.67the vitamin calcium phosphor homeostasis . vitamin immune system.48this achieved via phagocytic monocytes9and decreasing secretion il-6, il-12, tnf-α pge2 monocytes.10also, immature semi mature apc’s mature presence 1,25 (oh)2d.8many paracrine nerve synthesis  cns also, vitamin pregnancy period neural system disorder animal cases.811–14then,  ms results follows: first, latitude via exposure sun serum  ms prevalence, distance equator, norway.23815second, vander et al.']
S43-PMC3075531	PMC3075531	7/2010	S43-PMC3075531	['relative to sun exposure, diet is a POOR source of Colecalciferol, providing ONLY 40-400 iu per Food serving,12WHEREAS whole-body uvb exposure for 20 min for a light-skinned Person during the summer months will produce AT LEAST 10,000 iu.713HOWEVER, increased skin pigmentation, age, use of sunscreen, built environment, and environmental FACTORS that reduce the strength of uvb reaching the earth’s surface (e.g., winter season, high latitude, pollution, cloud cover, and Ozone levels) all CONTRIBUTE to reduce skin Colecalciferol production to the point at which diet MIGHT become the primary source.7–14BECAUSE Melanin Pigment in Human skin absorbs uvb,28black People have lower 25 Hydroxyvitamin D concentrations than white People, and are OFTEN Vitamin D deficient.21HOWEVER, the risk of ms in black People is lower than in white People (BECAUSE of Genetic differences).28analyses of the RELATION between Vitamin D status and ms risk are THEREFORE BETTER done separately within each race/ethnic group.']	[('IMPORTANT_CONSIDERATION', 36), ('ANOMALY_CURIOUS_FINDING', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('PROBABLE_UNDERSTANDING', 219), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 241), ('SUPERFICIAL_RELATIONSHIP', 339), ('SUPERFICIAL_RELATIONSHIP', 491), ('INCOMPLETE_EVIDENCE', 570), ('PROBABLE_UNDERSTANDING', 606), ('PROBABLE_UNDERSTANDING', 744), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 772), ('PROBABLE_UNDERSTANDING', 843), ('SUPERFICIAL_RELATIONSHIP', 893), ('PROBABLE_UNDERSTANDING', 943), ('IMPORTANT_CONSIDERATION', 953)]	15	[('CHEBI_50553', 'mancude carbobicyclic parent', 51, 'colecalciferol'), ('CHEBI_33290', 'food', 96, 'food'), ('NCBITaxon_10088', 'Mus <genus>', 174, 'person'), ('CHEBI_25812', 'ozone', 473, 'ozone'), ('CHEBI_50553', 'mancude carbobicyclic parent', 517, 'colecalciferol'), ('CHEBI_25179', 'melanins', 614, 'melanin'), ('CHEBI_26130', 'biological pigment', 622, 'pigment'), ('NCBITaxon_9606', 'Homo sapiens', 633, 'human'), ('NCBITaxon_10088', 'Mus <genus>', 664, 'people'), ('CHEBI_67828', 'rel-(3aR,4S,6aS,7R,9aR,10aS)-10a-Hydroxy-7-isopropyl-1,4,9a-trimethyl-4,5,6,6a,7,8,9,9a,10,10a-decahydro-3aH-dicyclopenta[a,d]cycloocten-3-one', 682, '25 hydroxyvitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 728, 'people'), ('CHEBI_27300', 'vitamin D', 750, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 805, 'people'), ('NCBITaxon_10088', 'Mus <genus>', 835, 'people'), ('SO_0000704', 'gene', 854, 'genetic'), ('CHEBI_27300', 'vitamin D', 910, 'vitamin D')]	0	['relative sun exposure, diet colecalciferol, 40-400 iu food serving,12whereas whole-body uvb exposure 20 min light-skinned person summer months produce 10,000 iu.713however, skin pigmentation, age, sunscreen, built environment, environmental uvb reaching earth’s surface (e.g., winter season, latitude, pollution, cover, ozone levels) skin colecalciferol production diet source.7–14because melanin pigment human skin absorbs uvb,28black people 25 hydroxyvitamin concentrations white people,  deficient.21however, ms black people white people (because  differences).28analyses  status ms done separately race/ethnic group.']
S56-PMC3075531	PMC3075531	7/2010	S56-PMC3075531	['Genes also CAN AFFECT Vitamin D Metabolism, skin color, and behavior, all of which CAN INFLUENCE circulating 25-Hydroxyvitamin D concentrations.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 87)]	4	[('SO_0000704', 'gene', 0, 'Genes'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 22, 'vitamin D metabolism'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 109, '25-hydroxyvitamin D')]	0	['  metabolism, skin color, behavior, circulating 25-hydroxyvitamin concentrations.']
S57-PMC3075531	PMC3075531	7/2010	S57-PMC3075531	['furthermore, Genetic variations in Vitamin-D-related and other Genes MIGHT INFLUENCE the EFFECTS of Vitamin D on the Immune System.']	[('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 75), ('SUPERFICIAL_RELATIONSHIP', 89)]	3	[('SO_0000704', 'gene', 13, 'genetic'), ('CHEBI_83326', 'tedizolid phosphate', 35, 'vitamin-D'), ('SO_0000704', 'gene', 63, 'genes'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('UBERON_0002405', 'immune system', 117, 'immune system')]	0	['furthermore,  vitamin-d-related   immune system.']
S58-PMC3075531	PMC3075531	7/2010	S58-PMC3075531	['THEREFORE, Genetic variations in Vitamin-D-related Genes MIGHT also AFFECT ms risk, EITHER directly OR by modifying the EFFECTS of Vitamin D.40\nour IMPLICATIONS for FUTURE RESEARCH and ms prevention and ACCORDING TO the basis of the results of the ONLY longitudinal study of Serum 25-Hydroxyvitamin D and ms onset,18and ASSUM-ING that these results are unbiased and Vitamin D is TRULY PROTECTIVE against ms, over 70% of ms cases in the usa and europe COULD BE PREVENTED by increasing the Serum 25-Hydroxyvitamin D concentration of adolescents and young Adults to above 100 nmol/l.4142these concentrations are commonly FOUND ONLY in Individuals with outdoor lifestyles in sunny regions, BUT COULD BE reached in MOST People by taking 1000-4000 iu Colecalciferol daily.8254344ALTHOUGH these doses are LARGELY CONSIDERED SAFE and POTENTIALLY beneficial for other outcomes,819CONFIRMATION of SAFETY and efficacy in a LARGE randomized TRIAL is NEEDED before making general RECOMMENDATIONS.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 84), ('SUPERFICIAL_RELATIONSHIP', 120), ('IMPORTANT_CONSIDERATION', 148), ('FUTURE_WORK', 165), ('INCOMPLETE_EVIDENCE', 203), ('INCOMPLETE_EVIDENCE', 248), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 320), ('PROBABLE_UNDERSTANDING', 379), ('SUPERFICIAL_RELATIONSHIP', 385), ('INCOMPLETE_EVIDENCE', 451), ('SUPERFICIAL_RELATIONSHIP', 460), ('INCOMPLETE_EVIDENCE', 618), ('ANOMALY_CURIOUS_FINDING', 624), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 686), ('INCOMPLETE_EVIDENCE', 690), ('PROBABLE_UNDERSTANDING', 710), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 773), ('INCOMPLETE_EVIDENCE', 798), ('INCOMPLETE_EVIDENCE', 806), ('IMPORTANT_CONSIDERATION', 817), ('INCOMPLETE_EVIDENCE', 826), ('INCOMPLETE_EVIDENCE', 871), ('IMPORTANT_CONSIDERATION', 887), ('INCOMPLETE_EVIDENCE', 912), ('FUTURE_WORK', 938), ('FUTURE_WORK', 967)]	29	[('SO_0000704', 'gene', 11, 'genetic'), ('CHEBI_83326', 'tedizolid phosphate', 33, 'vitamin-D'), ('SO_0000704', 'gene', 51, 'genes'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('UBERON_0001977', 'blood serum', 275, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 281, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 366, 'vitamin D'), ('UBERON_0001977', 'blood serum', 488, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 494, '25-hydroxyvitamin D'), ('UBERON_0007023', 'adult organism', 553, 'adults'), ('NCBITaxon_1', 'root', 632, 'individuals'), ('NCBITaxon_10088', 'Mus <genus>', 715, 'people'), ('CHEBI_50553', 'mancude carbobicyclic parent', 745, 'colecalciferol')]	0	['therefore,  vitamin-d-related  ms risk, modifying .40\nour ms results longitudinal serum 25-hydroxyvitamin ms onset,18and results  ms, 70% ms cases usa europe serum 25-hydroxyvitamin concentration adolescents young adults 100 nmol/l.4142these concentrations individuals outdoor lifestyles sunny regions, people 1000-4000 iu colecalciferol daily.8254344although doses outcomes,819confirmation recommendations.']
S61-PMC3075531	PMC3075531	7/2010	S61-PMC3075531	['conclusions\nin conclusion, THIS STUDY SHOWED that Serum Vitamin D deficiency MIGHT be a POTENTIAL environmental predisposing FACTOR for developing multiple sclerosis in our region, and NEED to follow FACTORS that cause THIS PROBLEM including dietary, Genetic, and other ones.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 125), ('IMPORTANT_CONSIDERATION', 185), ('SUPERFICIAL_RELATIONSHIP', 200), ('QUESTION_ANSWERED_BY_THIS_WORK', 219), ('IMPORTANT_CONSIDERATION', 224)]	9	[('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('SO_0000704', 'gene', 251, 'genetic')]	0	['conclusions\nin conclusion, serum  environmental sclerosis region, dietary, ones.']
S62-PMC3075531	PMC3075531	7/2010	S62-PMC3075531	['WHEREAS FUTURE observational epidemiological studies and Genetic and molecular INVESTIGATIONS WILL be useful to strengthen and refine the HYPOTHESIS, it MIGHT be NECESSARY to do a LARGE randomized TRIAL to establish the SAFETY and efficacy NEEDED to promote large-scale Vitamin D supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 8), ('FUTURE_WORK', 79), ('FUTURE_PREDICTION', 94), ('INCOMPLETE_EVIDENCE', 138), ('INCOMPLETE_EVIDENCE', 153), ('IMPORTANT_CONSIDERATION', 162), ('FUTURE_WORK', 180), ('IMPORTANT_CONSIDERATION', 220), ('FUTURE_WORK', 240)]	10	[('SO_0000704', 'gene', 57, 'genetic'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D')]	0	['whereas epidemiological  molecular hypothesis,  supplementation.']
S129-PMC3257641	PMC3257641	3/2010	S129-PMC3257641	['Genes of the Vitamin D pathway (25 Hydroxylase, 1Α Hydroxylase and 24 Hydroxylase) and vdr are Expressed in Rat Brain Cells [99] and the distribution of Vdr and 1Α hydroxylase IS THOUGHT TO be SIMILAR in Rat and Human Brains [100].']	[('INCOMPLETE_EVIDENCE', 176), ('INCOMPLETE_EVIDENCE', 179), ('SUPERFICIAL_RELATIONSHIP', 193)]	3	[('SO_0000704', 'gene', 0, 'Genes'), ('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('PR_000003664', 'acyl-coenzyme A synthetase ACSM1, mitochondrial', 32, '25 hydroxylase'), ('PR_000003753', 'adenylate cyclase type 2', 48, '1α hydroxylase'), ('PR_000003664', 'acyl-coenzyme A synthetase ACSM1, mitochondrial', 67, '24 hydroxylase'), ('GO_0010467', 'gene expression', 95, 'expressed'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 108, 'rat'), ('CL_0000312', 'keratinocyte', 112, 'brain cells'), ('UBERON_0000955', 'brain', 112, 'brain'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 153, 'VDR'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 161, '1α'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 204, 'rat'), ('NCBITaxon_9606', 'Homo sapiens', 212, 'human'), ('UBERON_0000955', 'brain', 218, 'brains')]	0	['  (25 hydroxylase, 1α hydroxylase 24 hydroxylase) vdr expressed rat brain cells [99] distribution vdr 1α hydroxylase rat human brains [100].']
S70-PMC3277098	PMC3277098	12/2011	S70-PMC3277098	['the exact physiological mechanisms behind these OBSERVATIONS REMAINS unanswered, however there is GROWING EVIDENCE of Genetic variability that Modulates sensitivity to, and EFFECTS of, Vitamin D exposure.']	[('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 98), ('SUPERFICIAL_RELATIONSHIP', 173)]	4	[('SO_0000704', 'gene', 118, 'genetic'), ('GO_0065007', 'biological regulation', 143, 'modulates'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]	0	['exact physiological mechanisms behind unanswered,  sensitivity to, of,  exposure.']
S201-PMC3277098	PMC3277098	12/2011	S201-PMC3277098	['FUTURE RESEARCH MUST accurately account for the DIFFERENT sources of Vitamin D, stage of Immune Development and Genetic FACTORS in order to understand the immunological consequences of changing Vitamin d status through supplementation or lifestyle changes.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('SUPERFICIAL_RELATIONSHIP', 120)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0001822', 'kidney development', 89, 'immune development'), ('UBERON_0002405', 'immune system', 89, 'immune'), ('SO_0000704', 'gene', 112, 'genetic'), ('CHEBI_33229', 'vitamin (role)', 194, 'vitamin')]	0	['future sources immune  immunological changing vitamin status supplementation lifestyle changes.']
S204-PMC3277098	PMC3277098	12/2011	S204-PMC3277098	['there is MUCH EVIDENCE to SHOW Vitamin D AFFECTS Differentiation and Proliferation Of Immune Cells [2,24,25] and that Genetic polymorphisms, including of vdr and Vdbp , MAY CONTRIBUTE to disease susceptibility [42,78,79,80,81].']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 169), ('SUPERFICIAL_RELATIONSHIP', 173)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0030254', 'protein secretion by the type III secretion system', 49, 'differentiation ...'), ('GO_0008283', 'cell proliferation', 69, 'proliferation of ... cells'), ('CL_0000738', 'leukocyte', 86, 'immune cells'), ('UBERON_0002405', 'immune system', 86, 'immune'), ('SO_0000704', 'gene', 118, 'genetic'), ('PR_000017279', 'testis-specific basic protein Y 1', 162, 'VDBP')]	0	[' proliferation immune cells [2,24,25]  polymorphisms, vdr vdbp disease [42,78,79,80,81].']
S83-PMC3296991	PMC3296991	2/2012	S83-PMC3296991	['polymorphisms in the Vitamin D Receptor Gene MAY CONTRIBUTE to racial DISPARITIES in fetal growth and bone mineralization [20,21], although ADDITIONAL RESEARCH IS WARRANTED in this area.']	[('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 70), ('FUTURE_WORK', 140), ('FUTURE_WORK', 151)]	5	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 21, 'vitamin D receptor'), ('SO_0000704', 'gene', 40, 'gene')]	0	['polymorphisms  receptor  racial fetal bone mineralization [20,21], area.']
S63-PMC3347028	PMC3347028	3/2012	S63-PMC3347028	['vdre are found ONLY in the Ll-37 Gene Promoters of Primates, SUGGESTING that the ability of Vitamin D to promote Ll-37 antibacterial action is a relatively recent event in evolution.']	[('ANOMALY_CURIOUS_FINDING', 15), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 61)]	3	[('PR_000009809', 'leukocyte immunoglobulin-like receptor subfamily B member 2', 27, 'LL-37'), ('SO_0000704', 'gene', 33, 'gene'), ('SO_0000167', 'promoter', 38, 'promoters'), ('NCBITaxon_33208', 'Metazoa', 51, 'primates'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('PR_000009809', 'leukocyte immunoglobulin-like receptor subfamily B member 2', 113, 'LL-37')]	0	['vdre ll-37  promoters primates, ability  ll-37 antibacterial event evolution.']
S234-PMC3347028	PMC3347028	3/2012	S234-PMC3347028	['in those women with a specific Genetic repertoire—affinity for Vitamin D and receptor processing—Vitamin D deficiency MAY very well be the LOST KEY to stopping the Cascade of Events.']	[('INCOMPLETE_EVIDENCE', 118), ('IMPORTANT_CONSIDERATION', 139), ('IMPORTANT_CONSIDERATION', 144)]	3	[('SO_0000704', 'gene', 31, 'genetic'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0055097', 'high density lipoprotein particle mediated signaling', 164, 'cascade'), ('GO_0006897', 'endocytosis', 175, 'events')]	0	['women  repertoire—affinity  receptor processing— stopping cascade events.']
S18-PMC3348565	PMC3348565	4/2012	S18-PMC3348565	['HOWEVER, the risk of repeated pneumonia in the subsequent 3 months was 13% (relative risk [rr] 0·78, 95% ci 0·64–0·94; p=0·01) lower in the Vitamin D3Compared with the placebo group.3OTHER more RECENT STUDIES assessing different outcomes in children or Adults have CONFLICTING findings on the effectiveness of Vitamin D.\nthere is GROWING EVIDENCE of the Vitamin D parancrine system enhancing Innate Immunity:4the activation of toll-like receptors on Monocytes and Macrophages by Microbial pathogens results in increased Expression of Cyp27B1 and Vitamin D Receptor ( vdr ) Genes within these cells.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 183), ('INCOMPLETE_EVIDENCE', 194), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 265), ('INCOMPLETE_EVIDENCE', 330)]	6	[('CHEBI_59884', 'XDP(3-)', 140, 'vitamin D3compared'), ('UBERON_0007023', 'adult organism', 253, 'adults'), ('CHEBI_27300', 'vitamin D', 310, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 354, 'vitamin D'), ('GO_0045087', 'innate immune response', 392, 'innate immunity'), ('CL_0000576', 'monocyte', 450, 'monocytes'), ('CL_0000235', 'macrophage', 464, 'macrophages'), ('NCBITaxon_10088', 'Mus <genus>', 479, 'microbial'), ('GO_0010467', 'gene expression', 520, 'expression'), ('PR_000006101', 'cytochrome P450 1A1', 534, 'CYP27B1'), ('CHEBI_27300', 'vitamin D', 546, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 546, 'vitamin D receptor'), ('SO_0000704', 'gene', 573, 'genes')]	0	['however, pneumonia 3 months 13% (relative [rr] 0·78, 95% ci 0·64–0·94; p=0·01) vitamin d3compared placebo group.3other outcomes children adults .\nthere  parancrine system innate immunity:4the activation toll-like receptors monocytes macrophages microbial pathogens results expression cyp27b1  receptor vdr  cells.']
S32-PMC3356951	PMC3356951	4/2012	S32-PMC3356951	['[614–16] the local Production Of 1,25(Oh)2D MAY BE responsible for Regulating up to 200 Genes[17] that MAY facilitate MANY of the pleiotropic health benefits that HAVE BEEN REPORTED for Vitamin D.[38914]\n\nVitamin D deficiency: prevalence\nvdd HAS BEEN historically defined and RECENTLY RECOMMENDED by the institute of medicine (iom) AS a 25(Oh)D of less than 0.8 iu.']	[('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 163), ('INCOMPLETE_EVIDENCE', 242), ('INCOMPLETE_EVIDENCE', 276), ('FUTURE_WORK', 285), ('PROBABLE_UNDERSTANDING', 332)]	8	[('GO_0008283', 'cell proliferation', 19, 'production of ... )2D'), ('CHEBI_37958', 'dye', 33, '1,'), ('CHEBI_66212', '5,7,3*,4*-tetrahydroxy-2*-(3,3-dimethylallyl)isoflavone', 35, '25(OH)2D'), ('GO_0065007', 'biological regulation', 67, 'regulating'), ('SO_0000704', 'gene', 88, 'genes'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 205, 'Vitamin D'), ('CHEBI_71657', 'versiconol acetate', 337, '25(OH)D')]	0	['[614–16] local production 1,25(oh)2d 200 [17] pleiotropic .[38914]\n\nvitamin deficiency: prevalence\nvdd institute medicine (iom) 25(oh)d 0.8 iu.']
S21-PMC3395583	PMC3395583	7/2012	S21-PMC3395583	['DESPITE these DIFFERENCES, an abnormal Activation Of the Immune System is a common thread LINKING these conditions and several OBSERVATIONS INDICATE that similar Genetic pathways and environmental agents, such as Vitamin D deficiency, smoking behaviour and various infections, are INVOLVED in the pathogenesis of these disorders [18-20,22-25].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('SUPERFICIAL_RELATIONSHIP', 90), ('INCOMPLETE_EVIDENCE', 127), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 281)]	7	[('GO_0000103', 'sulfate assimilation', 39, 'activation of ... immune system'), ('UBERON_0002405', 'immune system', 57, 'immune system'), ('SO_0000704', 'gene', 162, 'genetic'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]	0	['despite differences, abnormal activation immune system thread conditions  environmental agents,  deficiency, smoking behaviour infections, pathogenesis disorders [18-20,22-25].']
S89-PMC3395583	PMC3395583	7/2012	S89-PMC3395583	['furthermore, in utero Vitamin D deficiency has a significant EFFECT on the developing Immune System and our group has RECENTLY SHOWN that Genes ASSOCIATED with ms, ra, cd, sle and t1d are significantly enriched for Vitamin D receptor Binding Sites [44-46].']	[('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 144)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0002405', 'immune system', 86, 'immune system'), ('SO_0000704', 'gene', 138, 'genes'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 223, 'D'), ('SO_0000409', 'binding_site', 234, 'binding sites')]	0	['furthermore, utero  immune system  ms, ra, cd, sle t1d enriched  receptor binding sites [44-46].']
S91-PMC3395583	PMC3395583	7/2012	S91-PMC3395583	['it MAY BE that in utero Vitamin D deficiency, in conjunction with individual Genetic variation and subsequent exposure to other environmental agents, MAY then LEAD TO disease specificity.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 150), ('SUPERFICIAL_RELATIONSHIP', 159)]	3	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('SO_0000704', 'gene', 77, 'genetic')]	0	['utero  deficiency, individual  exposure environmental agents, disease specificity.']
S262-PMC3407995	PMC3407995	7/2012	S262-PMC3407995	['polymorphisms in the Vitamin D Receptor Gene MAY CONTRIBUTE to Vitamin D-RELATED DISPARITIES in foetal growth [141].']	[('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 49), ('SUPERFICIAL_RELATIONSHIP', 73), ('IMPORTANT_CONSIDERATION', 81)]	4	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 21, 'vitamin D receptor'), ('SO_0000704', 'gene', 40, 'gene'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]	0	['polymorphisms  receptor  -related foetal [141].']
S183-PMC3424155	PMC3424155	8/2012	S183-PMC3424155	['research SUGGESTS that Vitamin D is IMPORTANT for differentiation and maturation during Cell Proliferation[9]and that it down-regulates Renin Gene Expression in the Kidneys[13].']	[('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 36)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0008283', 'cell proliferation', 88, 'cell proliferation'), ('PR_000014368', 'RuvB-like 1', 136, 'renin'), ('GO_0010467', 'gene expression', 142, 'gene expression'), ('SO_0000704', 'gene', 142, 'gene'), ('UBERON_0002113', 'kidney', 165, 'kidneys')]	0	['research  maturation cell proliferation[9]and down-regulates renin  expression kidneys[13].']
S15-PMC3427192	PMC3427192	4/2012	S15-PMC3427192	['vdrs are Expressed on a variety of Airway Immune Cells, where they function as classic Nuclear Steroid Hormone receptors and ultimately Regulate the transcription of numerous Genes associated with inflammation and Immunomodulation.27vitamin d also plays an IMPORTANT ROLE in Respiratory infection by facilitating Toll-Like Receptor Signaling through increased Synthesis of Human Cathelicidin Antimicrobial peptide,28-30which is cleaved to generate the active Cationic peptide, Ll-37.31,32vitamin D also exerts direct EFFECTS on target cells independent of Gene transcription33and MAY THEREFORE be of relevance to Airway inflammatory disorders.34while Vitamin D can suppress il-1735and Il-4-mediated Expression of Il-13,35,36it CAN also shift the th1/th2 balance toward th2 dominance.37THESE CONTRADICTORY actions MAY BE DUE to the direct actions of Vitamin D on cd4+T Cells to promote an Il-10-secreting T-Regulatory population.38\n\nBiosynthesis Of Vitamin D\nBiosynthesis Of Vitamin D begins PRIMARILY with absorption of solar ultravoilet-b (uvb) radiation and secondarily via Consumption of Vitamin D-rich and fortified foods, such as oily fish, fortified grains and dairy products.26following exposure to uvb radiation, 7-Dehydrocholesterol within the skin is converted to Previtamin D3( fig.']	[('IMPORTANT_CONSIDERATION', 257), ('SUPERFICIAL_RELATIONSHIP', 267), ('SUPERFICIAL_RELATIONSHIP', 517), ('INCOMPLETE_EVIDENCE', 580), ('PROBABLE_UNDERSTANDING', 584), ('INCOMPLETE_EVIDENCE', 727), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 783), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 791), ('INCOMPLETE_EVIDENCE', 813), ('IMPORTANT_CONSIDERATION', 820), ('PROBABLE_UNDERSTANDING', 991)]	11	[('GO_0010467', 'gene expression', 9, 'expressed'), ('UBERON_0001005', 'respiratory airway', 35, 'airway'), ('CL_0000738', 'leukocyte', 42, 'immune cells'), ('UBERON_0002405', 'immune system', 42, 'immune'), ('GO_0005634', 'nucleus', 87, 'nuclear'), ('CHEBI_26764', 'steroid hormone', 95, 'steroid hormone'), ('GO_0065007', 'biological regulation', 136, 'regulate'), ('SO_0000704', 'gene', 175, 'genes'), ('GO_0050900', 'leukocyte migration', 214, 'immunomodulation'), ('UBERON_0001004', 'respiratory system', 275, 'respiratory'), ('GO_0002770', 'T cell inhibitory signaling pathway', 313, 'Toll-like receptor signaling'), ('GO_0009057', 'macromolecule catabolic process', 360, 'synthesis'), ('NCBITaxon_9606', 'Homo sapiens', 373, 'human'), ('PR_000006009', 'alpha-catulin', 379, 'cathelicidin'), ('CHEBI_65381', 'albizoside C', 392, 'antimicrobial'), ('CHEBI_36916', 'cation', 459, 'cationic'), ('PR_000009809', 'leukocyte immunoglobulin-like receptor subfamily B member 2', 477, 'LL-37'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 496, 'D'), ('SO_0000704', 'gene', 556, 'gene'), ('UBERON_0001005', 'respiratory airway', 613, 'airway'), ('CHEBI_27300', 'vitamin D', 651, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 685, 'IL-4'), ('GO_0010467', 'gene expression', 699, 'expression'), ('PR_000001470', 'interleukin-28B', 713, 'IL-13'), ('CHEBI_27300', 'vitamin D', 849, 'vitamin D'), ('CL_0000084', 'T cell', 866, 'T cells'), ('PR_000001470', 'interleukin-28B', 888, 'IL-10'), ('CL_0000895', 'naive thymus-derived CD4-positive, alpha-beta T cell', 904, 'T'), ('CL_0000232', 'erythrocyte', 906, 'regulatory'), ('GO_0065007', 'biological regulation', 906, 'regulatory'), ('GO_0033593', 'BRCA2-MAGE-D1 complex', 932, 'Biosynthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 948, 'vitamin D'), ('GO_0033593', 'BRCA2-MAGE-D1 complex', 958, 'Biosynthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 974, 'vitamin D'), ('GO_0007631', 'feeding behavior', 1076, 'consumption'), ('CHEBI_27300', 'vitamin D', 1091, 'vitamin D'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 1221, '7-dehydrocholesterol'), ('PR_000014709', 'neuroserpin', 1274, 'previtamin D3')]	0	['vdrs expressed airway immune cells, nuclear steroid hormone receptors regulate transcription  inflammation immunomodulation.27vitamin plays respiratory infection facilitating toll-like receptor signaling synthesis human cathelicidin antimicrobial peptide,28-30which cleaved generate cationic peptide, ll-37.31,32vitamin exerts cells  transcription33and airway inflammatory disorders.34while  suppress il-1735and il-4-mediated expression il-13,35,36it th1/th2 balance toward th2 dominance.37these actions  cd4+t cells il-10-secreting t-regulatory population.38\n\nbiosynthesis \nbiosynthesis  begins absorption solar ultravoilet-b (uvb) radiation secondarily via consumption -rich fortified foods, oily fish, fortified grains dairy products.26following exposure uvb radiation, 7-dehydrocholesterol skin converted previtamin d3( fig.']
S18-PMC3427192	PMC3427192	4/2012	S18-PMC3427192	['1,25(Oh)2D3, also referred to as Calcitriol, is then transported throughout the body via the Blood to various cells types that Express vdrs, where Gene Expression is induced.24,39BECAUSE the MAJORITY of Vitamin D Metabolism occurs in this skin, several FACTORS ARE THOUGHT TO INFLUENCE Vitamin D skin Metabolism, including age, body fat, the level of skin Melanin, and OTHER variables such as latitude, the amount and degree of sun exposure, and use of sunscreen products with uv protection.40these FACTORS HAVE BEEN PREVIOUSLY ASSOCIATED with Vitamin D deficiency in epidemiologic studies.41-43\n\ncaption (fig): figure 2.']	[('PROBABLE_UNDERSTANDING', 177), ('PROBABLE_UNDERSTANDING', 191), ('SUPERFICIAL_RELATIONSHIP', 253), ('INCOMPLETE_EVIDENCE', 261), ('INCOMPLETE_EVIDENCE', 265), ('SUPERFICIAL_RELATIONSHIP', 276), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 369), ('SUPERFICIAL_RELATIONSHIP', 499), ('INCOMPLETE_EVIDENCE', 507), ('INCOMPLETE_EVIDENCE', 517), ('SUPERFICIAL_RELATIONSHIP', 528)]	11	[('CHEBI_37958', 'dye', 0, '1,'), ('CHEBI_73394', 'Ala-Ser', 2, '25(OH)2D3'), ('CHEBI_17823', 'calcitriol', 33, 'calcitriol'), ('UBERON_0000178', 'blood', 93, 'blood'), ('GO_0010467', 'gene expression', 127, 'express'), ('GO_0010467', 'gene expression', 147, 'gene expression'), ('SO_0000704', 'gene', 147, 'gene'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 203, 'vitamin D metabolism'), ('CHEBI_27300', 'vitamin D', 286, 'vitamin D'), ('GO_0008152', 'metabolic process', 301, 'metabolism'), ('CHEBI_25179', 'melanins', 356, 'melanin'), ('CHEBI_27300', 'vitamin D', 544, 'vitamin D')]	0	['1,25(oh)2d3, calcitriol, transported throughout via blood cells express vdrs,  expression induced.24,39because  metabolism occurs skin,  skin metabolism, age, fat, skin melanin, latitude, amount degree sun exposure, sunscreen products uv protection.40these  epidemiologic studies.41-43\n\ncaption (fig): figure 2.']
S60-PMC3427192	PMC3427192	4/2012	S60-PMC3427192	['studies of Vitamin D status in Adults with asthmaauthoryearn(% male)age (years)study designsampleoutcome measuresfindingsblack80200514,091 (55)> 20 ycross-sectionalgeneral us populationlung functionhigher Serum 25(Oh)D ASSOCIATED with increased Lung functionkeet8120116857 (49)23.6cross-sectionalgeneral us populationwheeze, history of asthma, and asthma exacerbationhigher serum 25(Oh)D ASSOCIATED with decreased odds of current wheezing and asthma as well as emergency visits for asthma and asthma exacerbationsli822011435 (38)48.57cross-sectionalnewly diagnosed asthmaticslung function, total Serum igehigher 25(Oh)D ASSOCIATED with greater Lung function with no associations NOTED for igeoren832008290 (26)43cross-sectionalobese patientsasthma and allergic rhinitis25(Oh)D deficiency (< 25 ng/ml) ASSOCIATED with increased odds of atopic dermatitis BUT no associations with asthmasutherland84201054 (43)38.3cross-sectionalpersistent asthmalung function, Airway hyper-responsiveness, Glucocorticoid responsivenessdecreased 25(Oh)D ASSOCIATED with decreased Lung function, increased Airway hyperresponsiveness, and reduced Glucocorticoid responses\n\ngenetics of Vitamin D and asthma\nSOME STUDIES have FOCUSED on Genetic ASSOCIATIONS between Vitamin D and asthma in larger populations.']	[('SUPERFICIAL_RELATIONSHIP', 219), ('SUPERFICIAL_RELATIONSHIP', 388), ('SUPERFICIAL_RELATIONSHIP', 620), ('ANOMALY_CURIOUS_FINDING', 679), ('SUPERFICIAL_RELATIONSHIP', 801), ('ANOMALY_CURIOUS_FINDING', 853), ('SUPERFICIAL_RELATIONSHIP', 1034), ('INCOMPLETE_EVIDENCE', 1184), ('QUESTION_ANSWERED_BY_THIS_WORK', 1202), ('SUPERFICIAL_RELATIONSHIP', 1221)]	10	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0007023', 'adult organism', 31, 'adults'), ('UBERON_0001977', 'blood serum', 205, 'serum'), ('CHEBI_71657', 'versiconol acetate', 211, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 211, '25(OH)D'), ('UBERON_0002048', 'lung', 245, 'lung'), ('CHEBI_71657', 'versiconol acetate', 380, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 380, '25(OH)D'), ('UBERON_0001977', 'blood serum', 596, 'serum'), ('CHEBI_71657', 'versiconol acetate', 612, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 612, '25(OH)D'), ('UBERON_0002048', 'lung', 644, 'lung'), ('CHEBI_33010', 'chromide(1-)', 771, '(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 775, 'D'), ('UBERON_0001005', 'respiratory airway', 958, 'airway'), ('CHEBI_24261', 'glucocorticoid', 987, 'glucocorticoid'), ('CHEBI_71657', 'versiconol acetate', 1026, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 1029, 'OH ... D'), ('UBERON_0002048', 'lung', 1060, 'lung'), ('UBERON_0001005', 'respiratory airway', 1085, 'airway'), ('CHEBI_24261', 'glucocorticoid', 1125, 'glucocorticoid'), ('CHEBI_28384', 'vitamin K', 1163, 'Vitamin D'), ('SO_0000704', 'gene', 1213, 'genetic'), ('CHEBI_27300', 'vitamin D', 1242, 'vitamin D')]	0	['studies  status adults designsampleoutcome measuresfindingsblack80200514,091 (55)> 20 ycross-sectionalgeneral us populationlung functionhigher serum 25(oh)d lung functionkeet8120116857 (49)23.6cross-sectionalgeneral us populationwheeze, asthma, asthma exacerbationhigher serum 25(oh)d decreased wheezing asthma visits asthma asthma exacerbationsli822011435 (38)48.57cross-sectionalnewly diagnosed asthmaticslung function, serum igehigher 25(oh)d lung igeoren832008290 (26)43cross-sectionalobese patientsasthma allergic rhinitis25(oh)d (< 25 ng/ml) atopic dermatitis asthmasutherland84201054 (43)38.3cross-sectionalpersistent asthmalung function, airway hyper-responsiveness, glucocorticoid responsivenessdecreased 25(oh)d decreased lung function, airway hyperresponsiveness, glucocorticoid responses\n\ngenetics vitamin asthma\nsome   asthma populations.']
S64-PMC3427192	PMC3427192	4/2012	S64-PMC3427192	['Genetic studies of Vitamin D and asthmaauthoryearnlocation/ populationoutcome measuresfindingsbossé8620091,064québec, canada/ french-canadian familiesgenotype of Genes INVOLVED in the Vitamin D pathwaysnps in Il10, Cyp24A1, Cyp2R1, Il1Rl1 and Cd86 were ASSOCIATED with asthma and atopypoon8720041,139quebecvdr Genetic variants in family-based cohortssix Allelic varients were ASSOCIATED with asthma, while four varients were ASSOCIATED with atopyraby882004582united states/ multi-centertwenty-eight loci in 7 positional candidates were genotypedvdr polymorphism DEMONSTRATED significant transmission distortionsaadi8920091,090jinan china/ han Populationsnps in the vdronly one marker showed a significant ASSOCIATION with asthma.']	[('SUPERFICIAL_RELATIONSHIP', 168), ('SUPERFICIAL_RELATIONSHIP', 253), ('SUPERFICIAL_RELATIONSHIP', 376), ('SUPERFICIAL_RELATIONSHIP', 425), ('INCOMPLETE_EVIDENCE', 562), ('SUPERFICIAL_RELATIONSHIP', 705)]	6	[('SO_0000704', 'gene', 0, 'Genetic'), ('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('SO_0000704', 'gene', 162, 'genes'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('GO_0007601', 'visual perception', 184, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 209, 'IL10'), ('PR_000006101', 'cytochrome P450 1A1', 215, 'CYP24A1'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 224, 'CYP2R1'), ('PR_000008998', 'interleukin-21 receptor', 232, 'IL1RL1'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 243, 'CD86'), ('SO_0000704', 'gene', 310, 'genetic'), ('SO_0001023', 'allele', 354, 'allelic'), ('SO_0000751', 'proviral_location', 643, 'populationSNPs')]	0	['  asthmaauthoryearnlocation/ populationoutcome measuresfindingsbossé8620091,064québec, canada/ french-canadian familiesgenotype   pathwaysnps il10, cyp24a1, cyp2r1, il1rl1 cd86 asthma atopypoon8720041,139quebecvdr  variants family-based cohortssix allelic varients asthma, four varients atopyraby882004582united states/ multi-centertwenty-eight loci 7 positional genotypedvdr polymorphism transmission distortionsaadi8920091,090jinan china/ han populationsnps vdronly asthma.']
S65-PMC3427192	PMC3427192	4/2012	S65-PMC3427192	['Haplotype analysis of the vdr polymorphisms SHOWED a significant ASSOCIATION with asthmavollmert90200432munich, germany/ germansnps in the vdr and Integrin Β7None of the Snps were ASSOCIATED with asthmawjst912005951munich, germany/ germany and sweden13 Snps in the vdrin unaffected siblings, Allele in the 5′ region was undertransmitted while two other Alleles in the 3′ terminal region were overtransmittedwjst922006947munich, germany/ germany and swedenserum levels of Vitamin D and genotyping of dna Single Base variantsat least one positive Snp with a transmission disequilibrium of for asthma or total Ige and Vitamin D was FOUND in several Genes\nONLY a HANDFUL OF STUDIES have evaluated the LINK between asthma and polymorphisms in other Genes INVOLVED in Vitamin d synthesis, bioavailability and Metabolism.']	[('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 180), ('INCOMPLETE_EVIDENCE', 629), ('INCOMPLETE_EVIDENCE', 652), ('INCOMPLETE_EVIDENCE', 659), ('SUPERFICIAL_RELATIONSHIP', 697), ('SUPERFICIAL_RELATIONSHIP', 750)]	8	[('SO_0001024', 'haplotype', 0, 'Haplotype'), ('PR_000009070', 'integrator complex subunit 3', 147, 'integrin β7None'), ('SO_0000694', 'SNP', 170, 'SNPs'), ('SO_0000694', 'SNP', 253, 'SNPs'), ('SO_0001023', 'allele', 292, 'allele'), ('SO_0001023', 'allele', 353, 'alleles'), ('CHEBI_27300', 'vitamin D', 471, 'vitamin D'), ('SO_0000984', 'single', 503, 'single base'), ('SO_0000694', 'SNP', 545, 'SNP'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 607, 'IgE'), ('CHEBI_27300', 'vitamin D', 615, 'vitamin D'), ('SO_0000704', 'gene', 646, 'genes'), ('SO_0000704', 'gene', 744, 'genes'), ('CHEBI_33229', 'vitamin (role)', 762, 'vitamin'), ('GO_0008152', 'metabolic process', 803, 'metabolism')]	0	['haplotype vdr polymorphisms asthmavollmert90200432munich, germany/ germansnps vdr integrin β7none snps asthmawjst912005951munich, germany/ germany sweden13 snps vdrin unaffected siblings, allele 5′ region undertransmitted alleles 3′ terminal region overtransmittedwjst922006947munich, germany/ germany swedenserum levels  genotyping dna single variantsat positive snp transmission disequilibrium asthma ige  \nonly asthma polymorphisms  vitamin synthesis, bioavailability metabolism.']
S66-PMC3427192	PMC3427192	4/2012	S66-PMC3427192	['in ONE STUDY, modest ASSOCIATIONS were NOTED between several Genes in the Vitamin D pathway and asthma and allergic sensitization in populations enriched for subjects with current asthma.86a separate study of asthmatics also FOUND Haplotype ASSOCIATIONS for Cyp24A1 , the primary enzyme ASSOCIATED with Calcidiol Metabolism, where a 5-point Haplotype was ASSOCIATED with asthma, allergic sensitization, and Vitamin D Metabolites in asthmatic subjects.92while these PRELIMINARY results SUGGEST that Genetic components MAY account for Vitamin D status in subjects with asthma, OTHER STUDIES ARE NEEDED to determine tease out the Genetic vs. environmental UNDERPINNINGS of Vitamin D status in this population.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 21), ('ANOMALY_CURIOUS_FINDING', 39), ('INCOMPLETE_EVIDENCE', 225), ('SUPERFICIAL_RELATIONSHIP', 241), ('SUPERFICIAL_RELATIONSHIP', 287), ('SUPERFICIAL_RELATIONSHIP', 355), ('INCOMPLETE_EVIDENCE', 465), ('INCOMPLETE_EVIDENCE', 485), ('INCOMPLETE_EVIDENCE', 517), ('FUTURE_WORK', 575), ('FUTURE_WORK', 581), ('SUPERFICIAL_RELATIONSHIP', 653)]	13	[('SO_0000704', 'gene', 61, 'genes'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('SO_0001024', 'haplotype', 231, 'haplotype'), ('PR_000006101', 'cytochrome P450 1A1', 258, 'CYP24A1'), ('CHEBI_17933', 'calcidiol', 303, 'calcidiol'), ('GO_0008152', 'metabolic process', 313, 'metabolism'), ('SO_0001024', 'haplotype', 341, 'haplotype'), ('CHEBI_27300', 'vitamin D', 407, 'vitamin D'), ('CHEBI_25212', 'metabolite', 417, 'metabolites'), ('SO_0000704', 'gene', 498, 'genetic'), ('CHEBI_27300', 'vitamin D', 533, 'vitamin D'), ('SO_0000704', 'gene', 627, 'genetic'), ('CHEBI_27300', 'vitamin D', 670, 'vitamin D')]	0	['study,   asthma allergic sensitization populations enriched subjects asthmatics haplotype cyp24a1 enzyme calcidiol metabolism, 5-point haplotype asthma, allergic sensitization,  metabolites asthmatic subjects.92while   status subjects asthma, tease  vs. environmental  status population.']
S160-PMC3458940	PMC3458940	9/2012	S160-PMC3458940	['THUS, the ROLES for the tra/rar target Genes IDENTIFIED in THIS STUDY in the aforementioned Renal anomalies ASSOCIATED to post-Natal Vitamin A deficiency DESERVE FURTHER studies.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 45), ('QUESTION_ANSWERED_BY_THIS_WORK', 59), ('SUPERFICIAL_RELATIONSHIP', 108), ('IMPORTANT_CONSIDERATION', 154), ('IMPORTANT_CONSIDERATION', 154), ('FUTURE_WORK', 162)]	8	[('SO_0000704', 'gene', 39, 'genes'), ('UBERON_0002113', 'kidney', 92, 'renal'), ('GO_0007567', 'parturition', 127, 'natal'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin A')]	0	['thus, tra/rar  renal anomalies post-natal  studies.']
S75-PMC3470091	PMC3470091	9/2012	S75-PMC3470091	['the mechanism of pth reduction is that an increased Serum Vitamin D LEADS to a decrease in pth Gene Translation, and THUS pth secretion.']	[('SUPERFICIAL_RELATIONSHIP', 68), ('PROBABLE_UNDERSTANDING', 117)]	2	[('UBERON_0001977', 'blood serum', 52, 'serum'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('SO_0000704', 'gene', 95, 'gene'), ('GO_0006412', 'translation', 100, 'translation')]	0	['pth reduction serum  decrease pth  translation, pth secretion.']
S99-PMC3476426	PMC3476426	8/2012	S99-PMC3476426	['Genetic polymorphisms of Cytochrome P450 enzymes HAVE also BEEN LINKED to autism, specifically Cyp27B1 that is ESSENTIAL for proper Vitamin D Metabolism.']	[('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 64), ('IMPORTANT_CONSIDERATION', 111)]	3	[('SO_0000704', 'gene', 0, 'Genetic'), ('CHEBI_38557', 'cytochrome c2', 25, 'cytochrome P450'), ('PR_000006101', 'cytochrome P450 1A1', 95, 'CYP27B1'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 132, 'vitamin D metabolism')]	0	[' polymorphisms cytochrome p450 enzymes autism, cyp27b1 proper  metabolism.']
S141-PMC3476426	PMC3476426	8/2012	S141-PMC3476426	['the Vitamin D THEORY of autism DOES NOT DIMINISH Genetic CONTRIBUTIONS to autism occurrence.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 57)]	3	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('SO_0000704', 'gene', 49, 'genetic')]	0	[' autism diminish  autism occurrence.']
S142-PMC3476426	PMC3476426	8/2012	S142-PMC3476426	['indeed, without the Genetic TENDENCY for autism, SEVERE maternal or early childhood Vitamin D deficiency MAY cause bone abnormalities with no EVIDENCE autism.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('IMPORTANT_CONSIDERATION', 49), ('INCOMPLETE_EVIDENCE', 105), ('INCOMPLETE_EVIDENCE', 142)]	4	[('SO_0000704', 'gene', 20, 'genetic'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]	0	['indeed,  autism, maternal childhood  bone abnormalities autism.']
S143-PMC3476426	PMC3476426	8/2012	S143-PMC3476426	['maternal and early childhood Vitamin D deficiency MAY allow the Genetic TENDENCY for autism to Express itself.']	[('INCOMPLETE_EVIDENCE', 50), ('SUPERFICIAL_RELATIONSHIP', 72)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('SO_0000704', 'gene', 64, 'genetic'), ('GO_0010467', 'gene expression', 95, 'express')]	0	['maternal childhood   autism express itself.']
S145-PMC3476426	PMC3476426	8/2012	S145-PMC3476426	['basic, Genetic, and epidemiological studies INDICATE a POTENTIAL ROLE of Vitamin D in the PREVENTION of Autoimmune diseases, BUT randomized and controlled TRIALS ARE NECESSARY to establish the clinical efficacy of Vitamin D supplementation in ill or at-RISK subjects [48].']	[('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 125), ('FUTURE_WORK', 155), ('FUTURE_WORK', 166), ('IMPORTANT_CONSIDERATION', 166), ('IMPORTANT_CONSIDERATION', 253)]	9	[('SO_0000704', 'gene', 7, 'genetic'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 104, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]	0	['basic, epidemiological  autoimmune diseases,  supplementation subjects [48].']
S137-PMC3488410	PMC3488410	10/2012	S137-PMC3488410	['this IDEA is SUPPORTED by FINDINGS that Vitamin D depletion depressed Promitotic Genes [131,137].']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 26)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0006508', 'proteolysis', 70, 'promitotic'), ('SO_0000704', 'gene', 81, 'genes')]	0	[' depletion depressed promitotic  [131,137].']
S3-PMC3515553	PMC3515553	12/2012	S3-PMC3515553	['we then examined the ASSOCIATION of Snps in maternal Genes Fut2 (rs492602) and tcn2 (rs1801198, rs9606756) that are RELATED to Plasma Vitamin B-12, with offspring iq.']	[('SUPERFICIAL_RELATIONSHIP', 21), ('SUPERFICIAL_RELATIONSHIP', 116)]	2	[('SO_0000694', 'SNP', 36, 'SNPs'), ('SO_0000704', 'gene', 53, 'genes'), ('PR_000007719', 'frizzled-2', 59, 'FUT2'), ('UBERON_0001969', 'blood plasma', 127, 'plasma'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 134, 'vitamin B-12')]	0	['snps maternal  fut2 (rs492602) tcn2 (rs1801198, rs9606756) plasma -12, offspring iq.']
S18-PMC3515553	PMC3515553	12/2012	S18-PMC3515553	['ONE WAY to avoid PROBLEMS of residual CONFOUNDING in OBSERVATIONAL epidemiology is to use Genetic variants that are KNOWN to be reliably RELATED to the modifiable risk factor of interest (here maternal Vitamin B-12) as PROXIES IN ORDER TO determine the causal EFFECT of the risk factor[9],[10].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 17), ('PROBLEM_COMPLICATION', 38), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 137), ('SUPERFICIAL_RELATIONSHIP', 219), ('QUESTION_ANSWERED_BY_THIS_WORK', 227), ('QUESTION_ANSWERED_BY_THIS_WORK', 236), ('SUPERFICIAL_RELATIONSHIP', 260)]	10	[('SO_0000704', 'gene', 90, 'genetic'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 202, 'vitamin B-12')]	0	['one residual epidemiology  variants reliably (here maternal -12) causal factor[9],[10].']
S20-PMC3515553	PMC3515553	12/2012	S20-PMC3515553	['additionally, non-synonymous polymorphisms in the tcn2 Gene (rs1801198, 776c>g, p259r; rs9606756, 67a>g, i23v), that codes for the Transcobalamin Ii protein, HAVE BEEN ASSOCIATED with differences in the holotranscobalamin and total transcobalamin fractions of Vitamin B-12 and total Hcy concentration[3],[13]–[16], ALTHOUGH their EFFECTS are not fully established[16].']	[('INCOMPLETE_EVIDENCE', 158), ('SUPERFICIAL_RELATIONSHIP', 168), ('ANOMALY_CURIOUS_FINDING', 315), ('SUPERFICIAL_RELATIONSHIP', 330)]	4	[('SO_0000704', 'gene', 55, 'gene'), ('PR_000016009', 'tumor-associated calcium signal transducer 2', 131, 'transcobalamin II'), ('CHEBI_27300', 'vitamin D', 260, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 260, 'vitamin B-12'), ('CHEBI_37958', 'dye', 283, 'Hcy'), ('PR_000008443', 'huntingtin-associated protein 1', 283, 'Hcy')]	0	['additionally, non-synonymous polymorphisms tcn2  (rs1801198, 776c>g, p259r; rs9606756, 67a>g, i23v), codes transcobalamin ii protein, holotranscobalamin transcobalamin fractions -12 hcy concentration[3],[13]–[16], established[16].']
S73-PMC3515553	PMC3515553	12/2012	S73-PMC3515553	['Genetic analysis\nmaternal and offspring genotypes were coded 0, 1, 2, based on the number of PUTATIVE Vitamin B-12 increasing Alleles, and were checked for deviation from hardy-weinberg equilibrium using the genhw function implemented in the program stata 11.0 (stata corporation, college station, texas).']	[('PROBABLE_UNDERSTANDING', 93)]	1	[('SO_0000704', 'gene', 0, 'Genetic'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 102, 'vitamin B-12'), ('SO_0001023', 'allele', 126, 'alleles')]	0	[' analysis\nmaternal offspring genotypes coded 0, 1, 2, -12 alleles, checked deviation hardy-weinberg equilibrium using genhw implemented program stata 11.0 (stata corporation, college station, texas).']
S76-PMC3515553	PMC3515553	12/2012	S76-PMC3515553	['we used an additive Genetic model taking as baseline the genotype ASSOCIATED with the lowest Vitamin B-12 and/or highest thcy concentrations (tt for Fut2 rs492602, gg for tcn2 rs1801198 and aa for tcn2 rs9606756).']	[('SUPERFICIAL_RELATIONSHIP', 66)]	1	[('SO_0000704', 'gene', 20, 'genetic'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 93, 'vitamin B-12'), ('PR_000007719', 'frizzled-2', 149, 'FUT2')]	0	[' baseline genotype lowest thcy concentrations (tt fut2 rs492602, gg tcn2 rs1801198 aa tcn2 rs9606756).']
S127-PMC3515553	PMC3515553	12/2012	S127-PMC3515553	['discussion\n\nmain findings\nTO THE BEST OF OUR KNOWLEDGE THIS is the FIRST STUDY to EXAMINE the IMPACT of differential concentrations of circulating Vitamin B-12 on offspring iq through the use of records of Maternal Pregnancy Vitamin B-12 intake, as well as Vitamin B-12 RELATED Genetic variants.']	[('PROBABLE_UNDERSTANDING', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 55), ('INCOMPLETE_EVIDENCE', 67), ('QUESTION_ANSWERED_BY_THIS_WORK', 73), ('QUESTION_ANSWERED_BY_THIS_WORK', 82), ('SUPERFICIAL_RELATIONSHIP', 94), ('SUPERFICIAL_RELATIONSHIP', 270)]	7	[('CHEBI_27300', 'vitamin D', 147, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 147, 'vitamin B-12'), ('GO_0007618', 'mating', 206, 'maternal'), ('GO_0007565', 'female pregnancy', 215, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 225, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 235, '12'), ('CHEBI_27300', 'vitamin D', 257, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 257, 'vitamin B-12'), ('SO_0000704', 'gene', 278, 'genetic')]	0	['discussion\n\nmain findings\nto concentrations circulating -12 offspring iq records maternal pregnancy -12 intake, -12  variants.']
S133-PMC3515553	PMC3515553	12/2012	S133-PMC3515553	['the effect size of this ASSOCIATION between genotypic variation and iq was of a magnitude expected given the RELATIONSHIPS between Genetic variation and Vitamin B-12 and the RELATIONSHIPS between Vitamin B-12 and iq OBSERVATIONALLY.']	[('SUPERFICIAL_RELATIONSHIP', 24), ('SUPERFICIAL_RELATIONSHIP', 109), ('SUPERFICIAL_RELATIONSHIP', 174), ('INCOMPLETE_EVIDENCE', 216)]	4	[('SO_0000704', 'gene', 131, 'genetic'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 153, 'vitamin B-12'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 196, 'vitamin B-12')]	0	['genotypic iq magnitude  -12 -12 iq observationally.']
S171-PMC3515553	PMC3515553	12/2012	S171-PMC3515553	['NONETHELESS, the fact that our OBSERVATIONAL ASSOCIATION of maternal dietary Intake attenuated NOTICEABLY with adjustment for CONFOUNDING FACTORS and that the Genetic ASSOCIATIONS are not very strong SUGGESTS that maternal Vitamin B-12 MAY not have an IMPORTANT causal EFFECT on offspring iq.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 45), ('ANOMALY_CURIOUS_FINDING', 95), ('PROBLEM_COMPLICATION', 126), ('SUPERFICIAL_RELATIONSHIP', 167), ('INCOMPLETE_EVIDENCE', 200), ('INCOMPLETE_EVIDENCE', 236), ('IMPORTANT_CONSIDERATION', 252), ('SUPERFICIAL_RELATIONSHIP', 269)]	10	[('GO_0007631', 'feeding behavior', 77, 'intake'), ('SO_0000704', 'gene', 159, 'genetic'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 223, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 233, '12')]	0	['nonetheless, maternal dietary intake attenuated adjustment  maternal -12 causal offspring iq.']
S179-PMC3586494	PMC3586494	2/2013	S179-PMC3586494	['female a/a Mice Fed a methyl-supplemented diet with extra Folate, Vitamin B-12,Choline, and betaine 2 weeks prior to Mating with male Avy/ a agouti Mice and throughout Pregnancy and Lactation passed along the agouti Gene to their offspring intact, YET DEMONSTRATED a shift in distribution towards having more offspring with the pseudoagouti phenotype [76].']	[('ANOMALY_CURIOUS_FINDING', 248), ('INCOMPLETE_EVIDENCE', 252)]	2	[('NCBITaxon_10088', 'Mus <genus>', 11, 'mice'), ('GO_0007631', 'feeding behavior', 16, 'fed'), ('CHEBI_30863', '5-azaorotic acid', 58, 'folate'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 66, 'vitamin B-12'), ('CHEBI_15354', 'choline', 79, 'choline'), ('GO_0007618', 'mating', 117, 'mating'), ('PR_000004155', 'apolipoprotein E', 134, 'Avy'), ('NCBITaxon_10088', 'Mus <genus>', 148, 'mice'), ('GO_0007565', 'female pregnancy', 168, 'pregnancy'), ('GO_0007595', 'lactation', 182, 'lactation'), ('SO_0000704', 'gene', 216, 'gene')]	0	['female a/a mice fed methyl-supplemented diet extra folate, -12,choline, betaine 2 weeks mating male avy/ agouti mice throughout pregnancy lactation passed along agouti  offspring intact, distribution offspring pseudoagouti phenotype [76].']
S0-PMC3613945	PMC3613945	2/2013	S0-PMC3613945	['common variants of the Vitamin D Binding Protein Gene and adverse health outcomes\n\nabstract\nthe Vitamin D Binding protein (dbp) is the MAJOR Plasma carrier for Vitamin D and its Metabolites, BUT it is also an actin scavenger, and is the precursor to the immunomodulatory protein, gc-maf.']	[('IMPORTANT_CONSIDERATION', 135), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 23, 'vitamin D binding protein'), ('SO_0000704', 'gene', 49, 'gene'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('PR_000017299', 'VIP peptides', 96, 'vitamin D binding'), ('UBERON_0001969', 'blood plasma', 141, 'plasma'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('CHEBI_25212', 'metabolite', 178, 'metabolites')]	0	['common variants  binding protein  outcomes\n\nabstract\nthe  binding protein (dbp) plasma carrier  metabolites, actin scavenger, immunomodulatory protein, gc-maf.']
S74-PMC3613945	PMC3613945	2/2013	S74-PMC3613945	['ASSOCIATION between common Genetic variants of the Vitamin D Binding Protein Gene (gc) and various diseases.sample size ( n )diseasereferencecasescontrolscountryethnicitygc polymorphisms studiedfindings cancer Breast cancerabbas et al.16014022608germanycaucasianagc1f, gc1s, gc2genotype Gc2-2 was ASSOCIATED with decreased risk of Postmenopausal Breast cancer, [or\u2009=\u20090.72 (ci\u2009=\u20090.54–0.96, p \u2009=\u20090.04)], when compared to the most frequently observed genotype, gc1s-1s.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 297)]	2	[('SO_0000704', 'gene', 27, 'genetic'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 51, 'vitamin D binding protein'), ('SO_0000704', 'gene', 77, 'gene'), ('UBERON_0000310', 'breast', 210, 'Breast'), ('PR_000008010', 'glycerol kinase', 287, 'Gc2-2'), ('GO_0007595', 'lactation', 331, 'postmenopausal'), ('UBERON_0000310', 'breast', 346, 'breast')]	0	['association  variants  binding protein  (gc) diseases.sample n )diseasereferencecasescontrolscountryethnicitygc polymorphisms studiedfindings cancer breast cancerabbas et al.16014022608germanycaucasianagc1f, gc1s, gc2genotype gc2-2 decreased postmenopausal breast cancer, [or\u2009=\u20090.72 (ci\u2009=\u20090.54–0.96, p \u2009=\u20090.04)], genotype, gc1s-1s.']
S121-PMC3613945	PMC3613945	2/2013	S121-PMC3613945	['AS SUCH, polymorphisms in the dbp Gene MIGHT provide INSIGHT into the ROLE of Vitamin D and diabetes.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 70)]	4	[('SO_0000704', 'gene', 34, 'gene'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]	0	['such, polymorphisms dbp   diabetes.']
S185-PMC3613945	PMC3613945	2/2013	S185-PMC3613945	['FURTHER EVIDENCE SUGGESTING an inverse CORRELATION between Vitamin D and asthma is provided by Genetic109,110and epidemiologic (geospatial and solar radiation) STUDIES111.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 160)]	4	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('SO_0000704', 'gene', 95, 'genetic109')]	0	[' asthma ,110and epidemiologic (geospatial solar radiation) studies111.']
S24-PMC3651971	PMC3651971	5/2013	S24-PMC3651971	['introduction\nrisk for Cognitive and motor impairment begins in the Womb, where nutritional restrictions on Embryofetal Tissue growth, differentiation, development and Maturation MAY disturb growth, maturation and function of the Central Nervous System.1neural myelination and Synaptogenesis are underway before 24\u2005weeks’ Gestational age, Neural Tube Formation and Cell Migration are complete before the third Trimester of Pregnancy, and basic structures of the Brain formed before Birth.2as complex structures and functions extend as a cascade, disruptions to nascent systems by nutritional and OTHER insults CAN be amplified with age.3\nEmbryofetal Development is sensitive to Gestational deficiency in Vitamin A,4most EVIDENT in Animals by gross anomalies in Organ and Tissue Morphogenesis, development, structure and function.5–7Retinoic Acid, the oxidised Metabolite and transcriptional ligand of Vitamin A, Regulates the Expression of hox Genes that are essential in Neural Tube Formation,8the Development Of Neurons, and in Synaptic Signalling that UNDERLIES Learning and Memory.9–13developing neural Tissue in the Mouse is ESPECIALLY sensitive to variation in Retinoic Acid exposure near Parturition, a time analogous to the second Trimester of Human Gestation, when deficiency can induce behavioural problems and mild structural damage within the Limbic Cortex.14\nchronic dietary Vitamin A deficiency is common among Pregnant women in poor countries,1516leading TO concern that it MAY have adverse consequences for Cognitive and Motor Development Of the Fetus.']	[('INCOMPLETE_EVIDENCE', 178), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 595), ('INCOMPLETE_EVIDENCE', 609), ('PROBABLE_UNDERSTANDING', 719), ('SUPERFICIAL_RELATIONSHIP', 1054), ('ANOMALY_CURIOUS_FINDING', 1129), ('QUESTION_ANSWERED_BY_THIS_WORK', 1469), ('INCOMPLETE_EVIDENCE', 1488)]	8	[('GO_0050890', 'cognition', 22, 'cognitive'), ('UBERON_0002396', 'vomer', 67, 'womb'), ('UBERON_0000922', 'embryo', 107, 'embryofetal'), ('UBERON_0000479', 'tissue', 119, 'tissue'), ('GO_0007618', 'mating', 167, 'maturation'), ('UBERON_0001017', 'central nervous system', 229, 'central nervous system'), ('GO_0007416', 'synapse assembly', 276, 'synaptogenesis'), ('GO_0007565', 'female pregnancy', 321, 'gestational'), ('GO_0042136', 'neurotransmitter biosynthetic process', 338, 'neural tube formation'), ('UBERON_0001049', 'neural tube', 338, 'neural tube'), ('GO_0016477', 'cell migration', 364, 'cell migration'), ('GO_0009294', 'DNA mediated transformation', 409, 'trimester'), ('GO_0007565', 'female pregnancy', 422, 'pregnancy'), ('UBERON_0000955', 'brain', 461, 'brain'), ('GO_0007567', 'parturition', 481, 'birth'), ('GO_0009790', 'embryo development', 637, 'Embryofetal development'), ('UBERON_0000922', 'embryo', 637, 'Embryofetal'), ('GO_0007565', 'female pregnancy', 677, 'gestational'), ('CHEBI_27300', 'vitamin D', 703, 'vitamin A'), ('NCBITaxon_33208', 'Metazoa', 730, 'animals'), ('UBERON_0000062', 'organ', 760, 'organ'), ('GO_0048729', 'tissue morphogenesis', 770, 'tissue morphogenesis'), ('UBERON_0000479', 'tissue', 770, 'tissue'), ('CHEBI_52071', 'dextran', 828, '5'), ('CHEBI_24115', 'fuconate', 830, '7Retinoic acid'), ('CHEBI_39382', 'flufenoxuron', 859, 'metabolite'), ('CHEBI_27300', 'vitamin D', 900, 'vitamin A'), ('GO_0065007', 'biological regulation', 911, 'regulates'), ('GO_0010467', 'gene expression', 925, 'expression'), ('SO_0000704', 'gene', 943, 'genes'), ('GO_0042136', 'neurotransmitter biosynthetic process', 971, 'neural tube formation'), ('UBERON_0001049', 'neural tube', 971, 'neural tube'), ('GO_0046697', 'decidualization', 998, 'development of neurons'), ('CL_0000540', 'neuron', 1013, 'neurons'), ('GO_0045202', 'synapse', 1029, 'synaptic'), ('GO_0099536', 'synaptic signaling', 1029, 'synaptic signalling'), ('GO_0007612', 'learning', 1064, 'learning'), ('GO_0007613', 'memory', 1077, 'memory'), ('UBERON_0000479', 'tissue', 1106, 'tissue'), ('NCBITaxon_10088', 'Mus <genus>', 1120, 'mouse'), ('CHEBI_26536', 'retinoic acid', 1166, 'retinoic acid'), ('GO_0019230', 'proprioception', 1194, 'parturition'), ('GO_0009294', 'DNA mediated transformation', 1238, 'trimester'), ('NCBITaxon_9606', 'Homo sapiens', 1251, 'human'), ('GO_0007565', 'female pregnancy', 1257, 'gestation'), ('UBERON_0016542', 'limbic cortex', 1354, 'limbic cortex'), ('CHEBI_27300', 'vitamin D', 1387, 'vitamin A'), ('GO_0007565', 'female pregnancy', 1424, 'pregnant'), ('GO_0050890', 'cognition', 1522, 'cognitive ...'), ('GO_0048870', 'cell motility', 1536, 'motor development of ... fetus')]	0	['introduction\nrisk cognitive motor impairment begins womb, nutritional embryofetal tissue growth, differentiation, maturation disturb growth, maturation central nervous system.1neural myelination synaptogenesis 24\u2005weeks’ gestational age, neural tube formation cell migration third trimester pregnancy, structures brain formed birth.2as structures functions cascade, nascent systems nutritional insults amplified age.3\nembryofetal sensitive gestational ,4most animals anomalies organ tissue morphogenesis, development, structure function.5–7retinoic acid, oxidised metabolite transcriptional ligand expression hox  neural tube formation,8the neurons, synaptic signalling learning memory.9–13developing neural tissue mouse sensitive retinoic acid exposure parturition, trimester human gestation, behavioural structural limbic cortex.14\nchronic dietary  among pregnant women countries,1516leading cognitive motor fetus.']
S131-PMC3659910	PMC3659910	1/2013	S131-PMC3659910	['RESEARCH has FOUND direct CONNECTIONS between Vitamin D and the Genes KNOWN to be INVOLVED in ms, BUT exact pathology and WHETHER Vitamin D supplements during Pregnancy OR childhood can lessen the likelihood of the child developing ms later in Life is NOT KNOWN.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 82), ('ANOMALY_CURIOUS_FINDING', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('FULL_UNKNOWN', 252)]	8	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('SO_0000704', 'gene', 64, 'genes'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007565', 'female pregnancy', 159, 'pregnancy'), ('UBERON_0000104', 'life cycle', 244, 'life')]	0	['research   ms, exact pathology  supplements pregnancy childhood child ms life known.']
S2-PMC3668200	PMC3668200	5/2013	S2-PMC3668200	['many Genetic, dietary, and environmental FACTORS AFFECT the body concentration of Vitamin D, Calcium, Phosphorus, and Bone Metabolism.']	[('SUPERFICIAL_RELATIONSHIP', 41), ('SUPERFICIAL_RELATIONSHIP', 49)]	2	[('SO_0000704', 'gene', 5, 'genetic'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 93, 'calcium'), ('CHEBI_35885', 'secondary phosphine', 102, 'phosphorus'), ('GO_0007567', 'parturition', 118, 'bone'), ('GO_0008152', 'metabolic process', 123, 'metabolism')]	0	['many dietary, environmental concentration calcium, phosphorus, bone metabolism.']
S52-PMC3668200	PMC3668200	5/2013	S52-PMC3668200	['Vitamin D concentration is AFFECTED by many Genetic, dietary, and environmental FACTORS; THEREFORE, it is RECOMMENDED that researchers CONSIDER the relative and EFFECTIVE FACTORS when performing STUDIES concerning Vitamin D concentrations.']	[('SUPERFICIAL_RELATIONSHIP', 27), ('SUPERFICIAL_RELATIONSHIP', 80), ('PROBABLE_UNDERSTANDING', 89), ('FUTURE_WORK', 106), ('FUTURE_WORK', 135), ('SUPERFICIAL_RELATIONSHIP', 161), ('SUPERFICIAL_RELATIONSHIP', 171), ('INCOMPLETE_EVIDENCE', 195)]	8	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('SO_0000704', 'gene', 44, 'genetic'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]	0	['vitamin concentration dietary, environmental factors; therefore, relative performing  concentrations.']
S15-PMC3672018	PMC3672018	5/2013	S15-PMC3672018	['widely distributed in body Tissues, a vdr, once bound to a Vitamin D ligand, travels to the Nucleus where it binds to sites within the Human Genome and CONSEQUENTLY INFLUENCES the activity, or Expression, of individual Genes.']	[('PROBABLE_UNDERSTANDING', 152), ('SUPERFICIAL_RELATIONSHIP', 165)]	2	[('UBERON_0000479', 'tissue', 27, 'tissues'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0005634', 'nucleus', 92, 'nucleus'), ('NCBITaxon_9606', 'Homo sapiens', 135, 'human'), ('SO_0001026', 'genome', 141, 'genome'), ('GO_0010467', 'gene expression', 193, 'expression'), ('SO_0000704', 'gene', 219, 'genes')]	0	['widely distributed tissues, vdr,  ligand, travels nucleus binds sites human genome activity, expression, individual .']
S16-PMC3672018	PMC3672018	5/2013	S16-PMC3672018	['a RECENT STUDY reported identification of as many as 2,776 sites of Vitamin D receptor binding and 229 Genes whose Expression was directly LINKED to changes in Vitamin d levels [2].']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 139)]	2	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('SO_0000704', 'gene', 103, 'genes'), ('GO_0010467', 'gene expression', 115, 'expression'), ('CHEBI_33229', 'vitamin (role)', 160, 'vitamin')]	0	['2,776 sites  receptor binding 229  whose expression changes vitamin levels [2].']
S92-PMC3672018	PMC3672018	5/2013	S92-PMC3672018	['exposure assessment\nfour main analyses of exposure related to initiation and termination of Vitamin D fortification will be considered for each of the disease outcomes:\n1. Perinatal exposure to Vitamin D for offspring;\n2. seasonal variation in Vitamin D exposure in different Pregnancy trimesters;\n3. exposure to Vitamin D adjusted for Genetic and common environmental INFLUENCES;\n4. levels of Vitamin D (25(Oh)D3) measured in infant Blood from dbs cards.']	[('SUPERFICIAL_RELATIONSHIP', 369)]	1	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0036268', 'swimming', 172, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 172, 'perinatal'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 244, 'vitamin D'), ('GO_0007565', 'female pregnancy', 276, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 313, 'vitamin D'), ('SO_0000704', 'gene', 336, 'genetic'), ('CHEBI_27300', 'vitamin D', 394, 'vitamin D'), ('CHEBI_62946', 'ammonium sulfate', 405, '25(OH)D3'), ('UBERON_0000178', 'blood', 434, 'blood')]	0	['exposure assessment\nfour main exposure initiation termination  fortification disease outcomes:\n1. perinatal exposure  offspring;\n2. seasonal  exposure pregnancy trimesters;\n3. exposure  adjusted  environmental influences;\n4. levels  (25(oh)d3) infant blood dbs cards.']
S29-PMC3685533	PMC3685533	6/2013	S29-PMC3685533	['country of origin, Genetic traits and cultural behaviour are IMPORTANT FACTORS in determining Vitamin D levels [17].']	[('IMPORTANT_CONSIDERATION', 61), ('SUPERFICIAL_RELATIONSHIP', 71)]	2	[('SO_0000704', 'gene', 19, 'genetic'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]	0	['country origin,  traits cultural behaviour  levels [17].']
S57-PMC3695234	PMC3695234	7/2013	S57-PMC3695234	['the 1,25(Oh)2D3Molecule induces Antimicrobial peptide Gene Expression in isolated Human Keratinocytes, Monocytes, Neutrophils, and Human cell lines.9tlr activation of Human Macrophages up-regulates the Expression of the Vitamin D receptor and Vitamin D-1-hydroxylase Genes, leading to the induction of the Cathelicidin.10these data SUGGEST a LINK between tlrs and Vitamin D-mediated Innate Immunity, INDICATING that a DIFFERENCE in the ability of Human populations to produce Vitamin D MAY contributes to susceptibility to Microbial infection.']	[('INCOMPLETE_EVIDENCE', 332), ('SUPERFICIAL_RELATIONSHIP', 342), ('INCOMPLETE_EVIDENCE', 400), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 418), ('INCOMPLETE_EVIDENCE', 486)]	5	[('CHEBI_84221', '1-ethyl-2-propylcyclohexane', 4, '1,25(OH)2D3molecule'), ('CHEBI_65381', 'albizoside C', 32, 'antimicrobial'), ('GO_0010467', 'gene expression', 54, 'gene expression'), ('SO_0000704', 'gene', 54, 'gene'), ('NCBITaxon_9606', 'Homo sapiens', 82, 'human'), ('CL_0000312', 'keratinocyte', 88, 'keratinocytes'), ('CL_0000576', 'monocyte', 103, 'monocytes'), ('CL_0000775', 'neutrophil', 114, 'neutrophils'), ('NCBITaxon_9606', 'Homo sapiens', 131, 'human'), ('NCBITaxon_9606', 'Homo sapiens', 167, 'human'), ('CL_0000235', 'macrophage', 173, 'macrophages'), ('GO_0010467', 'gene expression', 202, 'expression'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 228, 'D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D'), ('SO_0000704', 'gene', 267, 'genes'), ('PR_000006009', 'alpha-catulin', 306, 'cathelicidin'), ('CHEBI_27300', 'vitamin D', 364, 'vitamin D'), ('GO_0045087', 'innate immune response', 383, 'innate immunity'), ('NCBITaxon_9606', 'Homo sapiens', 447, 'human'), ('CHEBI_27300', 'vitamin D', 476, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 523, 'microbial')]	0	['1,25(oh)2d3molecule antimicrobial peptide  expression human keratinocytes, monocytes, neutrophils, human cell lines.9tlr activation human macrophages up-regulates expression  receptor -1-hydroxylase induction cathelicidin.10these tlrs -mediated innate immunity, ability human populations produce  microbial infection.']
S66-PMC3695234	PMC3695234	7/2013	S66-PMC3695234	['another prospective Birth cohort study investigated Vitamin D deficiency and Food sensitization, and genotyped 11 Genes INVOLVED in Regulating Ige and 25(Oh)D3Concentration.']	[('SUPERFICIAL_RELATIONSHIP', 120)]	1	[('GO_0007567', 'parturition', 20, 'birth'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_33290', 'food', 77, 'food'), ('SO_0000704', 'gene', 114, 'genes'), ('GO_0065007', 'biological regulation', 132, 'regulating'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 143, 'IgE'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 151, '25(OH)D3concentration'), ('PR_000010888', 'deubiquitinase MYSM1', 151, '25 ... OH ... D3concentration')]	0	['another birth  food sensitization, genotyped 11  ige 25(oh)d3concentration.']
S67-PMC3695234	PMC3695234	7/2013	S67-PMC3695234	['in that study, a significant INTERACTION between Il4 Gene polymorphism and Vitamin D deficiency was OBSERVED.17THESE data INDICATE that Vitamin D deficiency MAY increase the risk of Food sensitization in certain genotypes, PROVIDING EVIDENCE of Gene-Vitamin D INTERACTION in Food sensitization.']	[('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 100), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 122), ('INCOMPLETE_EVIDENCE', 157), ('PROBABLE_UNDERSTANDING', 223), ('INCOMPLETE_EVIDENCE', 233), ('SUPERFICIAL_RELATIONSHIP', 260)]	8	[('PR_000008989', 'interleukin-1 family member 7', 49, 'IL4'), ('SO_0000704', 'gene', 53, 'gene'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_33290', 'food', 182, 'food'), ('SO_0000704', 'gene', 245, 'gene'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin D'), ('CHEBI_33290', 'food', 275, 'food')]	0	['study, il4  polymorphism  observed.17these  increase food sensitization genotypes, food sensitization.']
S10-PMC3702245	PMC3702245	6/2013	S10-PMC3702245	['a second hydroxylation takes place in the Kidney, which converts 25(Oh)D to the most biologically active Metabolite, 1,25-Dihydroxyvitamin D, the major classical physiologic function of which is to increase calcium and Phosphorus absorption from the Gut in order to maintain Calcium Homeostasis and promote mineralization of Osteoid bone.9\nalthough the Renal 1-alpha hydroxylase (Cytochrome P450 [Cyp]27B1) enzyme is a MAJOR DETERMINANT of Synthesis of 1,25-Dihydroxyvitamin D, IT IS KNOWN that Cyp27B1 is Expressed in Nonrenal Tissues to produce 1,25 Dihydroxyvitamin D.6,19in addition, Vitamin D receptors are also Expressed in a variety of Organs, Tissues, and cells (seefigure 1).20the 1,25-Dihydroxyvitamin D locally produced in Extrarenal Tissues, such as immune cells, Pancreatic Beta Cells, the Intestine, Prostate, Breast, and other Organs, Controls multiple Vitamin D-responsive Genes, and THUS plays an important physiologic ROLE in Cardiovascular health,21,22the Adaptive and Innate Immune Responses,23,24insulin secretion,25,26regulation of Cell Proliferation, Differentiation, and Apoptosis, and inhibition of Angiogenesis.27\n\nVitamin D Homeostasis and functions during Pregnancy\nthe classical function of Vitamin D is to maintain calcium Homeostasis.']	[('IMPORTANT_CONSIDERATION', 419), ('SUPERFICIAL_RELATIONSHIP', 425), ('INCOMPLETE_EVIDENCE', 478), ('PROBABLE_UNDERSTANDING', 900), ('SUPERFICIAL_RELATIONSHIP', 936)]	5	[('UBERON_0002113', 'kidney', 42, 'kidney'), ('CHEBI_71657', 'versiconol acetate', 65, '25(OH)D'), ('CHEBI_39382', 'flufenoxuron', 105, 'metabolite'), ('CHEBI_67472', '15-epi-lupulin B', 117, '1,25-dihydroxyvitamin D'), ('CHEBI_35885', 'secondary phosphine', 219, 'phosphorus'), ('UBERON_0001555', 'digestive tract', 250, 'gut'), ('GO_0055073', 'cadmium ion homeostasis', 275, 'calcium homeostasis'), ('UBERON_0008883', 'osteoid', 325, 'osteoid'), ('UBERON_0002113', 'kidney', 353, 'renal'), ('CHEBI_4056', 'cytochrome', 380, 'cytochrome'), ('PR_000006100', 'aromatase', 380, 'cytochrome P450'), ('PR_000006138', 'cytochrome P450 4F11', 397, 'CYP ... 27B1'), ('GO_0009057', 'macromolecule catabolic process', 440, 'synthesis'), ('CHEBI_67472', '15-epi-lupulin B', 453, '1,25-dihydroxyvitamin D'), ('PR_000006101', 'cytochrome P450 1A1', 495, 'CYP27B1'), ('GO_0010467', 'gene expression', 506, 'expressed'), ('UBERON_0002481', 'bone tissue', 519, 'nonrenal tissues'), ('CHEBI_67469', '15-hydroxyajubractin C', 547, '1,25 dihydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 588, 'vitamin D'), ('GO_0010467', 'gene expression', 617, 'expressed'), ('UBERON_0000062', 'organ', 643, 'organs'), ('UBERON_0000479', 'tissue', 651, 'tissues'), ('CHEBI_67472', '15-epi-lupulin B', 690, '1,25-dihydroxyvitamin D'), ('UBERON_0005292', 'extraembryonic tissue', 734, 'extrarenal tissues'), ('CL_0000169', 'type B pancreatic cell', 776, 'pancreatic beta cells'), ('UBERON_0001264', 'pancreas', 776, 'pancreatic'), ('UBERON_0000160', 'intestine', 803, 'intestine'), ('UBERON_0002367', 'prostate gland', 814, 'prostate'), ('UBERON_0000310', 'breast', 824, 'breast'), ('UBERON_0000062', 'organ', 842, 'organs'), ('GO_0065007', 'biological regulation', 850, 'controls'), ('CHEBI_27300', 'vitamin D', 868, 'vitamin D'), ('SO_0000704', 'gene', 889, 'genes'), ('UBERON_0004535', 'cardiovascular system', 944, 'cardiovascular'), ('GO_0051886', 'negative regulation of timing of anagen', 975, 'adaptive ...'), ('GO_0044419', 'biological process involved in interspecies interaction between organisms', 988, 'innate immune responses'), ('UBERON_0002405', 'immune system', 995, 'immune'), ('GO_0030154', 'cell differentiation', 1054, 'cell proliferation ... differentiation'), ('GO_0006915', 'apoptotic process', 1095, 'apoptosis'), ('GO_0001525', 'angiogenesis', 1124, 'angiogenesis'), ('CHEBI_28384', 'vitamin K', 1141, 'Vitamin D'), ('GO_0042592', 'homeostatic process', 1151, 'homeostasis'), ('GO_0007565', 'female pregnancy', 1184, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1220, 'vitamin D'), ('GO_0042592', 'homeostatic process', 1253, 'homeostasis')]	0	['hydroxylation takes place kidney, converts 25(oh)d biologically metabolite, 1,25-dihydroxyvitamin d, physiologic increase calcium phosphorus absorption gut maintain calcium homeostasis mineralization osteoid bone.9\nalthough renal 1-alpha hydroxylase (cytochrome p450 [cyp]27b1) enzyme synthesis 1,25-dihydroxyvitamin d, cyp27b1 expressed nonrenal tissues produce 1,25 dihydroxyvitamin d.6,19in addition,  receptors expressed organs, tissues, cells (seefigure 1).20the 1,25-dihydroxyvitamin locally extrarenal tissues, immune cells, pancreatic beta cells, intestine, prostate, breast, organs, -responsive plays physiologic cardiovascular health,21,22the adaptive innate immune responses,23,24insulin secretion,25,26regulation cell proliferation, differentiation, apoptosis, inhibition angiogenesis.27\n\nvitamin homeostasis functions pregnancy\nthe  maintain calcium homeostasis.']
S40-PMC3702245	PMC3702245	6/2013	S40-PMC3702245	['randomized controlled STUDIES including larger sample sizes and repeated Vitamin D measurements during Pregnancy WILL BE NEEDED to CONFIRM the RELATIONSHIP between Vitamin D supplementation and fetal growth.82\n\nmaternal COMPLICATIONS\nOBSERVATIONAL studies REPORTED an ASSOCIATION between maternal Vitamin D status during Pregnancy and development of pre-eclampsia, which has both a Genetic and an immunologic pathogenesis.']	[('FUTURE_WORK', 22), ('FUTURE_WORK', 113), ('INCOMPLETE_EVIDENCE', 131), ('SUPERFICIAL_RELATIONSHIP', 143), ('PROBLEM_COMPLICATION', 220), ('INCOMPLETE_EVIDENCE', 234), ('INCOMPLETE_EVIDENCE', 256), ('SUPERFICIAL_RELATIONSHIP', 268)]	8	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 297, 'vitamin D'), ('GO_0007565', 'female pregnancy', 321, 'pregnancy'), ('SO_0000704', 'gene', 382, 'genetic')]	0	['randomized sample sizes  measurements pregnancy  supplementation fetal growth.82\n\nmaternal complications\nobservational maternal  status pregnancy pre-eclampsia,  immunologic pathogenesis.']
S37-PMC3705146	PMC3705146	5/2013	S37-PMC3705146	['clearly, the relative lack of sunlight had an evolutionary IMPACT on Genes AFFECTING Vitamin D generation from sunlight, BUT WHAT EVIDENCE is there that it MIGHT also have selected for a change in the prevalence of a disease such as schizophrenia?']	[('SUPERFICIAL_RELATIONSHIP', 59), ('SUPERFICIAL_RELATIONSHIP', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('EXPLICIT_QUESTION', 125), ('INCOMPLETE_EVIDENCE', 130), ('INCOMPLETE_EVIDENCE', 156), ('EXPLICIT_QUESTION', 246)]	7	[('SO_0000704', 'gene', 69, 'genes'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]	0	['clearly, relative sunlight evolutionary   generation sunlight, selected disease schizophrenia?']
S217-PMC3705146	PMC3705146	5/2013	S217-PMC3705146	['the need for Vitamin D MAY have played an IMPORTANT ROLE in selecting for polymorphisms in a variety of light-responsive Genes, including the melanotropins.']	[('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 42), ('SUPERFICIAL_RELATIONSHIP', 52)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('SO_0000704', 'gene', 121, 'genes')]	0	[' played selecting polymorphisms light-responsive melanotropins.']
S221-PMC3705146	PMC3705146	5/2013	S221-PMC3705146	['in such a manner, certain polymorphisms in melanotropin Genes MAY have become more prevalent in low-light environments IF they positively AFFECTED the natural Synthesis Of Vitamin D by reducing the Synthesis and Sequestration Of Melanin (valverde et al.,1995).']	[('INCOMPLETE_EVIDENCE', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 119), ('SUPERFICIAL_RELATIONSHIP', 138)]	3	[('SO_0000704', 'gene', 56, 'genes'), ('GO_0030474', 'spindle pole body duplication', 159, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D'), ('GO_0009057', 'macromolecule catabolic process', 198, 'synthesis'), ('GO_0098725', 'symmetric cell division', 212, 'sequestration of melanin'), ('CHEBI_25179', 'melanins', 229, 'melanin')]	0	['manner, polymorphisms melanotropin  low-light environments positively natural synthesis  reducing synthesis sequestration melanin (valverde et al.,1995).']
S223-PMC3705146	PMC3705146	5/2013	S223-PMC3705146	['ALTHOUGH no Genetic associations between Vitamin-D receptors or enzymes INVOLVED in its formation or degradation HAVE yet BEEN IDENTIFIED for schizophrenia, that outcome does not NECESSARILY mean that Vitamin D is without effect in modifying the phenotypic plasticity that is obviously present in the disease.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 72), ('INCOMPLETE_EVIDENCE', 113), ('INCOMPLETE_EVIDENCE', 127), ('PROBABLE_UNDERSTANDING', 179)]	6	[('SO_0000704', 'gene', 12, 'genetic'), ('CHEBI_83326', 'tedizolid phosphate', 41, 'vitamin-D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 41, 'vitamin-D'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D')]	0	['although  vitamin-d receptors enzymes formation degradation schizophrenia, outcome  modifying phenotypic plasticity disease.']
S262-PMC3705146	PMC3705146	5/2013	S262-PMC3705146	['the need for Vitamin D MAY have AFFECTED NOT ONLY Gene frequencies of relevance to schizophrenia BUT MAY ALSO have Modulated Gene-environment INTERACTIONS that CAN occur in differing light regimes.']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 32), ('ANOMALY_CURIOUS_FINDING', 41), ('ANOMALY_CURIOUS_FINDING', 97), ('INCOMPLETE_EVIDENCE', 101), ('ANOMALY_CURIOUS_FINDING', 105), ('SUPERFICIAL_RELATIONSHIP', 142), ('INCOMPLETE_EVIDENCE', 160)]	8	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('SO_0000704', 'gene', 50, 'gene'), ('GO_0065007', 'biological regulation', 115, 'modulated'), ('SO_0000704', 'gene', 125, 'gene')]	0	['  frequencies schizophrenia -environment occur regimes.']
S139-PMC3713405	PMC3713405	7/2013	S139-PMC3713405	['this Complex binds to Vitamin D response elements (vdre) in the Promoters of a number of Genes; to Regulate their transcription (christakos et al., 2003).']	[('DIFFICULT_TASK', 5)]	1	[('GO_0032991', 'protein-containing complex', 5, 'complex'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('SO_0000167', 'promoter', 64, 'promoters'), ('SO_0000704', 'gene', 89, 'genes'), ('GO_0065007', 'biological regulation', 99, 'regulate')]	0	['binds  response elements (vdre) promoters regulate transcription (christakos et al., 2003).']
S144-PMC3713405	PMC3713405	7/2013	S144-PMC3713405	['dvd-deficient e12 Embryos show decreased Gene Expression of nurr1, P57Kip2 and th (cui et al., 2010) SUGGESTING altered Vitamin D Signaling AFFECTS early Monoamine Cell Development, PERHAPS EVEN prior to e12.']	[('INCOMPLETE_EVIDENCE', 101), ('SUPERFICIAL_RELATIONSHIP', 140), ('INCOMPLETE_EVIDENCE', 182), ('ANOMALY_CURIOUS_FINDING', 190)]	4	[('UBERON_0000922', 'embryo', 18, 'embryos'), ('GO_0010467', 'gene expression', 41, 'gene expression'), ('SO_0000704', 'gene', 41, 'gene'), ('PR_000004267', 'AT-rich interactive domain-containing protein 4A', 67, 'p57Kip2'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('GO_0043931', 'ossification involved in bone maturation', 120, 'vitamin D signaling'), ('CHEBI_17134', 'octopamine', 154, 'monoamine'), ('GO_0048468', 'cell development', 164, 'cell development')]	0	['dvd-deficient e12 embryos decreased  expression nurr1, p57kip2 th (cui et al., 2010) altered  signaling monoamine cell development, e12.']
S129-PMC3717170	PMC3717170	5/2013	S129-PMC3717170	['li and colleagues have isolated Monocytes from patients and examined Expression of a number OF Genes RELATED to Vitamin D Metabolism and Immune Responses.']	[('ANOMALY_CURIOUS_FINDING', 92), ('SUPERFICIAL_RELATIONSHIP', 101)]	2	[('CL_0000576', 'monocyte', 32, 'monocytes'), ('GO_0010467', 'gene expression', 69, 'expression'), ('SO_0000704', 'gene', 95, 'genes'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 112, 'vitamin D metabolism'), ('GO_0006955', 'immune response', 137, 'immune responses'), ('UBERON_0002405', 'immune system', 137, 'immune')]	0	['li colleagues monocytes patients expression   metabolism immune responses.']
S7-PMC3773018	PMC3773018	4/2013	S7-PMC3773018	['conclusions\nPrenatal and early Postnatal Vitamin D levels, along with individual Genetic susceptibility, SHOULD BE CONSIDERED in assessing the ROLE of Vitamin D in the development of fs and Food allergy.']	[('FUTURE_WORK', 105), ('FUTURE_WORK', 115), ('SUPERFICIAL_RELATIONSHIP', 143)]	3	[('GO_0007565', 'female pregnancy', 12, 'Prenatal'), ('GO_0007567', 'parturition', 31, 'postnatal'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('SO_0000704', 'gene', 81, 'genetic'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('CHEBI_33290', 'food', 190, 'food')]	0	['conclusions\nprenatal postnatal  levels, along individual  susceptibility,  fs food allergy.']
S18-PMC3773018	PMC3773018	4/2013	S18-PMC3773018	['our study, conducted primarily in african american children in the u.s., was the FIRST to SHOW that Genetic polymorphisms MIGHT modify the EFFECTS of Vitamin D deficiency on the risk of fs (18).']	[('INCOMPLETE_EVIDENCE', 81), ('INCOMPLETE_EVIDENCE', 90), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 139)]	4	[('SO_0000704', 'gene', 100, 'genetic'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D')]	0	['study, african american children u.s.,  polymorphisms  fs (18).']
S20-PMC3773018	PMC3773018	4/2013	S20-PMC3773018	['in an earlier report, we examined a single time point Gene-Cord Blood Vitamin D INTERACTION on fs in the boston Birth cohort (16).']	[('SUPERFICIAL_RELATIONSHIP', 80)]	1	[('SO_0000704', 'gene', 54, 'gene'), ('UBERON_0002240', 'spinal cord', 59, 'cord'), ('UBERON_0000178', 'blood', 64, 'blood'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0007567', 'parturition', 112, 'Birth')]	0	['report, single -cord blood  fs boston birth (16).']
S22-PMC3773018	PMC3773018	4/2013	S22-PMC3773018	['HEREIN, we EXAMINED the INTERACTION of a Promoter polymorphism (rs2243250: c-590t) in the Il4 Gene and the longitudinal trajectory of Vitamin D status from Birth to early childhood on the risk of fs.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('SUPERFICIAL_RELATIONSHIP', 24)]	3	[('SO_0000167', 'promoter', 41, 'promoter'), ('PR_000008989', 'interleukin-1 family member 7', 90, 'IL4'), ('SO_0000704', 'gene', 94, 'gene'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007567', 'parturition', 156, 'birth')]	0	['herein, promoter polymorphism (rs2243250: c-590t) il4  longitudinal trajectory  status birth childhood fs.']
S72-PMC3773018	PMC3773018	4/2013	S72-PMC3773018	['we PREVIOUSLY reported the qualitative INTERACTIONS between Vitamin D deficiency, assessed from Cord Blood and a Genetic variant in the Gene Il4 (rs2243250), and fs in the same birth cohort (18).']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 39)]	2	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 96, 'cord'), ('UBERON_0000178', 'blood', 101, 'blood'), ('SO_0000704', 'gene', 113, 'genetic'), ('SO_0000704', 'gene', 136, 'gene'), ('PR_000008989', 'interleukin-1 family member 7', 141, 'IL4')]	0	['qualitative  deficiency, cord blood  variant  il4 (rs2243250), fs birth (18).']
S83-PMC3773018	PMC3773018	4/2013	S83-PMC3773018	['furthermore, we OBSERVED significant INTERACTION EFFECTS between the Il4 Gene polymorphism and persistently low Vitamin D status on fs in this SMALLER sized study sample.']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 37), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 143)]	4	[('PR_000008989', 'interleukin-1 family member 7', 69, 'IL4'), ('SO_0000704', 'gene', 73, 'gene'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]	0	['furthermore, il4  polymorphism  status fs sample.']
S87-PMC3773018	PMC3773018	4/2013	S87-PMC3773018	['for this subset study, we have ONLY presented findings for the Il4 Promoter polymorphism given that rs2243250 HAS BEEN commonly studied and has already been shown to have the most significant Gene-Vitamin D deficiency INTERACTION on fs (18).']	[('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 110), ('SUPERFICIAL_RELATIONSHIP', 218)]	3	[('PR_000008989', 'interleukin-1 family member 7', 63, 'IL4'), ('SO_0000167', 'promoter', 67, 'promoter'), ('SO_0000704', 'gene', 192, 'gene'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D')]	0	['subset study, il4 promoter polymorphism rs2243250 fs (18).']
S103-PMC3773018	PMC3773018	4/2013	S103-PMC3773018	['FUTURE laboratory STUDIES also SHOULD BE SERIOUSLY CONSIDERED to help BETTER UNDERSTAND the molecular basis UNDERLYING HOW the immunomodulatory EFFECT of Vitamin D and Regulatory EFFECT of the Il4 Gene on Ige Production JOINTLY INFLUENCE the risk of fs.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 31), ('IMPORTANT_CONSIDERATION', 41), ('FUTURE_WORK', 51), ('IMPORTANT_CONSIDERATION', 51), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 108), ('EXPLICIT_QUESTION', 119), ('SUPERFICIAL_RELATIONSHIP', 144), ('SUPERFICIAL_RELATIONSHIP', 179), ('SUPERFICIAL_RELATIONSHIP', 220), ('SUPERFICIAL_RELATIONSHIP', 228)]	12	[('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('GO_0065007', 'biological regulation', 168, 'regulatory'), ('PR_000008989', 'interleukin-1 family member 7', 193, 'IL4'), ('SO_0000704', 'gene', 197, 'gene'), ('GO_0032631', 'interleukin-27 production', 205, 'IgE production'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 205, 'IgE')]	0	['future laboratory molecular immunomodulatory  il4  ige production fs.']
S105-PMC3773018	PMC3773018	4/2013	S105-PMC3773018	['overall, THIS STUDY UNDERSCORES THE NEED to simultaneously CONSIDER both Cord Blood and Postnatal Vitamin D levels, along with Genetic susceptibility, in the development of fs and Food allergy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 32), ('FUTURE_WORK', 36), ('FUTURE_WORK', 59), ('IMPORTANT_CONSIDERATION', 59)]	6	[('UBERON_0002240', 'spinal cord', 73, 'cord'), ('UBERON_0000178', 'blood', 78, 'blood'), ('GO_0007567', 'parturition', 88, 'postnatal'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('SO_0000704', 'gene', 127, 'genetic'), ('CHEBI_33290', 'food', 180, 'food')]	0	['overall, cord blood postnatal  levels, along  susceptibility, fs food allergy.']
S106-PMC3773018	PMC3773018	4/2013	S106-PMC3773018	['the extent of Vitamin D insufficiency in this process MAY BE UNDERESTIMATED by a static, single value, and emphasizes that longer term exposure to a Vitamin D deficient state MIGHT have profound health consequences in a specific Genetic environment.']	[('INCOMPLETE_EVIDENCE', 54), ('PROBLEM_COMPLICATION', 61), ('INCOMPLETE_EVIDENCE', 175)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('SO_0000704', 'gene', 229, 'genetic')]	0	[' process static, single value, longer term exposure   environment.']
S2-PMC3926113	PMC3926113	1/2014	S2-PMC3926113	['in the PRESENT STUDY, we INVESTIGATED the developmental pattern and EFFECT of vitc deficiency on antioxidants, Vitamin E and Superoxide dismutase (sod), assessed oxidative damage by measuring Malondialdehyde (Mda), Hydroxynonenal (Hne) and Nitrotyrosine (Nt) and analysed Gene and protein Expression of Apoptosis marker Caspase-3 in the guinea pig foetal Brain at two Gestational (gd) time points, gd 45/pre-term and gd 56/near term following either a vitc sufficient (ctrl) or deficient (def) maternal dietary regime.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('SUPERFICIAL_RELATIONSHIP', 68)]	3	[('CHEBI_27300', 'vitamin D', 111, 'vitamin E'), ('CHEBI_18421', 'superoxide', 125, 'superoxide'), ('CHEBI_16480', 'nitric oxide', 192, 'malondialdehyde'), ('CHEBI_34840', 'methyl methacrylate', 209, 'MDA'), ('CHEBI_5445', 'glyceraldehyde', 215, 'hydroxynonenal'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 231, 'HNE'), ('CHEBI_50654', 'but-2-enoate ester', 240, 'nitrotyrosine'), ('CHEBI_13389', 'NAD', 255, 'NT'), ('SO_0000704', 'gene', 272, 'gene'), ('GO_0010467', 'gene expression', 289, 'expression'), ('GO_0006915', 'apoptotic process', 303, 'apoptosis'), ('PR_000002319', 'catenin beta-1 isoform 1', 320, 'caspase-3'), ('UBERON_0000955', 'brain', 355, 'brain'), ('GO_0007565', 'female pregnancy', 368, 'gestational')]	0	['study, developmental vitc antioxidants,  superoxide dismutase (sod), oxidative measuring malondialdehyde (mda), hydroxynonenal (hne) nitrotyrosine (nt)  protein expression apoptosis caspase-3 guinea pig foetal brain gestational (gd) points, gd 45/pre-term gd 56/near term following (def) maternal dietary regime.']
S1-PMC4045304	PMC4045304	2/2014	S1-PMC4045304	['though both Genetic and multiple environmental RISK FACTORS HAVE BEEN studied extensively, many POTENTIALLY modifiable RISK factors including nutritional and Immune function RELATED RISK FACTORS such as Vitamin D, Folic Acid, and Metabolic syndrome have NOT RECEIVED SUFFICIENT ATTENTION.']	[('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 119), ('SUPERFICIAL_RELATIONSHIP', 174), ('SUPERFICIAL_RELATIONSHIP', 182), ('INCOMPLETE_EVIDENCE', 254)]	7	[('SO_0000704', 'gene', 12, 'genetic'), ('UBERON_0002405', 'immune system', 158, 'immune'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('CHEBI_30751', 'formic acid', 214, 'folic acid'), ('GO_0008152', 'metabolic process', 230, 'metabolic')]	0	['though  environmental extensively, nutritional immune folic acid, metabolic syndrome received attention.']
S192-PMC4045304	PMC4045304	2/2014	S192-PMC4045304	['BECAUSE activated Vitamin D (1, 25-Dihydroxy Vitamin D), a Secosteroid, upregulates the Dna Repair Gene, Vitamin deficiency during development MAY inhibit the Repair of de novo dna mutations in fetuses and infants and THUS CONTRIBUTE to risk of autism.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 143), ('PROBABLE_UNDERSTANDING', 218), ('SUPERFICIAL_RELATIONSHIP', 223)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_50341', '1-hydroxyethyl group', 29, '1, 25-dihydroxy'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_35785', 'sphingoid', 59, 'secosteroid'), ('GO_0006281', 'DNA repair', 88, 'DNA repair'), ('SO_0000704', 'gene', 99, 'gene'), ('CHEBI_33229', 'vitamin (role)', 105, 'vitamin'), ('GO_0006281', 'DNA repair', 159, 'repair')]	0	['activated  (1, 25-dihydroxy ), secosteroid, upregulates dna repair vitamin inhibit repair de novo dna mutations fetuses infants autism.']
S195-PMC4045304	PMC4045304	2/2014	S195-PMC4045304	['cannell PROPOSED a THEORY for the Genetic component of autism involving the Vitamin D system [84].']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 19)]	2	[('SO_0000704', 'gene', 34, 'genetic'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]	0	['cannell  autism  system [84].']
S205-PMC4045304	PMC4045304	2/2014	S205-PMC4045304	['heritability of autism MAY BE EXPLAINED by quantitative Genetic variations in SOME facet of Vitamin D Metabolism, such as vdr or in the enzymes that activate Vitamin D [86].']	[('INCOMPLETE_EVIDENCE', 23), ('PROBABLE_UNDERSTANDING', 30), ('INCOMPLETE_EVIDENCE', 78)]	3	[('SO_0000704', 'gene', 56, 'genetic'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 92, 'vitamin D metabolism'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D')]	0	['heritability autism quantitative  facet  metabolism, vdr enzymes activate  [86].']
S224-PMC4045304	PMC4045304	2/2014	S224-PMC4045304	['the EFFECT of a Genetically impaired Vitamin D system combined with INADEQUATE amounts of Vitamin D MAY BE ASSOCIATED with de novo mutations REPORTED in autism.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('IMPORTANT_CONSIDERATION', 68), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 107), ('INCOMPLETE_EVIDENCE', 141)]	5	[('SO_0000704', 'gene', 16, 'genetically'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]	0	['  system combined amounts  de novo mutations autism.']
S226-PMC4045304	PMC4045304	2/2014	S226-PMC4045304	['the quantitative Genetic variation in various components of Vitamin D, as PROPOSED by cannall, MAY BE a piece of this puzzle.']	[('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 95)]	2	[('SO_0000704', 'gene', 17, 'genetic'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]	0	['quantitative  cannall, piece puzzle.']
S271-PMC4045304	PMC4045304	2/2014	S271-PMC4045304	['MORE RESEARCH IS also NEEDED to FURTHER investigate quantitative Genetic variations in various components of the Vitamin D system.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 5), ('FUTURE_WORK', 22), ('FUTURE_WORK', 32)]	4	[('SO_0000704', 'gene', 65, 'genetic'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D')]	0	['quantitative   system.']
S84-PMC4071151	PMC4071151	6/2014	S84-PMC4071151	['the precise pathogenesis of these conditions REMAINS UNKNOWN, BUT non-Genetic and non-infectious causes HAVE BEEN POSTULATED and include maternal Vitamin A deficiency [25].']	[('FULL_UNKNOWN', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 62), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 114)]	4	[('SO_0000704', 'gene', 70, 'genetic'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin A')]	0	['precise pathogenesis conditions unknown, non- non-infectious causes maternal  [25].']
S22-PMC4072587	PMC4072587	6/2014	S22-PMC4072587	['more RECENTLY, maternal Vitamin D deficiency HAS BEEN ASSOCIATED with impaired infant Language Development in school-aged children[24], and HAS BEEN SUGGESTED as a possible environmental risk FACTOR for autism spectrum disorder, HIGHLIGHTING the IMPORTANT ROLE of Vitamin D in Brain Development, Neuronal function and Gene Regulation[10],[25],[26].']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 192), ('INCOMPLETE_EVIDENCE', 229), ('IMPORTANT_CONSIDERATION', 246), ('SUPERFICIAL_RELATIONSHIP', 256)]	8	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0060132', 'prolactin secreting cell development', 86, 'language development'), ('CHEBI_27300', 'vitamin D', 264, 'vitamin D'), ('GO_0007420', 'brain development', 277, 'brain development'), ('UBERON_0000955', 'brain', 277, 'brain'), ('CL_0000540', 'neuron', 296, 'neuronal'), ('SO_0000704', 'gene', 318, 'gene'), ('GO_0065007', 'biological regulation', 323, 'regulation')]	0	['recently, maternal  infant language school-aged children[24], environmental autism spectrum disorder,  brain development, neuronal  regulation[10],[25],[26].']
S124-PMC4072587	PMC4072587	6/2014	S124-PMC4072587	['RECENT RESEARCH SUGGESTS that Vitamin D deficiency during Pregnancy or early childhood MAY BE an environmental TRIGGER for autism spectrum disorder in infants Genetically predisposed to autism, EITHER through its EFFECT on Neuronal function and Brain Development, or through Gene interaction and Regulation.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 194), ('SUPERFICIAL_RELATIONSHIP', 213)]	6	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('SO_0000704', 'gene', 159, 'genetically'), ('CL_0000540', 'neuron', 223, 'neuronal'), ('GO_0007420', 'brain development', 245, 'brain development'), ('UBERON_0000955', 'brain', 245, 'brain'), ('SO_0000704', 'gene', 275, 'gene'), ('GO_0065007', 'biological regulation', 296, 'regulation')]	0	['recent  pregnancy childhood environmental autism spectrum disorder infants  autism, neuronal brain development,  regulation.']
S179-PMC4113768	PMC4113768	7/2014	S179-PMC4113768	['FURTHER STUDIES assessing the EFFECT of Vitamin D supplementation, and RELATED molecular and Genetic FACTORS, on Colorectal cancer survival ARE WARRANTED.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 71), ('SUPERFICIAL_RELATIONSHIP', 101), ('FUTURE_WORK', 140)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('SO_0000704', 'gene', 93, 'genetic'), ('UBERON_0012652', 'colorectum', 113, 'colorectal')]	0	[' supplementation, molecular  factors, colorectal cancer survival warranted.']
S479-PMC4113768	PMC4113768	7/2014	S479-PMC4113768	['conclusions: (1) SINCE the use of supplements containing Vitamin A as well as Vitamin D is common, WHETHER in Cod Liver oil OR multi-vitamins, especially in developed countries, Vitamin A status is LIKELY to CONFOUND rcts of Vitamin D in westernized populations; (2) in particular, high Vitamin A Intakes COULD ACCOUNT for j or inverse u shaped curves for outcomes in rcts, AS COULD Gene polymorphisms increasing circulating Retinol/Retinoids; (3) CONVERSELY, poor Vitamin D status MAY BE expected to CONFOUND rcts of Vitamin A in developing countries; (4) as well as Vitamin A intakes, other lifestyle factors that are POTENTIAL CONFOUNDERS of the EFFECTS of Vitamin D SHOULD BE CONSIDERED in the PLANNING of FUTURE rcts of supplemental Vitamin D, including intakes of other Nutrients, tobacco usage, and also betel-chewing which MAY increase Catabolism Of Vitamin D and is a habit used by 10% of the world population.']	[('PROBABLE_UNDERSTANDING', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99), ('PROBABLE_UNDERSTANDING', 198), ('PROBLEM_COMPLICATION', 208), ('INCOMPLETE_EVIDENCE', 305), ('IMPORTANT_CONSIDERATION', 311), ('PROBABLE_UNDERSTANDING', 374), ('INCOMPLETE_EVIDENCE', 377), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 448), ('INCOMPLETE_EVIDENCE', 482), ('PROBLEM_COMPLICATION', 501), ('INCOMPLETE_EVIDENCE', 620), ('PROBLEM_COMPLICATION', 630), ('SUPERFICIAL_RELATIONSHIP', 649), ('FUTURE_WORK', 670), ('FUTURE_WORK', 680), ('FUTURE_WORK', 698), ('FUTURE_WORK', 710), ('INCOMPLETE_EVIDENCE', 831)]	19	[('CHEBI_27300', 'vitamin D', 57, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 110, 'cod'), ('UBERON_0002107', 'liver', 114, 'liver'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin A'), ('GO_0007631', 'feeding behavior', 297, 'intakes'), ('SO_0000704', 'gene', 383, 'gene'), ('CHEBI_26536', 'retinoic acid', 425, 'retinol'), ('CHEBI_26537', 'retinoid', 433, 'retinoids'), ('CHEBI_27300', 'vitamin D', 465, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 518, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 568, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 660, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 738, 'vitamin D'), ('CHEBI_33284', 'nutrient', 776, 'nutrients'), ('GO_0044851', 'hair cycle phase', 844, 'catabolism of vitamin D'), ('CHEBI_27300', 'vitamin D', 858, 'vitamin D')]	0	['conclusions: (1) supplements containing   common, cod liver oil multi-vitamins, countries,  status rcts  westernized populations; (2) particular,  intakes j u curves outcomes rcts,  polymorphisms circulating retinol/retinoids; (3) conversely,  status rcts  countries; (4)  intakes, lifestyle  rcts supplemental intakes nutrients, tobacco usage, betel-chewing increase catabolism  habit 10% world population.']
S912-PMC4113768	PMC4113768	7/2014	S912-PMC4113768	['studies carried out in a number of types of Dogs by may mellanby SHOWED that Vitamin D deficiency damaged the Development Of Teeth at the same time as Bones and that this COULD BE reversed with a diet high in Vitamin D. she conducted a series of early randomized controlled trials in orphanages too that SHOWED lower rates of caries in children under 12 who were given diets higher in Vitamin D. RECENT RESEARCH in children with specific syndromes and in Gene knockout Mice have CONFIRMED a central ROLE for Vitamin D in Tooth mineralization with EFFECTS on Tooth structure, as described by may mellanby.']	[('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 304), ('INCOMPLETE_EVIDENCE', 396), ('INCOMPLETE_EVIDENCE', 479), ('SUPERFICIAL_RELATIONSHIP', 499), ('SUPERFICIAL_RELATIONSHIP', 547)]	7	[('NCBITaxon_33208', 'Metazoa', 44, 'dogs'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0042466', 'chemokinesis', 110, 'development of teeth'), ('UBERON_0001091', 'calcareous tooth', 125, 'teeth'), ('UBERON_0001474', 'bone element', 151, 'bones'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 385, 'vitamin D'), ('SO_0000704', 'gene', 455, 'gene'), ('NCBITaxon_10088', 'Mus <genus>', 469, 'mice'), ('CHEBI_27300', 'vitamin D', 508, 'vitamin D'), ('UBERON_0001091', 'calcareous tooth', 521, 'tooth'), ('UBERON_0001091', 'calcareous tooth', 558, 'tooth')]	0	['studies carried dogs mellanby  damaged teeth bones diet . orphanages rates caries children 12 diets higher . children syndromes  knockout mice central  tooth mineralization tooth structure, mellanby.']
S962-PMC4113768	PMC4113768	7/2014	S962-PMC4113768	['thirty-seven Single Nucleotide Polymorphisms (Snps) in 13 Genes (dbp, Dhcr7, Cubn, Lrp2, Crtam, Lta4H, Cyp2R1, Cyp3A4, Cyp27A1, Cyp27B1, Cyp24A1, vdr, rxra), INVOLVED with Vitamin D Transport, Metabolism and Signalling were typed using taqman Allelic discrimination assays.']	[('SUPERFICIAL_RELATIONSHIP', 158)]	1	[('SO_0000694', 'SNP', 13, 'single nucleotide polymorphisms'), ('SO_0000694', 'SNP', 46, 'SNPs'), ('SO_0000704', 'gene', 58, 'genes'), ('PR_000006474', 'ATP-dependent RNA helicase A', 70, 'DHCR7'), ('PR_000006022', 'lysosomal protective protein', 77, 'CUBN'), ('PR_000009920', 'low-density lipoprotein receptor-related protein 1B', 83, 'LRP2'), ('PR_000005866', 'cAMP-responsive element modulator', 89, 'CRTAM'), ('PR_000009920', 'low-density lipoprotein receptor-related protein 1B', 96, 'LTA4H'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 103, 'CYP2R1'), ('PR_000006131', 'cytochrome P450 3A43', 111, 'CYP3A4'), ('PR_000006101', 'cytochrome P450 1A1', 119, 'CYP27A1'), ('PR_000006101', 'cytochrome P450 1A1', 128, 'CYP27B1'), ('PR_000006101', 'cytochrome P450 1A1', 137, 'CYP24A1'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D'), ('GO_0007601', 'visual perception', 172, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 182, 'transport ...'), ('GO_0009554', 'megasporogenesis', 193, 'metabolism ... signalling'), ('SO_0001023', 'allele', 243, 'allelic')]	0	['thirty-seven single nucleotide polymorphisms (snps) 13  (dbp, dhcr7, cubn, lrp2, crtam, lta4h, cyp2r1, cyp3a4, cyp27a1, cyp27b1, cyp24a1, vdr, rxra),  transport, metabolism signalling typed using taqman allelic discrimination assays.']
S963-PMC4113768	PMC4113768	7/2014	S963-PMC4113768	['logistic regression was used TO IDENTIFY environmental and Genetic factors independently ASSOCIATED with risk of Vitamin D deficiency DEFINED as Serum 25(Oh)D concentration <50 nmol/l.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('SUPERFICIAL_RELATIONSHIP', 89), ('PROBABLE_UNDERSTANDING', 134)]	3	[('SO_0000704', 'gene', 59, 'genetic'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('UBERON_0001977', 'blood serum', 145, 'serum'), ('CHEBI_71657', 'versiconol acetate', 151, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 151, '25(OH ... D')]	0	['logistic regression environmental   serum 25(oh)d concentration <50 nmol/l.']
S971-PMC4113768	PMC4113768	7/2014	S971-PMC4113768	['Genetic variants in the Vitamin D pathway that HAVE PREVIOUSLY BEEN shown to ASSOCIATE with risk of Vitamin D deficiency in healthy Adult populations were not associated with deficiency in this patient group.']	[('IMPORTANT_CONSIDERATION', 47), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 77)]	3	[('SO_0000704', 'gene', 0, 'Genetic'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('UBERON_0007023', 'adult organism', 132, 'adult')]	0	[' variants   healthy adult populations patient group.']
S1393-PMC4113768	PMC4113768	7/2014	S1393-PMC4113768	['the AIM of THIS STUDY was THEREFORE TO INVESTIGATE the EFFECTS of Vitamin D on the Gene Expression of IMPORTANT enzymes INVOLVED in Brain Steroidogenesis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('PROBABLE_UNDERSTANDING', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 36), ('SUPERFICIAL_RELATIONSHIP', 55), ('IMPORTANT_CONSIDERATION', 102), ('SUPERFICIAL_RELATIONSHIP', 120)]	7	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0010467', 'gene expression', 83, 'gene expression'), ('SO_0000704', 'gene', 83, 'gene'), ('UBERON_0000955', 'brain', 132, 'brain'), ('GO_0001501', 'skeletal system development', 138, 'steroidogenesis')]	0	['  expression enzymes brain steroidogenesis.']
S1399-PMC4113768	PMC4113768	7/2014	S1399-PMC4113768	['the strongest suppressive EFFECT was seen on Cyp11A1, 3Β-Hsd and Cyp19A1 where the Vitamin D treatment decreased the Gene Expression to 30% compared to control.']	[('SUPERFICIAL_RELATIONSHIP', 26)]	1	[('PR_000006110', 'cytochrome P450 27, mitochondrial', 45, 'CYP11A1'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 54, '3β-HSD'), ('PR_000006101', 'cytochrome P450 1A1', 65, 'CYP19A1'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0010467', 'gene expression', 117, 'gene expression'), ('SO_0000704', 'gene', 117, 'gene')]	0	['suppressive cyp11a1, 3β-hsd cyp19a1  treatment decreased  expression 30% control.']
S1400-PMC4113768	PMC4113768	7/2014	S1400-PMC4113768	['the EFFECTS on Cyp17A1 as well as Cyp19A1 SUGGEST that the levels of Estrogens MAY BE AFFECTED by Vitamin D.\nconclusions: the results INDICATE that Vitamin D has a suppressive EFFECT on some of the Genes for enzymes in the Brain Steroidogenesis implicating that the products of these enzymes MAY BE decreased.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 42), ('INCOMPLETE_EVIDENCE', 79), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 134), ('SUPERFICIAL_RELATIONSHIP', 176), ('INCOMPLETE_EVIDENCE', 292)]	7	[('PR_000006101', 'cytochrome P450 1A1', 15, 'CYP17A1'), ('PR_000006101', 'cytochrome P450 1A1', 34, 'CYP19A1'), ('CHEBI_50114', 'estrogen', 69, 'estrogens'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('SO_0000704', 'gene', 198, 'genes'), ('UBERON_0000955', 'brain', 223, 'brain'), ('GO_0001501', 'skeletal system development', 229, 'steroidogenesis')]	0	['cyp17a1 cyp19a1 levels estrogens .\nconclusions: results  suppressive  enzymes brain steroidogenesis products enzymes decreased.']
S1407-PMC4113768	PMC4113768	7/2014	S1407-PMC4113768	['to COMPLICATE the picture, Genetic DIFFERENCES in the Vitamin D receptor (vdr) MAY also be of IMPORTANCE.']	[('DIFFICULT_TASK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('INCOMPLETE_EVIDENCE', 79), ('IMPORTANT_CONSIDERATION', 94)]	4	[('SO_0000704', 'gene', 27, 'genetic'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]	0	['picture,  (vdr) importance.']
S1519-PMC4113768	PMC4113768	7/2014	S1519-PMC4113768	['THUS, Genetic FACTORS MAY help to identify who is MOST AT RISK of developing low Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 22), ('PROBABLE_UNDERSTANDING', 50), ('IMPORTANT_CONSIDERATION', 55)]	5	[('SO_0000704', 'gene', 6, 'genetic'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]	0	['thus,   status.']
S1522-PMC4113768	PMC4113768	7/2014	S1522-PMC4113768	['the participants were genotyped for 25 Snps in the Vitamin D pathway and two common Single Nucleotide Polymorphisms (Snps) in the Cyp2R1 Gene (rs10741657 and rs10766197) and two common Snps in the gc Gene (rs4588 and rs842999) were FOUND to PREDICT baseline S-25(Oh)D levels.']	[('INCOMPLETE_EVIDENCE', 232), ('SUPERFICIAL_RELATIONSHIP', 241)]	2	[('SO_0000694', 'SNP', 39, 'SNPs'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007601', 'visual perception', 51, 'vitamin D'), ('SO_0000694', 'SNP', 84, 'single nucleotide polymorphisms'), ('SO_0000694', 'SNP', 117, 'SNPs'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 130, 'CYP2R1'), ('SO_0000704', 'gene', 137, 'gene'), ('SO_0000694', 'SNP', 185, 'SNPs'), ('SO_0000704', 'gene', 200, 'gene'), ('PR_000015800', 'syntaxin-8', 258, 's-25(OH ... D'), ('CHEBI_71657', 'versiconol acetate', 260, '25(OH)D')]	0	['participants genotyped 25 snps  single nucleotide polymorphisms (snps) cyp2r1  (rs10741657 rs10766197) snps gc  (rs4588 rs842999) baseline s-25(oh)d levels.']
S1536-PMC4113768	PMC4113768	7/2014	S1536-PMC4113768	['in the FUTURE, Genetic FACTORS MIGHT be taken into ACCOUNT when RECOMMENDING Vitamin D supplementation or Food fortification.']	[('FUTURE_WORK', 7), ('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 31), ('IMPORTANT_CONSIDERATION', 51), ('FUTURE_WORK', 64)]	5	[('SO_0000704', 'gene', 15, 'genetic'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_33290', 'food', 106, 'food')]	0	['future,   supplementation food fortification.']
S1695-PMC4113768	PMC4113768	7/2014	S1695-PMC4113768	['THIS STUDY was AIMED TO INVESTIGATE the prevalence of Vitamin D deficiency in Adult female of local population in pakistan and TO find out social and Genetic FACTORS that may CONTRIBUTE in hypovitaminosis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('QUESTION_ANSWERED_BY_THIS_WORK', 127), ('SUPERFICIAL_RELATIONSHIP', 158), ('SUPERFICIAL_RELATIONSHIP', 175)]	6	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0007023', 'adult organism', 78, 'adult'), ('SO_0000704', 'gene', 150, 'genetic')]	0	[' adult female local population pakistan social  hypovitaminosis.']
S1852-PMC4113768	PMC4113768	7/2014	S1852-PMC4113768	['moreover, it HAS BEEN RECOGNIZED that Vitamin D has a WIDE RANGE of biological functions, including Cell Differentiation, inhibition of cell growth and Regulation Of Gene Expression.']	[('INCOMPLETE_EVIDENCE', 13), ('PROBABLE_UNDERSTANDING', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 54)]	3	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0030154', 'cell differentiation', 100, 'cell differentiation'), ('GO_0010468', 'regulation of gene expression', 152, 'regulation of gene expression'), ('SO_0000704', 'gene', 166, 'gene')]	0	['moreover,  biological functions, cell differentiation, inhibition cell  expression.']
S2244-PMC4113768	PMC4113768	7/2014	S2244-PMC4113768	['background: DESPITE the identification of several Genetic polymorphisms in the Vitamin D Receptor Gene (Vdrg), the rs2228570 polymorphism, identified by the Fok1 restriction enzyme, APPEARS to be the ONLY one INFLUENCING the size of the Translated protein.']	[('ANOMALY_CURIOUS_FINDING', 12), ('ANOMALY_CURIOUS_FINDING', 182), ('INCOMPLETE_EVIDENCE', 200), ('SUPERFICIAL_RELATIONSHIP', 209)]	4	[('SO_0000704', 'gene', 50, 'genetic'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 79, 'vitamin D receptor'), ('SO_0000704', 'gene', 98, 'gene'), ('PR_000017279', 'testis-specific basic protein Y 1', 104, 'VDRG'), ('PR_000007593', 'glutamate carboxypeptidase 2', 157, 'Fok1'), ('GO_0006412', 'translation', 237, 'translated')]	0	['background:  polymorphisms  receptor  (vdrg), rs2228570 polymorphism, fok1 enzyme, protein.']
S2257-PMC4113768	PMC4113768	7/2014	S2257-PMC4113768	['it is THUS CONCEIVABLE that polymorphisms in the Gene encoding this protein, the Vitamin D Receptor Gene (Vdr), MAY alter both its structure and functions and HENCE, MAY INFLUENCE one’s susceptibility to various debilitating diseases.']	[('PROBABLE_UNDERSTANDING', 6), ('INCOMPLETE_EVIDENCE', 11), ('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 112), ('PROBABLE_UNDERSTANDING', 159), ('INCOMPLETE_EVIDENCE', 166), ('SUPERFICIAL_RELATIONSHIP', 170)]	7	[('SO_0000704', 'gene', 49, 'gene'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 81, 'vitamin D receptor'), ('SO_0000704', 'gene', 100, 'gene'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 106, 'VDR')]	0	['polymorphisms  encoding protein,  receptor  (vdr), alter structure functions hence, one’s diseases.']
S2424-PMC4113768	PMC4113768	7/2014	S2424-PMC4113768	['contemporary and historical EVIDENCE INDICATES the VALUE of Vitamin D in treating tb and Genetic variation in Vitamin D receptors HAS BEEN LINKED to ethnic variations in tb.']	[('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 37), ('IMPORTANT_CONSIDERATION', 51), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 139)]	5	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('SO_0000704', 'gene', 89, 'genetic'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]	0	['contemporary  treating tb   receptors ethnic tb.']
S2563-PMC4113768	PMC4113768	7/2014	S2563-PMC4113768	['we AIMED TO EXAMINE the environmental and Genetic DETERMINANTS of change in 25 Hydroxy Vitamin D (25(Oh)D).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('SUPERFICIAL_RELATIONSHIP', 50)]	3	[('SO_0000704', 'gene', 42, 'genetic'), ('CHEBI_45557', 'sec-butyl group', 76, '25 hydroxy'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 98, '25(OH)D')]	0	['environmental  25 hydroxy  (25(oh)d).']
S2566-PMC4113768	PMC4113768	7/2014	S2566-PMC4113768	['eighty-eight Single Nucleotide Polymorphisms (Snps) in 41 candidate Genes RELATED to Vitamin D status were genotyped using sequenom massarray technology.']	[('SUPERFICIAL_RELATIONSHIP', 74)]	1	[('SO_0000694', 'SNP', 13, 'single nucleotide polymorphisms'), ('SO_0000694', 'SNP', 46, 'SNPs'), ('SO_0000704', 'gene', 68, 'genes'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]	0	['eighty-eight single nucleotide polymorphisms (snps) 41   status genotyped using sequenom massarray technology.']
S2574-PMC4113768	PMC4113768	7/2014	S2574-PMC4113768	['conclusion: THIS work SHOWS that Genetic FACTORS are ASSOCIATED with change in 25(Oh)D after Vitamin D supplementation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 41), ('SUPERFICIAL_RELATIONSHIP', 53)]	4	[('SO_0000704', 'gene', 33, 'genetic'), ('CHEBI_71657', 'versiconol acetate', 79, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]	0	['conclusion:  25(oh)d  supplementation.']
S3097-PMC4113768	PMC4113768	7/2014	S3097-PMC4113768	['THE CURRENT STUDY was DESIGNED TO IDENTIFY the EFFECT of Vitamin D insufficiency and deficiency (vdid) and host Genetic Single Nucleotide Polymorphisms (Snps) that alter Vitamin d receptor Expression on the RISK for tb in hiv-infected and –exposed infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('SUPERFICIAL_RELATIONSHIP', 47), ('IMPORTANT_CONSIDERATION', 207)]	5	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('SO_0000704', 'gene', 112, 'genetic'), ('SO_0000694', 'SNP', 120, 'single nucleotide polymorphisms'), ('SO_0000694', 'SNP', 153, 'SNPs'), ('CHEBI_33229', 'vitamin (role)', 170, 'Vitamin'), ('GO_0010467', 'gene expression', 189, 'expression')]	0	[' (vdid) host  single nucleotide polymorphisms (snps) alter vitamin receptor expression tb hiv-infected –exposed infants.']
S19-PMC4160835	PMC4160835	9/2014	S19-PMC4160835	['Vitamin C and E, for the PREVENTION of pre-eclampsia.19\norganic agriculture is a production system that relies on ecological processes, biodiversity and cycles adapted to local conditions, aiming at sustaining the health of soils, ecosystems and People.20organically produced Food is produced without the application of synthetic Pesticides, synthetic fertilisers or Genetically modified Organisms.']	[('SUPERFICIAL_RELATIONSHIP', 25)]	1	[('CHEBI_27300', 'vitamin D', 0, 'vitamin C'), ('PR_000004900', 'complement C3', 8, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 14, 'E'), ('NCBITaxon_10088', 'Mus <genus>', 246, 'people'), ('CHEBI_33290', 'food', 276, 'food'), ('CHEBI_35392', 'glucarate(1-)', 330, 'pesticides'), ('SO_0000704', 'gene', 367, 'genetically'), ('NCBITaxon_1', 'root', 388, 'organisms')]	0	[' e, pre-eclampsia.19\norganic agriculture production system relies ecological processes, biodiversity cycles adapted local conditions, sustaining soils, ecosystems people.20organically food application synthetic pesticides, synthetic fertilisers  organisms.']
S229-PMC4169453	PMC4169453	9/2014	S229-PMC4169453	['Animal data demonstrate that, INSTEAD of Vitamin D, Calcitriol, or the Vitamin D receptor, the increase in Intestinal calcium absorption is LIKELY due to the Pregnancy-RELATED increase in Duodenal Expression of the calcium transporter Gene Trpv6 [53].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('PROBABLE_UNDERSTANDING', 140), ('SUPERFICIAL_RELATIONSHIP', 168)]	3	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 52, 'calcitriol'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0000160', 'intestine', 107, 'intestinal'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy'), ('UBERON_0001245', 'anus', 188, 'duodenal'), ('GO_0010467', 'gene expression', 197, 'expression'), ('SO_0000704', 'gene', 235, 'gene'), ('PR_000016580', 'tropomyosin beta chain', 240, 'Trpv6')]	0	['animal that, calcitriol,  receptor, increase intestinal calcium absorption pregnancy-related increase duodenal expression calcium transporter  trpv6 [53].']
S32-PMC4251419	PMC4251419	12/2014	S32-PMC4251419	['this BELIEF is DRIVEN BY recognition of cellular Expression of the Vitamin D receptor (vdr), the FINDING of multiple primary 1,25(Oh)2D target Genes in Immune Cells and the discovery that many Immune Cells (Macrophages, Dendritic Cells, T and B Lymphocytes) CAN convert 25(Oh)D to 1,25(Oh)2D through Cyp27B1 activity and therefore provide significant local levels of 1,25(Oh)2D for functional outcomes (for review [8,19]).']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 97), ('INCOMPLETE_EVIDENCE', 258)]	4	[('GO_0010467', 'gene expression', 49, 'expression'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_82784', 'PVP38-Ag NP', 125, '1,25(OH)2D'), ('SO_0000704', 'gene', 143, 'genes'), ('CL_0000738', 'leukocyte', 152, 'immune cells'), ('UBERON_0002405', 'immune system', 152, 'immune'), ('CL_0000738', 'leukocyte', 193, 'immune cells'), ('UBERON_0002405', 'immune system', 193, 'immune'), ('CL_0000235', 'macrophage', 207, 'macrophages'), ('CL_0000451', 'dendritic cell', 220, 'dendritic cells'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 237, 'T ...'), ('CL_0000236', 'B cell', 243, 'B lymphocytes'), ('CHEBI_71657', 'versiconol acetate', 270, '25(OH)D'), ('CHEBI_82784', 'PVP38-Ag NP', 281, '1,25(OH)2D'), ('PR_000006101', 'cytochrome P450 1A1', 300, 'CYP27B1'), ('CHEBI_82784', 'PVP38-Ag NP', 367, '1,25(OH)2D')]	0	['cellular expression  receptor (vdr), 1,25(oh)2d  immune cells immune cells (macrophages, dendritic cells, b lymphocytes) convert 25(oh)d 1,25(oh)2d cyp27b1 activity local levels 1,25(oh)2d functional outcomes (for [8,19]).']
S139-PMC4251419	PMC4251419	12/2014	S139-PMC4251419	['Genetic variation in the physiological response to Vitamin D supplementation\na high degree of Individual VARIABILITY in the 25(Oh)D response to Vitamin D supplementation has been DESCRIBED that is the result of demographic, environmental and Genetic FACTORS [79].']	[('DIFFICULT_TASK', 105), ('INCOMPLETE_EVIDENCE', 179), ('SUPERFICIAL_RELATIONSHIP', 250)]	3	[('SO_0000704', 'gene', 0, 'Genetic'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('NCBITaxon_1', 'root', 94, 'individual'), ('CHEBI_71657', 'versiconol acetate', 124, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('SO_0000704', 'gene', 242, 'genetic')]	0	[' physiological response  supplementation\na degree individual 25(oh)d response  supplementation result demographic, environmental  [79].']
S185-PMC4277121	PMC4277121	12/2015	S185-PMC4277121	['antioxidants\noxidative stress and Mitochondrial dysfunction are both CONSIDERED hallmarks of ds Tissues and CONTRIBUTORS to Neurological phenotypes across the ds Lifespan.1,91cortical Neurons derived from ds fetal Brains show elevated levels of Reactive Oxygen Species, and survival is enhanced by treatment with Antioxidants.92several Hsa21 Genes, among them Sod1 , Bach1 , ets2 , and S100B , are KNOWN to CONTRIBUTE to the Regulation of oxidative stress when Overexpressed.9CONSISTENT with these OBSERVATIONS, it was SHOWN that levels of oxidative stress are elevated in the Brains of Adult ts65dn, and when male ts65dn Mice were Fed a diet high in Vitamin E (0.4 g per kg) from the age of 4 months to ~8 months and 10 months, the levels of oxidative stress were decreased.93performance in the Wram was improved at 8 months, and at 10 months; loss of the Trka receptor in the Bfcn had been PREVENTED.']	[('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 108), ('INCOMPLETE_EVIDENCE', 398), ('SUPERFICIAL_RELATIONSHIP', 407), ('SUPERFICIAL_RELATIONSHIP', 425), ('ANOMALY_CURIOUS_FINDING', 475), ('ANOMALY_CURIOUS_FINDING', 475), ('ANOMALY_CURIOUS_FINDING', 475), ('INCOMPLETE_EVIDENCE', 498), ('INCOMPLETE_EVIDENCE', 519), ('SUPERFICIAL_RELATIONSHIP', 892)]	11	[('GO_0005739', 'mitochondrion', 34, 'mitochondrial'), ('UBERON_0000479', 'tissue', 96, 'tissues'), ('UBERON_0001016', 'nervous system', 124, 'neurological'), ('UBERON_0000104', 'life cycle', 162, 'lifespan'), ('CL_0000540', 'neuron', 184, 'neurons'), ('UBERON_0000955', 'brain', 214, 'brains'), ('CHEBI_26523', 'reactive oxygen species', 245, 'reactive oxygen species'), ('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 313, 'antioxidants'), ('PR_000008820', 'heat shock protein beta-8', 336, 'Hsa21'), ('SO_0000704', 'gene', 342, 'genes'), ('PR_000015399', 'superoxide dismutase [Cu-Zn]', 360, 'SOD1'), ('PR_000004633', 'brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1', 367, 'BACH1'), ('PR_000014404', 'protein S100-A11', 386, 'S100B'), ('GO_0065007', 'biological regulation', 425, 'regulation'), ('GO_0003054', 'circadian regulation of systemic arterial blood pressure by the suprachiasmatic nucleus', 461, 'overexpressed'), ('UBERON_0000955', 'brain', 577, 'brains'), ('UBERON_0007023', 'adult organism', 587, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 622, 'mice'), ('GO_0007631', 'feeding behavior', 632, 'fed'), ('CHEBI_27300', 'vitamin D', 651, 'vitamin E'), ('PR_000001067', 'transient receptor potential cation channel TRPV1 isoform 1', 796, 'WRAM'), ('PR_000000123', 'ribosomal protein S6 kinase beta-1', 857, 'TRKA'), ('UBERON_0001943', 'midbrain tegmentum', 878, 'BFCN')]	0	['antioxidants\noxidative mitochondrial dysfunction hallmarks ds tissues neurological phenotypes ds lifespan.1,91cortical neurons ds fetal brains elevated levels reactive oxygen species, survival treatment antioxidants.92several hsa21 among sod1 bach1 ets2 s100b oxidative overexpressed.9consistent observations, levels oxidative elevated brains adult ts65dn, male ts65dn mice fed diet  (0.4 g kg) age 4 months ~8 months 10 months, levels oxidative decreased.93performance wram 8 months, 10 months; loss trka receptor bfcn prevented.']
S163-PMC4302429	PMC4302429	1/2015	S163-PMC4302429	['a central feature of many of these NON-CLASSICAL actions of Vitamin D is RELATED to the synthesis of active 1,25(Oh)2D in a cell-specific manner: enzyme 25Ohd-1α-hydroxylase (encoded by the Gene Cyp27B1 ) is Expressed by many Extrarenal Tissues, including the Immune System [14,34].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('SUPERFICIAL_RELATIONSHIP', 73)]	2	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_82784', 'PVP38-Ag NP', 108, '1,25(OH)2D'), ('CHEBI_72652', '7,2*-dihydroxy-4*-methoxyisoflavan-4-ylium cation', 153, '25OHD'), ('SO_0000704', 'gene', 190, 'gene'), ('PR_000006101', 'cytochrome P450 1A1', 195, 'CYP27B1'), ('GO_0010467', 'gene expression', 208, 'expressed'), ('UBERON_0005292', 'extraembryonic tissue', 226, 'extrarenal tissues'), ('UBERON_0002405', 'immune system', 260, 'immune system')]	0	['central  synthesis 1,25(oh)2d cell-specific manner: enzyme 25ohd-1α-hydroxylase (encoded  cyp27b1 expressed extrarenal tissues, immune system [14,34].']
S185-PMC4302429	PMC4302429	1/2015	S185-PMC4302429	['one REASON for the mild Antimicrobial properties of Vitamin D3 in the present in-vivo MODEL MIGHT be that, UNLIKE the Human Cathelicidin Gene, the Mouse Gene does not contain a Vitamin D response element, and is not induced directly by 1,25(Oh)2D [16].']	[('PROBABLE_UNDERSTANDING', 4), ('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 92), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 107)]	4	[('CHEBI_65381', 'albizoside C', 24, 'antimicrobial'), ('CHEBI_33279', 'vitamin D5', 52, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 52, 'vitamin D3'), ('NCBITaxon_9606', 'Homo sapiens', 118, 'human'), ('PR_000006009', 'alpha-catulin', 124, 'cathelicidin'), ('SO_0000704', 'gene', 137, 'gene'), ('NCBITaxon_10088', 'Mus <genus>', 147, 'mouse'), ('SO_0000704', 'gene', 153, 'gene'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D'), ('CHEBI_37958', 'dye', 236, '1,'), ('CHEBI_66212', '5,7,3*,4*-tetrahydroxy-2*-(3,3-dimethylallyl)isoflavone', 238, '25(OH)2D')]	0	['one antimicrobial properties vitamin d3 in-vivo that, human cathelicidin mouse  contain  response element, induced 1,25(oh)2d [16].']
S192-PMC4302429	PMC4302429	1/2015	S192-PMC4302429	['one mechanism of HOW Vitamin D3 MIGHT act beneficially in infections, COULD BE an increase in pathogen Phagocytosis with adequate levels of Vitamin D [21] and the ability of Calcitriol to maintain Antimicrobial peptide Gene Expression [13,14].']	[('EXPLICIT_QUESTION', 17), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 70)]	3	[('CHEBI_33279', 'vitamin D5', 21, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 21, 'vitamin D3'), ('GO_0006909', 'phagocytosis', 103, 'phagocytosis'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 174, 'calcitriol'), ('CHEBI_65381', 'albizoside C', 197, 'antimicrobial'), ('GO_0010467', 'gene expression', 219, 'gene expression'), ('SO_0000704', 'gene', 219, 'gene')]	0	['one vitamin d3 beneficially infections, increase pathogen phagocytosis levels  [21] ability calcitriol maintain antimicrobial peptide  expression [13,14].']
S29-PMC4303849	PMC4303849	1/2015	S29-PMC4303849	['this Complex recognizes Vitamin D response elements (vdre) in the Promoter regions of vd target Genes and recruits co-activators or co-repressors in order to induce or repress Gene transcription [6].']	[('DIFFICULT_TASK', 5)]	1	[('GO_0032991', 'protein-containing complex', 5, 'complex'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('SO_0000167', 'promoter', 66, 'promoter'), ('SO_0000704', 'gene', 96, 'genes'), ('SO_0000704', 'gene', 176, 'gene')]	0	[' response elements (vdre) promoter regions vd  recruits co-activators co-repressors repress  transcription [6].']
S14-PMC4329404	PMC4329404	10/2014	S14-PMC4329404	['an ASSOCIATION between Vitamin D Receptor (Vdr) Gene polymorphisms and asthma susceptibility is REPORTED (3,4); HOWEVER, the RELATIONSHIP between Serum Vitamin D levels and asthma REMAINS CONTROVERSIAL (5).']	[('SUPERFICIAL_RELATIONSHIP', 3), ('INCOMPLETE_EVIDENCE', 96), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('SUPERFICIAL_RELATIONSHIP', 125), ('INCOMPLETE_EVIDENCE', 180), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 188)]	6	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 23, 'vitamin D receptor'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 43, 'VDR'), ('SO_0000704', 'gene', 48, 'gene'), ('UBERON_0001977', 'blood serum', 146, 'serum'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D')]	0	[' receptor (vdr)  polymorphisms asthma (3,4); however, serum  levels asthma (5).']
S89-PMC4346113	PMC4346113	3/2015	S89-PMC4346113	['low maternal Protein Consumption or poor Vitamin B and methionine status are ASSOCIATED with behavioral and Cardiovascular abnormalities, and sex-specific changes in Hepatic Gene Expression in Rat fetuses and changes in Imprinted Gene Expression in the Rat Embryo-fetal axis [40,74-76].']	[('SUPERFICIAL_RELATIONSHIP', 77)]	1	[('GO_0006412', 'translation', 13, 'protein consumption'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin B'), ('UBERON_0004535', 'cardiovascular system', 108, 'cardiovascular'), ('UBERON_0002107', 'liver', 166, 'hepatic'), ('GO_0010467', 'gene expression', 174, 'gene expression'), ('SO_0000704', 'gene', 174, 'gene'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 193, 'rat'), ('GO_0071514', 'genetic imprinting', 220, 'imprinted'), ('GO_0010467', 'gene expression', 230, 'gene expression'), ('SO_0000704', 'gene', 230, 'gene'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 253, 'rat'), ('UBERON_0000922', 'embryo', 257, 'embryo')]	0	['low maternal protein consumption  methionine status behavioral cardiovascular abnormalities, sex-specific changes hepatic  expression rat fetuses changes imprinted  expression rat embryo-fetal [40,74-76].']
S159-PMC4377870	PMC4377870	3/2015	S159-PMC4377870	['there is research SUGGESTING a Genetic LINK between Vitamin D and copd pathogenesis.']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 39)]	2	[('SO_0000704', 'gene', 31, 'genetic'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]	0	['  copd pathogenesis.']
S22-PMC4396835	PMC4396835	1/2015	S22-PMC4396835	['FURTHER research HAS SHOWN that Vitamin D has a ROLE in Brain Development and function, including Neuronal differentiation, Axonal connectivity, Dopamine ontogeny, immunological modulation and transcriptional Control over a large number of Genes [18–21].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 48)]	3	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007420', 'brain development', 56, 'brain development'), ('UBERON_0000955', 'brain', 56, 'brain'), ('CL_0000540', 'neuron', 98, 'neuronal'), ('GO_0030424', 'axon', 124, 'axonal'), ('CHEBI_18243', 'dopamine', 145, 'dopamine'), ('GO_0065007', 'biological regulation', 209, 'control'), ('SO_0000704', 'gene', 240, 'genes')]	0	[' brain function, neuronal differentiation, axonal connectivity, dopamine ontogeny, immunological transcriptional  [18–21].']
S121-PMC4396835	PMC4396835	1/2015	S121-PMC4396835	['the study - TO OUR KNOWLEDGE - is the FIRST in which Vitamin D levels in dried Blood Spots, from the Newborn Period, HAVE BEEN analysed in samples of children with asd and in their non-asd siblings, thereby controlling for shared environmental and Genetic causes for asd.']	[('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 117)]	3	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 79, 'blood spots'), ('UBERON_0007221', 'neonate stage', 101, 'newborn period'), ('SO_0000704', 'gene', 248, 'genetic')]	0	['-  levels dried blood spots, newborn period, samples children asd non-asd siblings, controlling shared environmental  causes asd.']
S170-PMC4396835	PMC4396835	1/2015	S170-PMC4396835	['ALTHOUGH low levels of Vitamin D COULD have a Genetic origin and as SUCH be ASSOCIATED with asd, OUR STUDY is the FIRST TO RULE OUT asd-related lifestyle mechanisms AS EXPLANATION for low 25(Oh)D levels, SINCE the samples were taken in the Newborn Period.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 33), ('PROBABLE_UNDERSTANDING', 68), ('SUPERFICIAL_RELATIONSHIP', 76), ('QUESTION_ANSWERED_BY_THIS_WORK', 97), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 123), ('PROBABLE_UNDERSTANDING', 165), ('PROBABLE_UNDERSTANDING', 168), ('PROBABLE_UNDERSTANDING', 204)]	10	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('SO_0000704', 'gene', 46, 'genetic'), ('CHEBI_71657', 'versiconol acetate', 188, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 194, 'D'), ('UBERON_0007221', 'neonate stage', 240, 'newborn period')]	0	['although levels   origin asd, asd-related lifestyle mechanisms 25(oh)d levels, samples newborn period.']
S148-PMC4405493	PMC4405493	4/2015	S148-PMC4405493	['for example, there is SOME EVIDENCE Vitamin D AFFECTS transcription and function of Genes responsible for Trophoblast invasion and Angiogenesis, two factors CRITICAL for Placenta Development.']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 46), ('IMPORTANT_CONSIDERATION', 157)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('SO_0000704', 'gene', 84, 'genes'), ('UBERON_0000088', 'trophoblast', 106, 'trophoblast'), ('GO_0001525', 'angiogenesis', 131, 'angiogenesis'), ('GO_0001890', 'placenta development', 170, 'placenta development'), ('UBERON_0001987', 'placenta', 170, 'placenta')]	0	['example,  transcription  trophoblast invasion angiogenesis, placenta development.']
S14-PMC4408096	PMC4408096	4/2015	S14-PMC4408096	['WHILE iron deficiency IS CONSIDERED the LEADING cause of anemia, OTHER causes include deficiencies in Micronutrients such as Folate, Vitamin B12, and Vitamin A, infestations with parasites such as helminths or malaria, Genetically-inherited hemoglobinopathies, hiv/aids, and chronic inflammation [3,4].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 22), ('IMPORTANT_CONSIDERATION', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 65)]	4	[('CHEBI_33839', 'macromolecule', 102, 'micronutrients'), ('CHEBI_30863', '5-azaorotic acid', 125, 'folate'), ('CHEBI_33279', 'vitamin D5', 133, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin A'), ('SO_0000704', 'gene', 219, 'genetically')]	0	['iron anemia, causes micronutrients folate, vitamin b12, infestations parasites helminths malaria, -inherited hemoglobinopathies, hiv/aids, chronic inflammation [3,4].']
S127-PMC4417995	PMC4417995	4/2015	S127-PMC4417995	['[55] reported a Genetic association study in which a Vitamin D-related Gene polymorphism rs4674343 on Cyp27A1 was found to be PROTECTIVE against atopic eczema.']	[('SUPERFICIAL_RELATIONSHIP', 126)]	1	[('SO_0000704', 'gene', 16, 'genetic'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('SO_0000704', 'gene', 71, 'gene'), ('PR_000006101', 'cytochrome P450 1A1', 102, 'CYP27A1')]	0	['[55]  -related  polymorphism rs4674343 cyp27a1 atopic eczema.']
S20-PMC4427001	PMC4427001	4/2015	S20-PMC4427001	['Vitamin D—via its binding to the Vitamin D receptor (vdr)—Regulates Expression of hundreds of Genes (directly OR indirectly) including those that Control key processes AFFECTING cell fate [8].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 110), ('SUPERFICIAL_RELATIONSHIP', 168)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0065007', 'biological regulation', 58, 'regulates'), ('GO_0010467', 'gene expression', 68, 'expression'), ('SO_0000704', 'gene', 94, 'genes'), ('GO_0065007', 'biological regulation', 146, 'control')]	0	['vitamin d—via binding  receptor (vdr)—regulates expression hundreds  (directly indirectly) processes cell fate [8].']
S21-PMC4427001	PMC4427001	4/2015	S21-PMC4427001	['the COMPLEXITY of Vitamin D action is FURTHER increased by vdr Gene polymorphism.']	[('DIFFICULT_TASK', 4), ('INCOMPLETE_EVIDENCE', 38)]	2	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('SO_0000704', 'gene', 63, 'gene')]	0	[' vdr  polymorphism.']
S190-PMC4448820	PMC4448820	5/2015	S190-PMC4448820	['in this newly OBSERVED MODEL in Human Macrophages, Tlr Activation upregulates the Expression of the Vitamin D Receptor ( Vdr ) and the Vitamin D-1-hydroxylase Genes, leading to induction of the Antimicrobial peptide Cathelicidin and killing of Intracellular bacteria such as mycobacterium tuberculosis .']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 23)]	2	[('NCBITaxon_9606', 'Homo sapiens', 32, 'human'), ('CL_0000235', 'macrophage', 38, 'macrophages'), ('GO_0034104', 'negative regulation of tissue remodeling', 51, 'TLR activation'), ('GO_0010467', 'gene expression', 82, 'expression'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 100, 'vitamin D receptor'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 121, 'VDR'), ('CHEBI_28384', 'vitamin K', 135, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 135, 'Vitamin D'), ('SO_0000704', 'gene', 159, 'genes'), ('CHEBI_65381', 'albizoside C', 194, 'antimicrobial'), ('PR_000006009', 'alpha-catulin', 216, 'cathelicidin'), ('GO_0005622', 'intracellular anatomical structure', 244, 'intracellular')]	0	['human macrophages, tlr activation upregulates expression  receptor vdr vitamin d-1-hydroxylase induction antimicrobial peptide cathelicidin killing intracellular bacteria mycobacterium tuberculosis .']
S274-PMC4448820	PMC4448820	5/2015	S274-PMC4448820	['caption (boxed-text): text box 9\u2003\npotential pathways of intersection for Micronutrients\n\n● Myelomonocytic Cell Differentiation (Vitamins A and D)\n● Macrophage polarization (Vitamins a and d, zinc, Folic Acid)\n● B and T Cell Proliferation (zinc, Iron, Folic Acid, others)\n● T Cell Apoptosis (zinc, iron, Vitamin A, Vitamin E, others)\n● Regulation of Nf-Κb activity (Vitamins A, d, and e; zinc; iron; many others)\n● induction, and maintenance, of Treg Cells (Vitamins A and D, zinc, Folic Acid)\n● Regulation Of Gene Expression and/or activity of Protein Kinase C, cyclins, and cyclin-dependent kinases (e.g., as seen with iron): such defects in one or more of these factors MAY AFFECT or Modulate Lymphocyte Responses to stimuli\n\niv.']	[('INCOMPLETE_EVIDENCE', 672), ('SUPERFICIAL_RELATIONSHIP', 676)]	2	[('CHEBI_33839', 'macromolecule', 73, 'micronutrients'), ('CL_0000763', 'myeloid cell', 91, 'Myelomonocytic cell'), ('GO_0002270', 'plasmacytoid dendritic cell activation', 91, 'Myelomonocytic'), ('GO_0030154', 'cell differentiation', 106, 'cell differentiation'), ('CHEBI_27300', 'vitamin D', 128, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 137, 'A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 143, 'D'), ('PR_000006444', 'diacylglycerol kinase delta', 143, 'D'), ('CL_0000235', 'macrophage', 148, 'Macrophage'), ('CHEBI_33277', 'gamma-tocotrienol', 173, 'vitamins'), ('CHEBI_30751', 'formic acid', 197, 'folic acid'), ('CL_0000969', 'regulatory B cell', 211, 'B ...'), ('CL_0000084', 'T cell', 217, 'T cell'), ('GO_0008283', 'cell proliferation', 219, 'cell proliferation'), ('CHEBI_24870', 'ion', 245, 'iron'), ('CHEBI_30751', 'formic acid', 251, 'folic acid'), ('CL_0000084', 'T cell', 273, 'T cell'), ('GO_0006915', 'apoptotic process', 275, 'cell apoptosis'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 314, 'vitamin E'), ('GO_0065007', 'biological regulation', 335, 'Regulation'), ('GO_0035773', 'insulin secretion involved in cellular response to glucose stimulus', 349, 'NF-κB'), ('GO_0071159', 'NF-kappaB complex', 349, 'NF-κB'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 349, 'NF-κB'), ('CHEBI_27300', 'vitamin D', 365, 'vitamins A'), ('CL_0000960', 'T3 B cell', 445, 'Treg cells'), ('CHEBI_27300', 'vitamin D', 457, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 472, 'D'), ('CHEBI_30751', 'formic acid', 481, 'folic acid'), ('GO_0010468', 'regulation of gene expression', 495, 'Regulation of gene expression'), ('SO_0000704', 'gene', 509, 'gene'), ('PR_000013390', '26S proteasome non-ATPase regulatory subunit 8', 544, 'protein kinase C'), ('GO_0065007', 'biological regulation', 686, 'modulate'), ('CL_0000542', 'lymphocyte', 695, 'lymphocyte'), ('GO_0060033', 'anatomical structure regression', 706, 'responses')]	0	['caption (boxed-text): text box 9\u2003\npotential intersection micronutrients\n\n● myelomonocytic cell d)\n● macrophage polarization (vitamins d, zinc, folic acid)\n● b cell proliferation (zinc, iron, folic acid, others)\n● cell apoptosis (zinc, iron, , others)\n● nf-κb activity (, d, e; zinc; iron; others)\n● induction, maintenance, treg cells d, zinc, folic acid)\n●  expression and/or activity protein kinase c, cyclins, cyclin-dependent kinases (e.g., iron): defects lymphocyte responses stimuli\n\niv.']
S289-PMC4448820	PMC4448820	5/2015	S289-PMC4448820	['ALTHOUGH NEW DATA ARE NEEDED to FURTHER ELUCIDATE the magnitude of these RELATIONS, IT IS CLEAR that Vitamin A has multiple Genetically MEDIATED EFFECTS on the Immune Response via the activities of atra.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 9), ('FUTURE_WORK', 9), ('FUTURE_WORK', 32), ('FUTURE_WORK', 40), ('SUPERFICIAL_RELATIONSHIP', 73), ('PROBABLE_UNDERSTANDING', 84), ('SUPERFICIAL_RELATIONSHIP', 136), ('SUPERFICIAL_RELATIONSHIP', 145)]	9	[('CHEBI_27300', 'vitamin D', 101, 'vitamin A'), ('SO_0000704', 'gene', 124, 'genetically'), ('GO_0006955', 'immune response', 160, 'immune response'), ('UBERON_0002405', 'immune system', 160, 'immune')]	0	['although magnitude relations,   immune response via activities atra.']
S296-PMC4448820	PMC4448820	5/2015	S296-PMC4448820	['like Vitamin A, Vitamin D CAN AFFECT Immune function through this Genetic INTERACTION.']	[('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 74)]	3	[('CHEBI_27300', 'vitamin D', 5, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0002405', 'immune system', 37, 'immune'), ('SO_0000704', 'gene', 66, 'genetic')]	0	['like  immune  interaction.']
S297-PMC4448820	PMC4448820	5/2015	S297-PMC4448820	['because Vitamins A and D share a Nuclear receptor (rxr), compete for coactivators and corepressors, and reciprocally Regulate the Expression of their receptors, a wide variety of combined EFFECTS on Gene Regulation LIKELY occurs (190–192).']	[('SUPERFICIAL_RELATIONSHIP', 188), ('PROBABLE_UNDERSTANDING', 215)]	2	[('CHEBI_27300', 'vitamin D', 8, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 23, 'D'), ('GO_0005634', 'nucleus', 33, 'nuclear'), ('GO_0065007', 'biological regulation', 117, 'regulate'), ('GO_0010467', 'gene expression', 130, 'expression'), ('SO_0000704', 'gene', 199, 'gene'), ('GO_0065007', 'biological regulation', 204, 'regulation')]	0	[' nuclear receptor (rxr), compete coactivators corepressors, reciprocally regulate expression receptors, combined  occurs (190–192).']
S347-PMC4448820	PMC4448820	5/2015	S347-PMC4448820	['cell culture MODELS and a very SMALL NUMBER OF Human clinical STUDIES INDICATE that nutritional factors including Vitamins A and D AFFECT numerous Genes INVOLVED in Chromatin Remodeling or processes that are INVOLVED in epigenetic Regulation.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 131), ('SUPERFICIAL_RELATIONSHIP', 153), ('SUPERFICIAL_RELATIONSHIP', 208)]	7	[('NCBITaxon_9606', 'Homo sapiens', 47, 'human'), ('CHEBI_27300', 'vitamin D', 114, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 129, 'D'), ('SO_0000704', 'gene', 147, 'genes'), ('GO_0000785', 'chromatin', 165, 'chromatin'), ('GO_0006338', 'chromatin remodeling', 165, 'chromatin remodeling'), ('GO_0065007', 'biological regulation', 231, 'regulation')]	0	['cell culture human nutritional   chromatin remodeling processes epigenetic regulation.']
S351-PMC4448820	PMC4448820	5/2015	S351-PMC4448820	['because this mechanism has the POTENTIAL to alter the global abundance of Methyl Donors, and because Vitamin A has general actions on Cell Differentiation, it is UNKNOWN whether these EFFECTS are indirect OR WHETHER specific Genes are targeted for epigenetic Regulation by Vitamin A in vivo.']	[('INCOMPLETE_EVIDENCE', 31), ('FULL_UNKNOWN', 162), ('SUPERFICIAL_RELATIONSHIP', 184), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 205), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 208)]	5	[('CHEBI_6842', 'methoxychlor', 74, 'methyl donors'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin A'), ('GO_0030154', 'cell differentiation', 134, 'cell differentiation'), ('SO_0000704', 'gene', 225, 'genes'), ('GO_0065007', 'biological regulation', 259, 'regulation'), ('CHEBI_27300', 'vitamin D', 273, 'vitamin A')]	0	['alter abundance methyl donors,  cell differentiation,  epigenetic  vivo.']
S373-PMC4448820	PMC4448820	5/2015	S373-PMC4448820	['EVIDENCE is EMERGING for Vitamin D in epigenetic Regulation Of Gene Expression.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 12)]	2	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0010468', 'regulation of gene expression', 49, 'regulation of gene expression'), ('SO_0000704', 'gene', 63, 'gene')]	0	['evidence  epigenetic  expression.']
S405-PMC4448820	PMC4448820	5/2015	S405-PMC4448820	['v. Vitamin E.\npolymorphisms at cytokine Genes MAY determine the EFFECT of Vitamin E on Cytokine Production in the elderly (232).']	[('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 64)]	2	[('CHEBI_28384', 'vitamin K', 3, 'Vitamin E'), ('PR_000017279', 'testis-specific basic protein Y 1', 3, 'Vitamin E'), ('SO_0000704', 'gene', 40, 'genes'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin E'), ('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 87, 'cytokine production')]	0	['v. vitamin e.\npolymorphisms cytokine   cytokine production elderly (232).']
S412-PMC4448820	PMC4448820	5/2015	S412-PMC4448820	['by using Pbmcs from healthy men who were treated with Lps, ANOTHER STUDY SHOWED that anti-inflammatory EFFECTS of Vitamin E supplementation (e.g., decreased Il-6 secretion) DEPENDS on having the gg genotype at position 313 of the Gstp1 Gene (236).']	[('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 103), ('SUPERFICIAL_RELATIONSHIP', 173)]	4	[('CL_0002246', 'peripheral blood stem cell', 9, 'PBMCs'), ('CHEBI_16412', 'lipopolysaccharide', 54, 'LPS'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin E'), ('PR_000001470', 'interleukin-28B', 157, 'IL-6'), ('PR_000008294', 'glutathione S-transferase A1', 230, 'GSTP1'), ('SO_0000704', 'gene', 236, 'gene')]	0	['using pbmcs healthy men treated lps, anti-inflammatory  supplementation (e.g., decreased il-6 secretion) gg genotype position 313 gstp1  (236).']
S1193-PMC4448820	PMC4448820	5/2015	S1193-PMC4448820	['THIS STUDY, which was followed by numerous others, HIGHLIGHTS an IMPORTANT and underappreciated ROLE for Vitamin D in Drug Metabolism through the induction of Gene Expression of key Drug-Metabolizing enzymes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 51), ('IMPORTANT_CONSIDERATION', 65), ('SUPERFICIAL_RELATIONSHIP', 96)]	4	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CHEBI_23888', 'drug', 118, 'drug'), ('GO_0042737', 'drug catabolic process', 118, 'drug metabolism'), ('GO_0010467', 'gene expression', 159, 'gene expression'), ('SO_0000704', 'gene', 159, 'gene'), ('CHEBI_23888', 'drug', 182, 'drug'), ('GO_0016540', 'protein autoprocessing', 182, 'drug-metabolizing')]	0	['study, followed others,  drug metabolism induction  expression drug-metabolizing enzymes.']
S93-PMC4466139	PMC4466139	6/2015	S93-PMC4466139	['THESE STUDIES EVEN IF LIMITED to specific populations (caucasians [28], arab an asian [29], rural populations of south china [30]) SHOW a COMPLEX picture of Genetic FACTORS determining the level of 25Ohd and consequent risks of deficiency of Vitamin D. DESPITE this, the environmental COMPONENT is STILL preponderant ALTHOUGH LIMITED to 57–71% in determining the level of 25Ohd.']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 131), ('DIFFICULT_TASK', 138), ('SUPERFICIAL_RELATIONSHIP', 165), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 253), ('ANOMALY_CURIOUS_FINDING', 253), ('SUPERFICIAL_RELATIONSHIP', 285), ('IMPORTANT_CONSIDERATION', 298), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 317), ('INCOMPLETE_EVIDENCE', 326)]	13	[('SO_0000704', 'gene', 157, 'genetic'), ('CHEBI_72652', '7,2*-dihydroxy-4*-methoxyisoflavan-4-ylium cation', 198, '25OHD'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D'), ('CHEBI_72652', '7,2*-dihydroxy-4*-methoxyisoflavan-4-ylium cation', 372, '25OHD')]	0	['populations (caucasians [28], arab asian [29], rural populations south china [30]) picture  25ohd consequent . this, environmental preponderant 57–71% 25ohd.']
S115-PMC4466139	PMC4466139	6/2015	S115-PMC4466139	['moreover, SOME STUDIES HAVE SHOWN a large inter-Individual difference in response to treatment with identical doses of Vitamin D SUGGESTING that common Genetic variants IMPLICATED in Vitamin d Homeostasis MAY AFFECT the response to sun exposure or to Vitamin D supplementation [39].']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 169), ('INCOMPLETE_EVIDENCE', 205), ('SUPERFICIAL_RELATIONSHIP', 209)]	6	[('NCBITaxon_1', 'root', 48, 'individual'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('SO_0000704', 'gene', 152, 'genetic'), ('CHEBI_33229', 'vitamin (role)', 183, 'vitamin'), ('GO_0042592', 'homeostatic process', 193, 'homeostasis'), ('CHEBI_27300', 'vitamin D', 251, 'vitamin D')]	0	['moreover, inter-individual response treatment doses   variants vitamin homeostasis response sun exposure  supplementation [39].']
S116-PMC4466139	PMC4466139	6/2015	S116-PMC4466139	['the RELATIONSHIP between 25Ohd levels, ethnicity and supplementation in Pregnancy SUGGESTS a ROLE for Genetic DETERMINANTS for Vitamin D status and STRESSES the IMPORTANCE of Vitamin D integration in preventative STRATEGIES.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 82), ('SUPERFICIAL_RELATIONSHIP', 93), ('SUPERFICIAL_RELATIONSHIP', 110), ('IMPORTANT_CONSIDERATION', 148), ('IMPORTANT_CONSIDERATION', 161), ('FUTURE_WORK', 213)]	7	[('CHEBI_72652', '7,2*-dihydroxy-4*-methoxyisoflavan-4-ylium cation', 25, '25OHD'), ('GO_0007565', 'female pregnancy', 72, 'pregnancy'), ('SO_0000704', 'gene', 102, 'genetic'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D')]	0	['25ohd levels, ethnicity supplementation pregnancy   status  integration preventative strategies.']
S48-PMC4499946	PMC4499946	7/2015	S48-PMC4499946	['clinical, biochemical, and microbiological Surveillance of enrolled mother-infant pairs will enable a range of secondary objectives to be addressed, including (1) estimation of the EFFECT of maternal Vitamin D supplementation on the incidence of acute Respiratory infections (aris) during early infancy; (2) exploration of the ROLES of specific hormones, Nutrients, environmental Contaminants, and inflammatory markers in the mediation or modification of the EFFECT of Vitamin D on fetal and infant growth, with particular emphasis on the ROLE of the Parathyroid hormone (pth) system; and (3) investigation of the ROLE of epigenetic modification of Genes involved in Perinatal Vitamin D Metabolism in infant stunting.']	[('SUPERFICIAL_RELATIONSHIP', 181), ('SUPERFICIAL_RELATIONSHIP', 327), ('SUPERFICIAL_RELATIONSHIP', 459), ('SUPERFICIAL_RELATIONSHIP', 539), ('SUPERFICIAL_RELATIONSHIP', 614)]	5	[('GO_0065007', 'biological regulation', 43, 'surveillance'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 252, 'respiratory'), ('CHEBI_33284', 'nutrient', 355, 'nutrients'), ('CHEBI_60688', 'EC 4.2.1.20 (tryptophan synthase) inhibitor', 380, 'contaminants'), ('CHEBI_27300', 'vitamin D', 469, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 551, 'parathyroid'), ('SO_0000704', 'gene', 649, 'genes'), ('GO_0036268', 'swimming', 667, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 667, 'perinatal'), ('CHEBI_27300', 'vitamin D', 677, 'vitamin D'), ('GO_0008152', 'metabolic process', 687, 'metabolism')]	0	['clinical, biochemical, microbiological enrolled mother-infant pairs secondary addressed, (1) maternal  supplementation acute respiratory infections (aris) infancy; (2) hormones, nutrients, environmental contaminants, inflammatory  fetal infant growth, parathyroid hormone (pth) system; (3) epigenetic  perinatal  metabolism infant stunting.']
S205-PMC4499946	PMC4499946	7/2015	S205-PMC4499946	['Genomic dna will be subjected to Bisulfite modification, and amplified Pcr Products will be analyzed by quantitative pyrosequencing to assess Dna Methylation at several consecutive Cpg Sites within an APPROXIMATELY 150-Bp region at the Promoters of two Genes INVOLVED in Vitamin D Metabolism ( Cyp27B1 and Cyp24A1 ).']	[('INCOMPLETE_EVIDENCE', 201), ('SUPERFICIAL_RELATIONSHIP', 259)]	2	[('SO_0001026', 'genome', 0, 'Genomic'), ('CHEBI_29874', 'bromine dioxide', 33, 'bisulfite'), ('SO_0000006', 'PCR_product', 71, 'PCR products'), ('GO_0006306', 'DNA methylation', 142, 'DNA methylation'), ('SO_0000036', 'matrix_attachment_site', 181, 'CpG sites'), ('SO_0000028', 'base_pair', 219, 'bp'), ('SO_0000167', 'promoter', 236, 'promoters'), ('SO_0000704', 'gene', 253, 'genes'), ('CHEBI_27300', 'vitamin D', 271, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 271, 'vitamin D metabolism'), ('PR_000006101', 'cytochrome P450 1A1', 294, 'CYP27B1'), ('PR_000006101', 'cytochrome P450 1A1', 306, 'CYP24A1')]	0	['genomic dna subjected bisulfite modification, amplified pcr products quantitative pyrosequencing dna methylation consecutive cpg sites 150-bp region promoters   metabolism cyp27b1 cyp24a1 ).']
S43-PMC4516377	PMC4516377	6/2015	S43-PMC4516377	['Serum levels of Vitamin D were significantly ASSOCIATED with higher bmi, waist circumference and Serum Triacylglycerols, as well as lower hdl levels.20the authors of this study used the same categorization of Vitamin D levels of the iom, BUT cited another reference.22finally, a longitudinal study in the brazilian amazon region, followed children from 2007 to 2012 with the OBJECTIVE of evaluating the EFFECT of the Fto Gene on bmi modifications during childhood, as well as verifying WHETHER the Vitamin D status COULD modify this EFFECT.']	[('SUPERFICIAL_RELATIONSHIP', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 238), ('QUESTION_ANSWERED_BY_THIS_WORK', 375), ('SUPERFICIAL_RELATIONSHIP', 403), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 486), ('INCOMPLETE_EVIDENCE', 515), ('SUPERFICIAL_RELATIONSHIP', 533)]	7	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0001977', 'blood serum', 97, 'serum'), ('CHEBI_17075', '6-hydroxyhexano-6-lactone', 103, 'triacylglycerols'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('PR_000007702', 'galactoside alpha-(1,2)-fucosyltransferase 1', 417, 'FTO'), ('SO_0000704', 'gene', 421, 'gene'), ('CHEBI_27300', 'vitamin D', 498, 'vitamin D')]	0	['serum levels  higher bmi, waist circumference serum triacylglycerols, hdl levels.20the authors categorization  levels iom, reference.22finally, longitudinal brazilian amazon region, followed children 2007 2012 fto  bmi modifications childhood,  status effect.']
S187-PMC4516488	PMC4516488	9/2009	S187-PMC4516488	['Pea-15 is also on the list of about 50 differentially Expressed Genes in the Mouse Brain REVEALED by two-dimensional gel electrophoresis in a MODEL of developmental Vitamin D deficiency [44].']	[('INCOMPLETE_EVIDENCE', 89), ('INCOMPLETE_EVIDENCE', 142)]	2	[('PR_000001904', 'platelet endothelial cell adhesion molecule', 0, 'PEA-15'), ('GO_0010467', 'gene expression', 54, 'expressed'), ('SO_0000704', 'gene', 64, 'genes'), ('NCBITaxon_10088', 'Mus <genus>', 77, 'mouse'), ('UBERON_0000955', 'brain', 83, 'brain'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D')]	0	['pea-15 list 50 expressed  mouse brain two-dimensional gel electrophoresis developmental  [44].']
S33-PMC4595656	PMC4595656	10/2015	S33-PMC4595656	['the offspring of Vitamin D deficient Rats have larger Lateral Ventricles (eyles et al.,2003; féron et al.,2005), a thinner Cortex (eyles et al.,2003) diminished levels of Nerve Growth Factor (Ngf; eyles et al.,2003; féron et al.,2005), and reduced Expression of a number of Genes INVOLVED in Neuronal structure and Neurotransmission (féron et al.,2005).']	[('SUPERFICIAL_RELATIONSHIP', 280)]	1	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 37, 'rats'), ('UBERON_0002285', 'telencephalic ventricle', 54, 'lateral ventricles'), ('UBERON_0001851', 'cortex', 123, 'cortex'), ('PR_000011193', 'ephexin-1', 171, 'nerve growth factor'), ('UBERON_0001021', 'nerve', 171, 'nerve'), ('PR_000011159', 'nexilin', 192, 'NGF'), ('GO_0010467', 'gene expression', 248, 'expression'), ('SO_0000704', 'gene', 274, 'genes'), ('CL_0000540', 'neuron', 292, 'neuronal'), ('GO_0007266', 'Rho protein signal transduction', 315, 'neurotransmission')]	0	['offspring  rats lateral ventricles (eyles et al.,2003; féron et al.,2005), thinner cortex (eyles et al.,2003) diminished levels nerve (ngf; eyles et al.,2003; féron et al.,2005), expression  neuronal structure neurotransmission (féron et al.,2005).']
S36-PMC4595656	PMC4595656	10/2015	S36-PMC4595656	['targeted Gene arrays specific for Apoptosis and Cell Cycle Genes CONFIRM a pattern of transcription Deregulation in the deplete group CONSISTENT with the KNOWN properties of Vitamin D (ko et al.,2004).']	[('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 134), ('INCOMPLETE_EVIDENCE', 154)]	3	[('SO_0000704', 'gene', 9, 'gene'), ('GO_0006915', 'apoptotic process', 34, 'apoptosis'), ('GO_0007049', 'cell cycle', 48, 'cell cycle'), ('SO_0000704', 'gene', 59, 'genes'), ('GO_0050893', 'sensory processing', 100, 'deregulation'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D')]	0	['targeted  arrays apoptosis cell cycle  transcription deregulation deplete properties  (ko et al.,2004).']
S15-PMC4598849	PMC4598849	10/2015	S15-PMC4598849	['the CONFLICTING findings MAY BE DUE TO VARIATIONS of study designs including the Gestational weeks of Vitamin D testing, the cut-point of Vitamin D, ethnicity of the study population, Genetic variation and outcome variables.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 25), ('PROBLEM_COMPLICATION', 32), ('DIFFICULT_TASK', 39)]	4	[('GO_0007565', 'female pregnancy', 81, 'gestational'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('SO_0000704', 'gene', 184, 'genetic')]	0	['gestational weeks  testing, cut-point ethnicity population,  outcome variables.']
S175-PMC4663595	PMC4663595	11/2015	S175-PMC4663595	['our group also REPORTED that Dha supplementation with 400 mg/day during Pregnancy induced Dna Methylation changes in inflammatory Genes and Line-1 , especially in infants born to mothers who smoked during Pregnancy [99].nutrients-07-05467-t002_table 2\n\ncaption (table-wrap): table 2\n\nintervention studies for maternal nutritional status and epigenetic profile in offspring.Nutrientsmechanismoutcomesamplemethodref.Folate and Multivitamins(1)Dna Methylation↓ methylation of Igf2 2r in girls, ↓ methylation of Gtl2-2 in boyscord Blood27K illumina[93]folatedna methylation↓ methylation of Line1 Cord Bloodpyrosequencing[94]Dna Methylation↑ methylation of Igf2 dmrcord Bloodepi-typer[95]Dna Methylation↓ methylation of h19 dmr (4 cpgs)Cord Bloodpyrosequencing[96]Dna Methylation↓ methylation of peg3 and Line1 ; ↑ methylation of Igf2 Cord Bloodpyrosequencing[97]cholinedna methylationhistone modification↑ methylation of crh , Nr3C1 in Placenta; ↓ methylation of crh , Nr3C1 in Cord Blood Leukocyte; ↑ H3K9Me2Placenta, Cord Bloodlc-ms/ms[98]Dhadna Methylation↑ Line1 methylation ↑ Infγ/Il13 methylation ratiocord Bloodpyrosequencing[99]\n(1)Zinc and Vitamins A, b, c and d; Peg3, Paternally-Expressed Gene 3; Crh, Corticotropin-Releasing Hormone; Nr3C1, Nuclear receptor subfamily 3, Group C, Member 1.']	[('INCOMPLETE_EVIDENCE', 15)]	1	[('CHEBI_17874', 'dihydrozeatin', 29, 'DHA'), ('GO_0007565', 'female pregnancy', 72, 'pregnancy'), ('GO_0006306', 'DNA methylation', 90, 'DNA methylation'), ('SO_0000704', 'gene', 130, 'genes'), ('PR_000009877', 'loss of heterozygosity 11 chromosomal region 2 gene A protein', 140, 'LINE-1'), ('GO_0007565', 'female pregnancy', 205, 'pregnancy'), ('CHEBI_8329', 'Pomiferin', 373, 'NutrientsMechanismOutcomeSampleMethodRef'), ('CHEBI_81245', 'Vulpecholate', 414, 'Folate'), ('CHEBI_7036', 'Musennin', 425, 'Multivitamins'), ('GO_0006323', 'DNA packaging', 441, 'DNA methylation↓'), ('PR_000008989', 'interleukin-1 family member 7', 473, 'IGF2'), ('PR_000008305', 'glutathione S-transferase theta-1', 508, 'GTL2'), ('UBERON_0001977', 'blood serum', 527, 'blood27k'), ('PR_000009877', 'loss of heterozygosity 11 chromosomal region 2 gene A protein', 586, 'LINE1'), ('UBERON_0000948', 'heart', 592, 'Cord'), ('UBERON_0011919', 'yolk sac blood island', 597, 'bloodPyrosequencing'), ('GO_0006306', 'DNA methylation', 620, 'DNA methylation'), ('PR_000008989', 'interleukin-1 family member 7', 652, 'IGF2'), ('UBERON_0001970', 'bile', 665, 'bloodEpi'), ('GO_0006323', 'DNA packaging', 683, 'DNA methylation↓'), ('UBERON_0000948', 'heart', 731, 'Cord'), ('UBERON_0011919', 'yolk sac blood island', 736, 'bloodPyrosequencing'), ('GO_0006323', 'DNA packaging', 759, 'DNA methylation↓'), ('PR_000009877', 'loss of heterozygosity 11 chromosomal region 2 gene A protein', 800, 'LINE1'), ('PR_000008989', 'interleukin-1 family member 7', 825, 'IGF2'), ('UBERON_0000948', 'heart', 830, 'Cord'), ('UBERON_0011919', 'yolk sac blood island', 835, 'bloodPyrosequencing'), ('PR_000011403', 'photoreceptor-specific nuclear receptor', 923, 'NR3C1'), ('UBERON_0001987', 'placenta', 932, 'placenta'), ('PR_000011403', 'photoreceptor-specific nuclear receptor', 965, 'NR3C1'), ('CL_0000107', 'autonomic neuron', 974, 'cord blood'), ('UBERON_0002240', 'spinal cord', 974, 'cord'), ('UBERON_0000178', 'blood', 979, 'blood'), ('CL_0000738', 'leukocyte', 985, 'leukocyte'), ('SO_0001736', 'H3K9_methylation_site', 998, 'H3K9me2Placenta'), ('UBERON_0002240', 'spinal cord', 1015, 'cord'), ('UBERON_0000178', 'blood', 1020, 'bloodLC'), ('GO_0010424', 'DNA methylation on cytosine within a CG sequence', 1037, 'DHADNA methylation'), ('PR_000009877', 'loss of heterozygosity 11 chromosomal region 2 gene A protein', 1057, 'LINE1'), ('PR_000009020', 'Golgi-resident adenosine 3*,5*-bisphosphate 3*-phosphatase', 1077, 'INFγ'), ('PR_000001470', 'interleukin-28B', 1082, 'IL13'), ('UBERON_0011919', 'yolk sac blood island', 1109, 'bloodPyrosequencing'), ('CHEBI_27377', 'Unsym-bis(4*-chlorophenyl)ethylene', 1136, 'Zinc'), ('CHEBI_27300', 'vitamin D', 1145, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 1154, 'A'), ('PR_000012529', 'PDZK1-interacting protein 1', 1169, 'PEG3'), ('PR_000012270', 'pappalysin-1', 1175, 'paternally-expressed gene 3'), ('GO_0010467', 'gene expression', 1186, 'expressed'), ('SO_0000704', 'gene', 1196, 'gene'), ('PR_000005864', 'protein CREG2', 1204, 'CRH'), ('CHEBI_3918', 'crocetin', 1209, 'corticotropin'), ('PR_000005968', 'cystatin-M', 1209, 'corticotropin-releasing hormone'), ('CHEBI_33280', 'molecular messenger', 1233, 'hormone'), ('PR_000011403', 'photoreceptor-specific nuclear receptor', 1242, 'NR3C1'), ('GO_0005634', 'nucleus', 1249, 'nuclear'), ('PR_000008294', 'glutathione S-transferase A1', 1279, 'group C, member 1')]	0	['dha supplementation 400 mg/day pregnancy induced dna methylation changes inflammatory  line-1 infants born mothers smoked pregnancy [99].nutrients-07-05467-t002_table 2\n\ncaption (table-wrap): table 2\n\nintervention maternal nutritional status epigenetic profile offspring.nutrientsmechanismoutcomesamplemethodref.folate multivitamins(1)dna methylation↓ methylation igf2 2r girls, methylation gtl2-2 boyscord blood27k illumina[93]folatedna methylation↓ methylation line1 cord bloodpyrosequencing[94]dna methylation↑ methylation igf2 dmrcord bloodepi-typer[95]dna methylation↓ methylation h19 dmr (4 cpgs)cord bloodpyrosequencing[96]dna methylation↓ methylation peg3 line1 ↑ methylation igf2 cord bloodpyrosequencing[97]cholinedna methylationhistone modification↑ methylation crh nr3c1 placenta; methylation crh nr3c1 cord blood leukocyte; ↑ h3k9me2placenta, cord bloodlc-ms/ms[98]dhadna methylation↑ line1 methylation ↑ infγ/il13 methylation ratiocord bloodpyrosequencing[99]\n(1)zinc b, c d; peg3, paternally-expressed  3; crh, corticotropin-releasing hormone; nr3c1, nuclear receptor subfamily 3, c, member 1.']
S38-PMC4684854	PMC4684854	12/2015	S38-PMC4684854	['with the EMERGING EVIDENCE that Vitamin D acts epigenetically in the Regulation of over 2700 different Genes [36], there HAS BEEN much RECENT RESEARCH exploring the widespread prevalence of Vitamin D deficiency through the continuum of Life, including the Gestational and Neonatal Period.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 69), ('INCOMPLETE_EVIDENCE', 121), ('INCOMPLETE_EVIDENCE', 135)]	4	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0065007', 'biological regulation', 69, 'regulation'), ('SO_0000704', 'gene', 103, 'genes'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('UBERON_0000104', 'life cycle', 236, 'life'), ('GO_0007565', 'female pregnancy', 256, 'gestational'), ('UBERON_0007221', 'neonate stage', 272, 'neonatal period')]	0	[' epigenetically 2700  [36],  continuum life, gestational neonatal period.']
S103-PMC4684854	PMC4684854	12/2015	S103-PMC4684854	['there is escalating EVIDENCE in general that low Vitamin D levels are CORRELATED with higher RISK for a variety of mental health PROBLEMS including depressive illness [70], as Vitamin D IS KNOWN to play an IMPORTANT ROLE in activating Genes that release Neurotransmitters such as Dopamine and Serotonin [70,71].']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 70), ('IMPORTANT_CONSIDERATION', 93), ('IMPORTANT_CONSIDERATION', 129), ('INCOMPLETE_EVIDENCE', 186), ('IMPORTANT_CONSIDERATION', 206), ('SUPERFICIAL_RELATIONSHIP', 216)]	7	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D'), ('SO_0000704', 'gene', 235, 'genes'), ('CHEBI_25512', 'neurotransmitter', 254, 'neurotransmitters'), ('CHEBI_18243', 'dopamine', 280, 'dopamine'), ('CHEBI_28790', 'serotonin', 293, 'serotonin')]	0	['escalating  levels higher mental depressive illness [70],  play activating  release neurotransmitters dopamine serotonin [70,71].']
S139-PMC4684854	PMC4684854	12/2015	S139-PMC4684854	['with the recognition that Vitamin D plays an ESSENTIAL ROLE in myriad Genes that encode for health and Well-Being in the offspring, it behooves the medical and PUBLIC HEALTH community to endeavor to secure Vitamin D adequacy in the Gestational period.']	[('IMPORTANT_CONSIDERATION', 45), ('SUPERFICIAL_RELATIONSHIP', 55), ('IMPORTANT_CONSIDERATION', 160)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('SO_0000704', 'gene', 70, 'genes'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 103, 'well-being'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('GO_0007565', 'female pregnancy', 232, 'gestational')]	0	[' plays  encode well-being offspring, behooves medical community endeavor secure  gestational period.']
S135-PMC4690051	PMC4690051	12/2015	S135-PMC4690051	['Animal data SUGGEST the Genetic Expression of Fox2 , a regulator of Speech and Language, was lower in those on the Vitamin D deficiency diet at 14.5 days BUT Expression was higher at 17.5 days, compared to those on a Vitamin D sufficient diet [39].']	[('INCOMPLETE_EVIDENCE', 12), ('ANOMALY_CURIOUS_FINDING', 154)]	2	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('SO_0000704', 'gene', 24, 'genetic'), ('GO_0010467', 'gene expression', 32, 'expression'), ('PR_000017653', 'zinc finger protein ZFPM2', 46, 'Fox2'), ('GO_0008380', 'RNA splicing', 68, 'speech'), ('GO_0006266', 'DNA ligation', 79, 'language'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('GO_0010467', 'gene expression', 158, 'expression'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D')]	0	['animal  expression fox2 speech language,  diet 14.5 days expression higher 17.5 days,  diet [39].']
S53-PMC4764019	PMC4764019	1/2016	S53-PMC4764019	['well over 1000 Human Genes (and PERHAPS as many as 3000) have Vitamin D response elements.']	[('INCOMPLETE_EVIDENCE', 32)]	1	[('NCBITaxon_9606', 'Homo sapiens', 15, 'human'), ('SO_0000704', 'gene', 21, 'genes'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]	0	['well 1000 human  (and 3000)  response elements.']
S54-PMC4764019	PMC4764019	1/2016	S54-PMC4764019	['these Genes cover a broad range of functions ranging from cell-to-Cell adhesion, to Macrophage Production of defensins in response to mycobacterial infection, to Intestinal calcium absorption, and many others.13in ESSENTIALLY all such actions, Vitamin D, in its active form as 1,25(Oh)2D3, functions as a part of the molecular apparatus opening the Genome, permitting Expression of the Genes concerned.']	[('PROBABLE_UNDERSTANDING', 214)]	1	[('SO_0000704', 'gene', 6, 'genes'), ('GO_1901646', 'negative regulation of synoviocyte proliferation', 62, '- ...'), ('GO_0007049', 'cell cycle', 66, 'cell'), ('CL_0000235', 'macrophage', 84, 'macrophage'), ('GO_0007128', 'meiotic prophase I', 95, 'production'), ('UBERON_0000160', 'intestine', 162, 'intestinal'), ('CHEBI_27300', 'vitamin D', 244, 'vitamin D'), ('CHEBI_37958', 'dye', 277, '1,'), ('CHEBI_73394', 'Ala-Ser', 279, '25(OH)2D3'), ('SO_0001026', 'genome', 349, 'genome'), ('GO_0010467', 'gene expression', 368, 'expression'), ('SO_0000704', 'gene', 386, 'genes')]	0	[' cover broad functions cell-to-cell adhesion, macrophage production defensins response mycobacterial infection, intestinal calcium absorption, others.13in actions, form 1,25(oh)2d3, functions molecular apparatus opening genome, permitting expression  concerned.']
S55-PMC4764019	PMC4764019	1/2016	S55-PMC4764019	['THUS, the EFFECTS of Vitamin D inadequacy are as far-RANGING as the Tissues concerned, all of which require Vitamin D to gain access to information stored in their Genes.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 53)]	3	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0000479', 'tissue', 68, 'tissues'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('SO_0000704', 'gene', 164, 'genes')]	0	['thus,  inadequacy far-ranging tissues concerned,  gain access stored .']
S72-PMC4764019	PMC4764019	1/2016	S72-PMC4764019	['THAT MEANS that Vitamin D status CAN INFLUENCE not so much the content of our Genetic heritage as WHEN and to WHAT extent it gets Expressed.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 37), ('EXPLICIT_QUESTION', 98), ('EXPLICIT_QUESTION', 110)]	5	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('SO_0000704', 'gene', 78, 'genetic'), ('GO_0010467', 'gene expression', 130, 'expressed')]	0	[' status content  gets expressed.']
S108-PMC4765528	PMC4765528	12/2015	S108-PMC4765528	['the programming effect of an adverse in-utero environment and the role of epigenetics\nIT IS CLEAR that there is a strong Genetic predisposition to osteoporosis and although the Genes that Regulate bone mass have not been COMPLETELY established, responsible Gene variants include Vitamin D receptor polymorphisms [47], Collagen-1 Receptor [48] and Oestrogen receptor variants [49].']	[('PROBABLE_UNDERSTANDING', 86), ('PROBABLE_UNDERSTANDING', 221)]	2	[('SO_0000704', 'gene', 121, 'genetic'), ('SO_0000704', 'gene', 177, 'genes'), ('GO_0065007', 'biological regulation', 188, 'regulate'), ('SO_0000704', 'gene', 257, 'gene'), ('CHEBI_27300', 'vitamin D', 279, 'vitamin D'), ('PR_000003266', 'collagen type II alpha chain', 318, 'collagen-1 receptor'), ('CHEBI_50114', 'estrogen', 347, 'oestrogen')]	0	['programming in-utero environment epigenetics\nit  osteoporosis  regulate bone mass established,  variants  receptor polymorphisms [47], collagen-1 receptor [48] oestrogen receptor variants [49].']
S40-PMC4800340	PMC4800340	5/2016	S40-PMC4800340	['in the boston Birth cohort study, Cord Blood Vitamin D deficiency [25(Oh)D concentration <11 ng/ml] was not FOUND TO be ASSOCIATED with Food sensitization to eight common Food Allergen in children.67HOWEVER, when individual Genetic variant of 4 CANDIDATE Genes INVOLVED in Ige synthesis and Vitamin D Metabolism were jointly considered, there is a statistically strong Gene-Vitamin D INTERACTION (pinteraction=9×10-6) on Food sensitization.']	[('ANOMALY_CURIOUS_FINDING', 108), ('SUPERFICIAL_RELATIONSHIP', 120), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 197), ('INCOMPLETE_EVIDENCE', 245), ('SUPERFICIAL_RELATIONSHIP', 261), ('SUPERFICIAL_RELATIONSHIP', 384)]	6	[('GO_0007567', 'parturition', 14, 'birth'), ('UBERON_0002240', 'spinal cord', 34, 'cord'), ('UBERON_0000178', 'blood', 39, 'blood'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 67, '25(OH)D'), ('CHEBI_33290', 'food', 136, 'food'), ('CHEBI_33290', 'food', 171, 'food'), ('CHEBI_50904', 'allergen', 176, 'allergen'), ('SO_0000704', 'gene', 224, 'genetic'), ('SO_0000704', 'gene', 255, 'genes'), ('GO_0007630', 'jump response', 273, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 273, 'IgE'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin D'), ('GO_0018977', '1,1,1-trichloro-2,2-bis-(4-chlorophenyl)ethane metabolic process', 299, 'D metabolism'), ('SO_0000704', 'gene', 369, 'gene'), ('CHEBI_27300', 'vitamin D', 374, 'vitamin D'), ('CHEBI_33290', 'food', 421, 'food')]	0	['boston birth study, cord blood  [25(oh)d concentration <11 ng/ml] food sensitization eight food allergen children.67however, individual  variant 4  ige synthesis  metabolism considered, statistically (pinteraction=9×10-6) food sensitization.']
S51-PMC4800340	PMC4800340	5/2016	S51-PMC4800340	['the results of these studies SUGGEST that differential Dna Methylation in the regions of Genes RELATED to T-Cell Differentiation and balance between th1 and th2 during the critical Period Of early Life MAY BE POTENTIAL mechanisms of allergic disease development.73\n\nepigenetic Regulation by Nutrients\nALTHOUGH POSSIBLE ROLES of Prenatal Folate, N-3 Pufa, and Vitamin D in Immune programming HAVE BEEN SUGGESTED,3474only a LIMITED NUMBER OF STUDIES examined epigenetic Regulation by these Nutrients as a POTENTIAL biological pathway of allergic diseases.']	[('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 95), ('INCOMPLETE_EVIDENCE', 202), ('INCOMPLETE_EVIDENCE', 209), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 301), ('ANOMALY_CURIOUS_FINDING', 301), ('INCOMPLETE_EVIDENCE', 310), ('SUPERFICIAL_RELATIONSHIP', 319), ('INCOMPLETE_EVIDENCE', 391), ('INCOMPLETE_EVIDENCE', 401), ('INCOMPLETE_EVIDENCE', 422), ('INCOMPLETE_EVIDENCE', 503)]	12	[('GO_0006306', 'DNA methylation', 55, 'DNA methylation'), ('SO_0000704', 'gene', 89, 'genes'), ('CL_0000084', 'T cell', 106, 'T-cell'), ('GO_0030217', 'T cell differentiation', 106, 'T-cell differentiation'), ('UBERON_0008266', 'periodontal ligament', 181, 'period of ... life'), ('GO_0065007', 'biological regulation', 277, 'regulation'), ('CHEBI_33284', 'nutrient', 291, 'nutrients'), ('GO_0007565', 'female pregnancy', 328, 'prenatal'), ('CHEBI_30863', '5-azaorotic acid', 337, 'folate'), ('CHEBI_80445', '9,10-EOT', 345, 'n-3 PUFA'), ('CHEBI_27300', 'vitamin D', 359, 'vitamin D'), ('GO_0007566', 'embryo implantation', 372, 'immune'), ('UBERON_0002405', 'immune system', 372, 'immune'), ('GO_0065007', 'biological regulation', 468, 'regulation'), ('CHEBI_33284', 'nutrient', 488, 'nutrients')]	0	['results dna methylation regions  t-cell balance th1 th2 period life mechanisms allergic disease development.73\n\nepigenetic nutrients\nalthough prenatal folate, n-3 pufa,  immune programming suggested,3474only epigenetic nutrients biological allergic diseases.']
S24-PMC4829940	PMC4829940	5/2016	S24-PMC4829940	['the activated Vitamin D receptor has a large number of POTENTIAL target Genes, identified both experimentally using in vitro MODELS and in silico by identification of Vitamin D responsive elements[15].']	[('INCOMPLETE_EVIDENCE', 55), ('INCOMPLETE_EVIDENCE', 125)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('SO_0000704', 'gene', 72, 'genes'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 175, 'D')]	0	['activated  receptor experimentally using  responsive elements[15].']
S28-PMC4829940	PMC4829940	5/2016	S28-PMC4829940	['another STUDY explored epigenetic Regulation of Vitamin D converting enzymes[18], WHILE a third FOUND a RELATIONSHIP between methylation of the Genes Cyp24R1 and Cyp27A1 and variations in circulating 25(Oh)D levels[19].']	[('INCOMPLETE_EVIDENCE', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 104)]	4	[('GO_0065007', 'biological regulation', 34, 'regulation'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('SO_0000704', 'gene', 144, 'genes'), ('PR_000006101', 'cytochrome P450 1A1', 150, 'CYP24R1'), ('PR_000006101', 'cytochrome P450 1A1', 162, 'CYP27A1'), ('CHEBI_71657', 'versiconol acetate', 200, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 200, '25(OH ... D')]	0	['another epigenetic  converting enzymes[18], third methylation  cyp24r1 cyp27a1 circulating 25(oh)d levels[19].']
S115-PMC4829940	PMC4829940	5/2016	S115-PMC4829940	['DESPITE the EXISTING HYPOTHESIS that maternal Vitamin D status MAY INFLUENCE offspring health[41], we FOUND NO EVIDENCE for any Dna Methylation based EFFECT in Cord Blood, EITHER Genome-wide or in four candidate Genes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 67), ('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 150), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 172)]	10	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0006306', 'DNA methylation', 128, 'DNA methylation'), ('UBERON_0002240', 'spinal cord', 160, 'cord'), ('UBERON_0000178', 'blood', 165, 'blood'), ('SO_0001026', 'genome', 179, 'genome'), ('SO_0000704', 'gene', 212, 'genes')]	0	['despite maternal  status offspring health[41], dna methylation cord blood, four .']
S118-PMC4829940	PMC4829940	5/2016	S118-PMC4829940	['epigenetic EFFECTS of maternal Vitamin D levels on offspring methylomes can NEVERTHELESS not be excluded; the cpg’s in the neighborhood of the CANDIDATE Genes, as mapped by the illumina humanmethylation450 beadchip, MAY not be the same as the ones REPORTED from OTHER studies.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76), ('INCOMPLETE_EVIDENCE', 143), ('INCOMPLETE_EVIDENCE', 216), ('INCOMPLETE_EVIDENCE', 248), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 262), ('INCOMPLETE_EVIDENCE', 262)]	7	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('SO_0000704', 'gene', 153, 'genes')]	0	['epigenetic maternal  levels offspring methylomes excluded; cpg’s neighborhood illumina humanmethylation450 beadchip, ones studies.']
S127-PMC4829940	PMC4829940	5/2016	S127-PMC4829940	['HOWEVER, a FEW other STUDIES have explored RELATIONSHIPS between Vitamin D supplementation or circulating 25(Oh)D and methylation at a few Cpg Sites in two to four candidate Genes in Adults[18],[46], and one Genome-wide Dna Methylation study explored ASSOCIATION with Vitamin D deficiency in african children[17].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 251)]	4	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 106, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 106, '25(OH)D'), ('SO_0000036', 'matrix_attachment_site', 139, 'CpG sites'), ('SO_0000704', 'gene', 174, 'genes'), ('UBERON_0007023', 'adult organism', 183, 'adults'), ('SO_0001026', 'genome', 208, 'genome'), ('GO_0006306', 'DNA methylation', 220, 'DNA methylation'), ('CHEBI_27300', 'vitamin D', 268, 'vitamin D')]	0	['however,  supplementation circulating 25(oh)d methylation cpg sites four  adults[18],[46], genome-wide dna methylation  african children[17].']
S22-PMC4832516	PMC4832516	10/2015	S22-PMC4832516	['Age At Menarche is a well-recalled measure of Pubertal timing in girls and HAS BEEN LINKED to Vitamin D status in prospective[13]and Genetic[14]studies.']	[('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 84)]	2	[('GO_0007568', 'aging', 0, 'Age at'), ('GO_0042696', 'menarche', 7, 'menarche'), ('GO_0007567', 'parturition', 46, 'pubertal'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('SO_0000704', 'gene', 133, 'genetic')]	0	['age menarche well-recalled measure pubertal timing girls  status prospective[13]and [14]studies.']
S109-PMC4832516	PMC4832516	10/2015	S109-PMC4832516	['furthermore, recent Genetic studies have INDICATED POTENTIAL aetiological ROLES for the Vitamin D receptor (vdr) and RELATED Nuclear hormone receptors in Pubertal timing[14].']	[('INCOMPLETE_EVIDENCE', 41), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 74), ('SUPERFICIAL_RELATIONSHIP', 117)]	4	[('SO_0000704', 'gene', 20, 'genetic'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('GO_0005634', 'nucleus', 125, 'nuclear'), ('GO_0007567', 'parturition', 154, 'pubertal')]	0	['furthermore,  aetiological  receptor (vdr) nuclear hormone receptors pubertal timing[14].']
S162-PMC4846845	PMC4846845	4/2016	S162-PMC4846845	['1,25(Oh)2D then binds the Vitamin D receptor, which can subsequently act as a transcription factor by targeting the Vitamin D response element (vdre) motif within the Promoter of the target Gene to AFFECT Gene Expression [126].']	[('SUPERFICIAL_RELATIONSHIP', 198)]	1	[('CHEBI_37983', 'sulfur-35 atom', 0, '1'), ('CHEBI_17996', 'chloride', 1, ','), ('CHEBI_66212', '5,7,3*,4*-tetrahydroxy-2*-(3,3-dimethylallyl)isoflavone', 2, '25(OH)2D'), ('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('SO_0000167', 'promoter', 167, 'promoter'), ('SO_0000704', 'gene', 190, 'gene'), ('GO_0010467', 'gene expression', 205, 'gene expression'), ('SO_0000704', 'gene', 205, 'gene')]	0	['1,25(oh)2d binds  receptor, transcription  response element (vdre) motif promoter   expression [126].']
S169-PMC4846845	PMC4846845	4/2016	S169-PMC4846845	['a RECENT STUDY has FOUND ASSOCIATIONS between Vitamin D levels in maternal and Cord Blood and Immune Cell type proportions, as well as Placental Expression of Immune System related Genes [130].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 25)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 79, 'cord'), ('UBERON_0000178', 'blood', 84, 'blood'), ('CL_0000738', 'leukocyte', 94, 'immune cell'), ('UBERON_0002405', 'immune system', 94, 'immune'), ('UBERON_0001987', 'placenta', 135, 'placental'), ('GO_0010467', 'gene expression', 145, 'expression'), ('UBERON_0002405', 'immune system', 159, 'immune system'), ('SO_0000704', 'gene', 181, 'genes')]	0	[' levels maternal cord blood immune cell type proportions, placental expression immune system  [130].']
S351-PMC4864049	PMC4864049	1/2016	S351-PMC4864049	['in addition, WHILE THERE IS EVIDENCE that Vitamin D MAY increase Dna Demethylation of selected Gene Promoters, the mechanisms behind this EFFECT are NOT CLEAR\xa0[162].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 138), ('FULL_UNKNOWN', 149)]	5	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0006306', 'DNA methylation', 65, 'DNA demethylation'), ('SO_0000704', 'gene', 95, 'gene'), ('SO_0000167', 'promoter', 100, 'promoters')]	0	['addition,  increase dna demethylation selected  promoters, mechanisms behind clear\xa0[162].']
S353-PMC4864049	PMC4864049	1/2016	S353-PMC4864049	['moreover, aside from activating Vitamin D responsive Genes through a coactivator mediated pathway, the means by which Vitamin D facilitates changes in Chromatin Relaxation are ONLY beginning to be understood.']	[('INCOMPLETE_EVIDENCE', 176)]	1	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('SO_0000704', 'gene', 53, 'genes'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0000785', 'chromatin', 151, 'chromatin'), ('GO_0032809', 'neuronal cell body membrane', 161, 'relaxation')]	0	['moreover, aside activating  responsive  coactivator pathway,  facilitates changes chromatin relaxation understood.']
S394-PMC4896250	PMC4896250	4/2016	S394-PMC4896250	['a28 tgfβ1 level is ASSOCIATED with vdr Gene polymorphism in children with allergy diseases\n\ntatiana sentsova1, ilya vorozhko1, olga chernyak1, vera revyakina1, anna timopheeva1, andrey donnikov2\n\n1institute of nutrition;2dna-technology, jsc\n\ncorrespondence: tatiana sentsova – institute of nutrition, russia\nbackground: Vitamin D Receptor (Vdr) is Intracellulary located on the cells Of the Immune System and is INVOLVED in the Immune Response.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 412)]	2	[('SO_0000704', 'gene', 39, 'gene'), ('CHEBI_27300', 'vitamin D', 320, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 320, 'vitamin D receptor'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 340, 'VDR'), ('GO_0005622', 'intracellular anatomical structure', 348, 'intracellulary'), ('CL_0000024', 'oogonial cell', 384, 'of'), ('UBERON_0002405', 'immune system', 391, 'immune system'), ('CL_0000034', 'stem cell', 398, 'system'), ('GO_0006955', 'immune response', 428, 'immune response'), ('UBERON_0002405', 'immune system', 428, 'immune')]	0	['a28 tgfβ1 vdr  polymorphism children allergy diseases\n\ntatiana sentsova1, ilya vorozhko1, olga chernyak1, vera revyakina1, anna timopheeva1, andrey donnikov2\n\n1institute nutrition;2dna-technology, jsc\n\ncorrespondence: tatiana sentsova institute nutrition, russia\nbackground:  receptor (vdr) intracellulary located cells immune system immune response.']
S3695-PMC4896250	PMC4896250	4/2016	S3695-PMC4896250	['a259 ASSOCIATION of vdr and Cyp2R1 polymorphisms with persistent allergic rhinitis in a han chinese population\n\nhui-qin tian, lei cheng, xin-yuan chen\n\nthe first affiliated hospital of nanjing medical university, china\n\ncorrespondence: hui-qin tian – the first affiliated hospital of nanjing medical university china\na) background: as recent STUDIES have DESCRIBED an ASSOCIATION between Vitamin D and allergic rhinitis, we HYPOTHESIZED that Genes encoding components of the Vitamin D pathway MAY BE CANDIDATE Genes for susceptibility to allergic rhinitis.']	[('SUPERFICIAL_RELATIONSHIP', 5), ('INCOMPLETE_EVIDENCE', 342), ('INCOMPLETE_EVIDENCE', 355), ('SUPERFICIAL_RELATIONSHIP', 368), ('INCOMPLETE_EVIDENCE', 424), ('INCOMPLETE_EVIDENCE', 493), ('INCOMPLETE_EVIDENCE', 500)]	7	[('PR_000006110', 'cytochrome P450 27, mitochondrial', 28, 'CYP2R1'), ('CHEBI_27300', 'vitamin D', 388, 'vitamin D'), ('SO_0000704', 'gene', 442, 'genes'), ('CHEBI_27300', 'vitamin D', 475, 'vitamin D'), ('GO_0007601', 'visual perception', 475, 'vitamin D'), ('SO_0000704', 'gene', 510, 'genes')]	0	['a259 vdr cyp2r1 polymorphisms allergic rhinitis han chinese population\n\nhui-qin tian, lei cheng, xin-yuan chen\n\nthe affiliated hospital nanjing medical university, china\n\ncorrespondence: hui-qin tian affiliated hospital nanjing medical university china\na) background:  allergic rhinitis,  encoding   allergic rhinitis.']
S3696-PMC4896250	PMC4896250	4/2016	S3696-PMC4896250	['THIS STUDY SOUGHT TO EVALUATE WHETHER Genetic variants in the Vitamin D pathway-related Genes are ASSOCIATED with allergic rhinitis in a han chinese population.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('SUPERFICIAL_RELATIONSHIP', 98)]	5	[('SO_0000704', 'gene', 38, 'genetic'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007601', 'visual perception', 62, 'vitamin D'), ('SO_0000704', 'gene', 88, 'genes')]	0	[' variants  pathway-related  allergic rhinitis han chinese population.']
S133-PMC4910734	PMC4910734	6/2015	S133-PMC4910734	['autistic children are NOTORIOUS picky eaters, leading to SOME DOCUMENTED DEFICIENCIES in individual case STUDIES, such as Vitamin A deficiencies.53nutritional status based on dietary record keeping, not surprisingly, gives CONFLICTING results,118in PART BECAUSE autistic children OFTEN SUFFER from Gastrointestinal mal-absorption PROBLEMS77OR BECAUSE Genetic factors MAY play a ROLE in nutritional deficiency.']	[('IMPORTANT_CONSIDERATION', 22), ('IMPORTANT_CONSIDERATION', 22), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 62), ('IMPORTANT_CONSIDERATION', 73), ('INCOMPLETE_EVIDENCE', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 223), ('SUPERFICIAL_RELATIONSHIP', 249), ('PROBABLE_UNDERSTANDING', 254), ('PROBABLE_UNDERSTANDING', 280), ('IMPORTANT_CONSIDERATION', 286), ('IMPORTANT_CONSIDERATION', 330), ('PROBABLE_UNDERSTANDING', 343), ('INCOMPLETE_EVIDENCE', 367), ('SUPERFICIAL_RELATIONSHIP', 378)]	15	[('CHEBI_27300', 'vitamin D', 122, 'vitamin A'), ('UBERON_0005409', 'alimentary part of gastrointestinal system', 298, 'gastrointestinal'), ('SO_0000704', 'gene', 351, 'genetic')]	0	['autistic children picky eaters, individual studies,  deficiencies.53nutritional status dietary keeping, surprisingly, results,118in autistic children gastrointestinal mal-absorption  play nutritional deficiency.']
S157-PMC4933662	PMC4933662	4/2016	S157-PMC4933662	['lower Transcript Expression of\xa0Vitamin D Receptor and Interferon Gamma in Skeletal muscle Tissue was ASSOCIATED with higher lean mass and lower Gene Expression of Interleukin 6 (il‐6), Tumour Necrosis Factor‐alpha (Tnf‐Α) and Interleukin‐1 Receptor (Il1R1) in community‐dwelling older men (patel et\xa0al .,2014).']	[('SUPERFICIAL_RELATIONSHIP', 101)]	1	[('SO_0000673', 'transcript', 6, 'transcript'), ('GO_0010467', 'gene expression', 17, 'expression'), ('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 31, 'vitamin D receptor'), ('PR_000002050', 'interferon regulatory factor 8', 54, 'interferon gamma'), ('CHEBI_37958', 'dye', 65, 'gamma'), ('UBERON_0004288', 'skeleton', 74, 'skeletal'), ('UBERON_0000479', 'tissue', 90, 'tissue'), ('GO_0010467', 'gene expression', 144, 'gene expression'), ('SO_0000704', 'gene', 144, 'gene'), ('PR_000008988', 'interleukin-1 family member 5', 163, 'interleukin 6'), ('PR_000016589', 'tumor protein p63-regulated gene 1 protein', 185, 'tumour necrosis factor'), ('PR_000000134', 'tumor necrosis factor alpha', 215, 'TNF‐α'), ('PR_000001364', 'interleukin-1 receptor type II', 226, 'interleukin‐1 receptor'), ('PR_000001385', 'interleukin-27 subunit alpha', 250, 'IL1R1')]	0	['lower transcript expression of\xa0 receptor interferon gamma skeletal muscle tissue higher lean mass  expression interleukin 6 (il‐6), tumour necrosis factor‐alpha (tnf‐α) interleukin‐1 receptor (il1r1) community‐dwelling older men (patel et\xa0al .,2014).']
S20-PMC4934634	PMC4934634	11/2015	S20-PMC4934634	['factors INFLUENCING Vitamin D status\nnumerous and diverse lifestyle choices, and environmental and Genetic FACTORS CAN alter Vitamin D status [6];figure 1.']	[('SUPERFICIAL_RELATIONSHIP', 8), ('SUPERFICIAL_RELATIONSHIP', 107), ('INCOMPLETE_EVIDENCE', 115)]	3	[('CHEBI_28384', 'vitamin K', 20, 'Vitamin D'), ('SO_0000704', 'gene', 99, 'genetic'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]	0	['factors vitamin status\nnumerous lifestyle choices, environmental  alter  status [6];figure 1.']
S28-PMC4934634	PMC4934634	11/2015	S28-PMC4934634	['Genetic variations in Cyp2R1 and Vitamin D binding protein CAN reduce the subsequent increases of Serum Vitamin D after uvb exposure and Consumption of Vitamin D fortified foods, respectively, SUGGESTING genetics play a ROLE in determining Vitamin D status [7].']	[('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 220)]	3	[('SO_0000704', 'gene', 0, 'Genetic'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 22, 'CYP2R1'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0001977', 'blood serum', 98, 'serum'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007631', 'feeding behavior', 137, 'consumption'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]	0	[' cyp2r1  binding protein serum  uvb exposure consumption  fortified foods, respectively, genetics play  status [7].']
S106-PMC4934634	PMC4934634	11/2015	S106-PMC4934634	['cathelicidins, Antimicrobial peptides that can defend against pathogens, are up regulated by Vitamin D. vdr can bind to response elements Of the Human Cathelicidin peptide Gene (Cathelicidin Antimicrobial peptide; camp) increasing the Killing ability of Innate Immune Cells, Macrophages, THUS strengthening the innate Immune System’s response [41].']	[('PROBABLE_UNDERSTANDING', 288)]	1	[('CHEBI_65381', 'albizoside C', 15, 'antimicrobial'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('SO_0001467', 'RST', 138, 'of'), ('NCBITaxon_9606', 'Homo sapiens', 145, 'human'), ('PR_000006009', 'alpha-catulin', 151, 'cathelicidin'), ('SO_0000704', 'gene', 172, 'gene'), ('CHEBI_3364', 'Canthiumine', 178, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 178, 'cathelicidin'), ('CHEBI_65381', 'albizoside C', 191, 'antimicrobial'), ('GO_0007601', 'visual perception', 235, 'killing'), ('CL_0002088', 'interstitial cell of Cajal', 254, 'innate immune cells'), ('GO_0044409', 'entry into host', 254, 'innate immune cells'), ('UBERON_0002405', 'immune system', 261, 'immune'), ('CL_0000235', 'macrophage', 275, 'macrophages'), ('UBERON_0002405', 'immune system', 318, 'immune system')]	0	['cathelicidins, antimicrobial peptides defend pathogens, . vdr bind response elements human cathelicidin peptide  (cathelicidin antimicrobial peptide; camp) killing ability innate immune cells, macrophages, innate immune system’s response [41].']
S175-PMC4934634	PMC4934634	11/2015	S175-PMC4934634	['through vdr, Vitamin D is INVOLVED in Modulation Of Histone Acetylation and Methylation resulting in the activation or silencing of Genes [63,64,65].']	[('SUPERFICIAL_RELATIONSHIP', 26)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0061724', 'lipophagy', 38, 'modulation of'), ('CHEBI_15358', 'histone', 52, 'histone'), ('GO_0034729', 'histone H3-K79 methylation', 52, 'histone acetylation ... methylation'), ('PR_000043452', 'core histone', 52, 'histone'), ('SO_0000704', 'gene', 132, 'genes')]	0	['vdr,  histone acetylation methylation resulting activation silencing  [63,64,65].']
S6-PMC4979151	PMC4979151	8/2016	S6-PMC4979151	['HOWEVER, Pha stimulation significantly induced the Expression of Genes encoding th1 and th2 cytokines and down-regulated a number of Genes INVOLVED in T-Cell Development, Proliferation and Differentiation Of B Cells, signal transduction pathway, transcriptional Regulation and pattern recognition receptors (prrs) in the Vitamin D group (vitd group).']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 139)]	2	[('CHEBI_34926', 'Pitrazepin', 9, 'PHA'), ('GO_0010467', 'gene expression', 51, 'expression'), ('SO_0000704', 'gene', 65, 'genes'), ('SO_0000704', 'gene', 133, 'genes'), ('CL_0000084', 'T cell', 151, 'T-cell'), ('GO_0002296', 'T-helper 1 cell lineage commitment', 151, 'T-cell development'), ('GO_0007565', 'female pregnancy', 171, 'proliferation ...'), ('GO_0030154', 'cell differentiation', 189, 'differentiation of B cells'), ('CL_0000236', 'B cell', 208, 'B cells'), ('GO_0065007', 'biological regulation', 262, 'regulation'), ('CHEBI_27300', 'vitamin D', 321, 'vitamin D')]	0	['however, pha stimulation induced expression  encoding th1 th2 cytokines down-regulated  t-cell development, proliferation b cells, signal transduction pathway, transcriptional receptors (prrs)  (vitd group).']
S146-PMC4979151	PMC4979151	8/2016	S146-PMC4979151	['down-regulation of Genes in the Tcr Complex, T Cell co-stimulatory Molecules and Major Histocompatibility Complexes (T Cell Adaptive Immunity) in the vitd group SUGGESTS suppression of T Cell Signaling Pathway by Vitamin D. induction of Cd2, Cd40Lg and Il-12Rb2 Expression that are IMPORTANT in T and Nk Cell function and inflammatory responses, and down-regulation of receptors for these ligands SUGGEST balanced responses to in vivo vitd3supplementation that would be expected to mitigate MAJOR downstream effects.']	[('DIFFICULT_TASK', 36), ('INCOMPLETE_EVIDENCE', 161), ('IMPORTANT_CONSIDERATION', 282), ('INCOMPLETE_EVIDENCE', 397), ('IMPORTANT_CONSIDERATION', 491)]	5	[('SO_0000704', 'gene', 19, 'genes'), ('GO_0042101', 'T cell receptor complex', 32, 'TCR complex'), ('CL_0000084', 'T cell', 45, 'T cell'), ('CHEBI_36357', 'polyatomic entity', 67, 'molecules'), ('GO_0042611', 'MHC protein complex', 81, 'major histocompatibility complexes'), ('CL_0000084', 'T cell', 117, 'T cell'), ('GO_0002456', 'T cell mediated immunity', 117, 'T cell adaptive immunity'), ('CL_0000084', 'T cell', 185, 'T cell'), ('GO_0002770', 'T cell inhibitory signaling pathway', 185, 'T cell signaling pathway'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('PR_000001204', 'C-C chemokine receptor type 8', 237, 'CD2'), ('PR_000001309', 'CD70 molecule', 242, 'CD40LG'), ('PR_000008990', 'interleukin-1 family member 9', 253, 'IL-12RB2'), ('GO_0010467', 'gene expression', 262, 'expression'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 295, 'T ...'), ('CL_0000623', 'natural killer cell', 301, 'NK cell'), ('GO_0005634', 'nucleus', 301, 'NK')]	0	['down-regulation  tcr complex, cell co-stimulatory molecules histocompatibility complexes (t cell adaptive immunity) vitd suppression cell signaling . induction cd2, cd40lg il-12rb2 expression nk cell inflammatory responses, down-regulation receptors ligands responses vivo vitd3supplementation mitigate effects.']
S10-PMC4998950	PMC4998950	4/2016	S10-PMC4998950	['environmental and Genetic FACTORS APPEAR equally IMPORTANT,1ALTHOUGH asd with and without intellectual disability MAY IN PART have DIFFERENT origins.2,3\nin high-latitude countries such as sweden, children of mothers with dark complexion are at PARTICULARLY elevated RISK of asd with intellectual disability.3because such women OFTEN have very low Vitamin d levels due to Melanin absorption of uvb radiation, maternal Vitamin D deficiency HAS BEEN SUGGESTED to CONTRIBUTE to asd risk in offspring.4,5indeed, experimentally induced Vitamin D deficiency in Pregnant dams is REPORTED to AFFECT foetal Neurodevelopment and behaviour in Adult offspring in Rats,4AND a RECENT STUDY DEMONSTRATED lower neonatal Vitamin D levels in children with asd compared with their siblings.6\nearly Life Vitamin D deficiency is THUS a POSSIBLE RISK FACTOR for asd, BUT direct SUPPORT of an ASSOCIATION IS LACKING.4maternal hypovitaminosis d is treatable, THUS INVESTIGATION of the matter IS WARRANTED.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('ANOMALY_CURIOUS_FINDING', 34), ('IMPORTANT_CONSIDERATION', 49), ('ANOMALY_CURIOUS_FINDING', 59), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 118), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('ANOMALY_CURIOUS_FINDING', 244), ('IMPORTANT_CONSIDERATION', 244), ('IMPORTANT_CONSIDERATION', 266), ('PROBABLE_UNDERSTANDING', 327), ('INCOMPLETE_EVIDENCE', 438), ('SUPERFICIAL_RELATIONSHIP', 460), ('INCOMPLETE_EVIDENCE', 571), ('SUPERFICIAL_RELATIONSHIP', 583), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 655), ('INCOMPLETE_EVIDENCE', 662), ('INCOMPLETE_EVIDENCE', 675), ('PROBABLE_UNDERSTANDING', 807), ('INCOMPLETE_EVIDENCE', 814), ('SUPERFICIAL_RELATIONSHIP', 823), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 844), ('INCOMPLETE_EVIDENCE', 855), ('SUPERFICIAL_RELATIONSHIP', 869), ('INCOMPLETE_EVIDENCE', 881), ('FULL_UNKNOWN', 884), ('PROBABLE_UNDERSTANDING', 934), ('FUTURE_WORK', 939), ('FUTURE_WORK', 967)]	29	[('SO_0000704', 'gene', 18, 'genetic'), ('CHEBI_33229', 'vitamin (role)', 347, 'vitamin'), ('CHEBI_25179', 'melanins', 371, 'melanin'), ('CHEBI_27300', 'vitamin D', 417, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 530, 'vitamin D'), ('GO_0007565', 'female pregnancy', 554, 'pregnant'), ('GO_0007399', 'nervous system development', 597, 'neurodevelopment'), ('UBERON_0007023', 'adult organism', 631, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 650, 'rats'), ('CHEBI_27300', 'vitamin D', 703, 'vitamin D'), ('UBERON_0000104', 'life cycle', 778, 'life'), ('CHEBI_27300', 'vitamin D', 783, 'vitamin D')]	0	['environmental  important,1although asd intellectual disability origins.2,3\nin high-latitude countries sweden, children mothers dark complexion asd intellectual disability.3because women vitamin levels melanin absorption uvb radiation, maternal  asd offspring.4,5indeed, experimentally induced  pregnant dams foetal neurodevelopment behaviour adult offspring rats,4and neonatal  levels children asd siblings.6\nearly life  asd, lacking.4maternal hypovitaminosis treatable, warranted.']
S43-PMC4998950	PMC4998950	4/2016	S43-PMC4998950	['our finding of a stronger ASSOCIATION between maternal hypovitaminosis d and asd with intellectual disability than without intellectual disability is IN LINE WITH migrant STUDIES, DEMONSTRATING that offspring risk of severe forms of asd – BUT NOT asperger’s syndrome or asd without intellectual disability – is increased in migrant populations where Vitamin D deficiency is highly prevalent.3–6,8there is also MOUNTING EVIDENCE that environmental FACTORS are more RELEVANT (THAN Genetic factors) for the development of lower-functioning asd.2we, as well as others,6FURTHER OBSERVED heterogeneity in the ASSOCIATIONS between Vitamin D deficiency and asd between children with and without maternal migrant history.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 150), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 180), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 239), ('ANOMALY_CURIOUS_FINDING', 239), ('INCOMPLETE_EVIDENCE', 410), ('SUPERFICIAL_RELATIONSHIP', 447), ('IMPORTANT_CONSIDERATION', 464), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 474), ('INCOMPLETE_EVIDENCE', 564), ('INCOMPLETE_EVIDENCE', 573), ('SUPERFICIAL_RELATIONSHIP', 603)]	13	[('CHEBI_27300', 'vitamin D', 350, 'vitamin D'), ('SO_0000704', 'gene', 479, 'genetic'), ('CHEBI_27300', 'vitamin D', 624, 'vitamin D')]	0	['maternal hypovitaminosis asd intellectual disability intellectual disability migrant studies, offspring forms asd asperger’s syndrome asd intellectual disability migrant populations  prevalent.3–6,8there environmental (than  factors) lower-functioning asd.2we, others,6further  asd children maternal migrant history.']
S30-PMC5014971	PMC5014971	8/2016	S30-PMC5014971	['in vitro studies HAVE SHOWN that 1,25-Dihydroxyvitamin D downregulates Gene Expression of inflammatory markers and Contractile associated proteins in Human Myometrial Cells [23,24], providing a biologically PLAUSIBLE mechanism for Vitamin D action in reducing inflammatory and contractile responses due to infection.']	[('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 207)]	2	[('CHEBI_67472', '15-epi-lupulin B', 33, '1,25-dihydroxyvitamin D'), ('GO_0010467', 'gene expression', 71, 'gene expression'), ('SO_0000704', 'gene', 71, 'gene'), ('GO_0006936', 'muscle contraction', 115, 'contractile'), ('NCBITaxon_9606', 'Homo sapiens', 150, 'human'), ('CL_0002366', 'myometrial cell', 156, 'myometrial cells'), ('UBERON_0001697', 'orbit of skull', 156, 'myometrial'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D')]	0	['1,25-dihydroxyvitamin downregulates  expression inflammatory contractile proteins human myometrial cells [23,24], biologically  reducing inflammatory contractile responses infection.']
S86-PMC5028238	PMC5028238	10/2016	S86-PMC5028238	['improved hip formation IS THOUGHT TO enable females to produce more offspring and thereby provide another carrier advantage.11,35in addition, Vitamin D HAS BEEN SHOWN to increase chances of Pregnancy for infertile women receiving in Vitro Fertilization.48vitamin d has many pleiotropic ROLES in Reproductive outcomes and CAN AFFECT both male and female Fertility.49THEREFORE, there COULD BE MULTIPLE mechanisms that COULD EXPLAIN WHY evolution favors Vitamin D Production in northern climates through mutations in Dhcr7 (and other Genes).']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 152), ('SUPERFICIAL_RELATIONSHIP', 286), ('INCOMPLETE_EVIDENCE', 321), ('SUPERFICIAL_RELATIONSHIP', 325), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 363), ('INCOMPLETE_EVIDENCE', 382), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 391), ('INCOMPLETE_EVIDENCE', 416), ('PROBABLE_UNDERSTANDING', 422), ('EXPLICIT_QUESTION', 430)]	12	[('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('GO_0007565', 'female pregnancy', 190, 'pregnancy'), ('GO_0007601', 'visual perception', 233, 'vitro'), ('GO_0009566', 'fertilization', 239, 'fertilization'), ('GO_0000003', 'reproduction', 295, 'reproductive'), ('GO_0009566', 'fertilization', 353, 'fertility'), ('CHEBI_27300', 'vitamin D', 451, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 451, 'vitamin D production'), ('PR_000006474', 'ATP-dependent RNA helicase A', 514, 'DHCR7'), ('SO_0000704', 'gene', 531, 'genes')]	0	['improved hip formation females produce offspring carrier advantage.11,35in addition,  increase pregnancy infertile women receiving fertilization.48vitamin pleiotropic reproductive outcomes male female fertility.49therefore, mechanisms evolution  production northern climates mutations dhcr7 (and ).']
S94-PMC5028238	PMC5028238	10/2016	S94-PMC5028238	['one POSSIBLE biological EXPLANATION that fits with the literature-derived mechanism (figure 3) is that slos patients spent less time outdoors thereby reducing their Ultraviolet b exposure (another CRITICAL REQUIREMENT for Vitamin D Synthesis).55\n\nGenetic understanding of slos-inducing Dhcr7 mutations: IMPLICATIONS for FUTURE WORK\n\nchanging our understanding of slos genetics using large-scale Genomics studies\nusing exac,24we were able to compare the frequencies of Dhcr7 slos-inducing mutations in the slos population (extracted from the literature) and the assumed-healthy exac population.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 24), ('IMPORTANT_CONSIDERATION', 197), ('IMPORTANT_CONSIDERATION', 206), ('IMPORTANT_CONSIDERATION', 303), ('FUTURE_WORK', 320)]	6	[('CHEBI_75275', 'tetradecyl sulfonic acid', 165, 'ultraviolet'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin D'), ('GO_0031151', 'histone methyltransferase activity (H3-K79 specific)', 230, 'D synthesis'), ('SO_0000704', 'gene', 247, 'Genetic'), ('PR_000006474', 'ATP-dependent RNA helicase A', 286, 'DHCR7'), ('SO_0001026', 'genome', 395, 'genomics'), ('PR_000006474', 'ATP-dependent RNA helicase A', 468, 'DHCR7')]	0	['one biological literature-derived (figure 3) slos patients spent outdoors reducing ultraviolet b exposure (another  synthesis).55\n\n slos-inducing dhcr7 mutations: work\n\nchanging slos genetics using genomics studies\nusing exac,24we able frequencies dhcr7 slos-inducing mutations slos population (extracted literature) assumed-healthy exac population.']
S66-PMC5045784	PMC5045784	10/2016	S66-PMC5045784	['given that Vitamin D has IMPORTANT ROLES in early Lung Development and Innate Immunity, the LACK OF ASSOCIATION between Vitamin D status and development of bpd SUPPORTS the multifactorial etiology of and POSSIBLE Genetic predisposition to bpd.']	[('IMPORTANT_CONSIDERATION', 25), ('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 100), ('INCOMPLETE_EVIDENCE', 160), ('INCOMPLETE_EVIDENCE', 204)]	6	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0030324', 'lung development', 50, 'lung development'), ('UBERON_0002048', 'lung', 50, 'lung'), ('GO_0045087', 'innate immune response', 71, 'innate immunity'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('SO_0000704', 'gene', 213, 'genetic')]	0	['given  lung innate immunity,  status bpd etiology  bpd.']
S69-PMC5045784	PMC5045784	10/2016	S69-PMC5045784	['a variety of host FACTORS MAY confer altered susceptibility to bpd in preterm infants and SOME of these MAY BE Genetic and RELATED to Vitamin D bioavailability that is not REFLECTED in 25(Oh)D levels.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 90), ('INCOMPLETE_EVIDENCE', 104), ('SUPERFICIAL_RELATIONSHIP', 123), ('INCOMPLETE_EVIDENCE', 172), ('SUPERFICIAL_RELATIONSHIP', 172)]	7	[('SO_0000704', 'gene', 111, 'genetic'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 185, '25(OH)D')]	0	['host altered bpd preterm infants   bioavailability 25(oh)d levels.']
S71-PMC5062906	PMC5062906	10/2016	S71-PMC5062906	['results\n\ndietary depletion of circulating Plasma 25(Oh)D is DEPENDENT on Genetic background\nTO DETERMINE the extent of Vitamin D depletion in g0dams Fed diet lacking Vitamin d (lvd) compared with dams on control diet (con) (fig.']	[('SUPERFICIAL_RELATIONSHIP', 60), ('QUESTION_ANSWERED_BY_THIS_WORK', 92)]	2	[('UBERON_0001969', 'blood plasma', 42, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 49, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 49, '25(OH)D'), ('SO_0000704', 'gene', 73, 'genetic'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('GO_0007631', 'feeding behavior', 149, 'fed'), ('CHEBI_33229', 'vitamin (role)', 166, 'vitamin')]	0	['results\n\ndietary depletion circulating plasma 25(oh)d  background\nto  depletion g0dams fed diet vitamin (lvd) dams diet (con) (fig.']
S78-PMC5062906	PMC5062906	10/2016	S78-PMC5062906	['1c) DEMONSTRATING a Genetic INFLUENCE on response to dietary Vitamin D depletion.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 28)]	2	[('SO_0000704', 'gene', 20, 'genetic'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]	0	['1c)  response dietary  depletion.']
S153-PMC5062906	PMC5062906	10/2016	S153-PMC5062906	['maternal Vitamin D depletion alters Dna Methylation in Soma and germline of Adult g1and g2males in a parent and grandparent of origin-DEPENDENT manner\nwe INVESTIGATED WHETHER Vitamin D depletion AFFECTS Dna Methylation state at Imprinted Genes in g1and g2males and WHETHER these differences are LINKED to the developmental changes described above.']	[('SUPERFICIAL_RELATIONSHIP', 134), ('QUESTION_ANSWERED_BY_THIS_WORK', 154), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 167), ('SUPERFICIAL_RELATIONSHIP', 195), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 265), ('SUPERFICIAL_RELATIONSHIP', 295)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0006306', 'DNA methylation', 36, 'DNA methylation'), ('GO_0044297', 'cell body', 55, 'soma'), ('UBERON_0007023', 'adult organism', 76, 'adult'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('GO_0006306', 'DNA methylation', 203, 'DNA methylation'), ('GO_0071514', 'genetic imprinting', 228, 'imprinted'), ('SO_0000704', 'gene', 238, 'genes')]	0	['maternal  depletion alters dna methylation soma germline adult g1and g2males parent grandparent origin-dependent manner\nwe  depletion dna methylation imprinted  g1and g2males developmental changes above.']
S251-PMC5062906	PMC5062906	10/2016	S251-PMC5062906	['our data HIGHLIGHT two mechanisms that CONTRIBUTE to interindividual DIFFERENCES in response to Vitamin D deficiency: the Genetic INFLUENCE on maternal Plasma depletion of 25(Oh)D and the INFLUENCE of parent and grandparent of origin in the extent of Vitamin D-DEPENDENT developmental and epigenetic outcomes.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 39), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 69), ('SUPERFICIAL_RELATIONSHIP', 130), ('SUPERFICIAL_RELATIONSHIP', 188), ('SUPERFICIAL_RELATIONSHIP', 261)]	6	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('SO_0000704', 'gene', 122, 'genetic'), ('UBERON_0001969', 'blood plasma', 152, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 172, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 251, 'vitamin D')]	0	['mechanisms interindividual response  deficiency:  maternal plasma depletion 25(oh)d parent grandparent origin -dependent developmental epigenetic outcomes.']
S254-PMC5062906	PMC5062906	10/2016	S254-PMC5062906	['this is MOST LIKELY the result of Genetic DIFFERENCES in Vitamin D Metabolism and STUDIES are ONGOING to identify and characterize the loci responsible.']	[('PROBABLE_UNDERSTANDING', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('INCOMPLETE_EVIDENCE', 82), ('IMPORTANT_CONSIDERATION', 94)]	4	[('SO_0000704', 'gene', 34, 'genetic'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 57, 'vitamin D metabolism')]	0	['result   metabolism characterize loci responsible.']
S256-PMC5062906	PMC5062906	10/2016	S256-PMC5062906	['Genetic INFLUENCES on adiposity MAY also indirectly explain DIFFERENCES in Vitamin D depletion SINCE adiposity HAS BEEN LINKED to Vitamin D levels [55].']	[('SUPERFICIAL_RELATIONSHIP', 8), ('INCOMPLETE_EVIDENCE', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('PROBABLE_UNDERSTANDING', 95), ('INCOMPLETE_EVIDENCE', 111), ('SUPERFICIAL_RELATIONSHIP', 120)]	6	[('SO_0000704', 'gene', 0, 'Genetic'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]	0	[' adiposity  depletion adiposity  levels [55].']
S264-PMC5062906	PMC5062906	10/2016	S264-PMC5062906	['THEREFORE, the Vitamin D-dependent parent of origin EFFECTS REPORTED HERE MAY BE INFLUENCED by EITHER epigenetic mechanisms OR Genetic DIFFERENCES in cis or trans .']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 60), ('QUESTION_ANSWERED_BY_THIS_WORK', 69), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135)]	8	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('SO_0000704', 'gene', 127, 'genetic')]	0	['therefore, -dependent parent origin epigenetic mechanisms  trans .']
S313-PMC5062906	PMC5062906	10/2016	S313-PMC5062906	['STUDIES are ONGOING to characterize Genome-wide epigenetic EFFECTS of maternal Vitamin D depletion including the IMPACT of Genetic differences in determining epigenetic and phenotypic outcomes.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 12), ('SUPERFICIAL_RELATIONSHIP', 59), ('SUPERFICIAL_RELATIONSHIP', 113)]	4	[('SO_0001026', 'genome', 36, 'genome'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('SO_0000704', 'gene', 123, 'genetic')]	0	['studies characterize genome-wide epigenetic maternal  depletion  epigenetic phenotypic outcomes.']
S82-PMC5095257	PMC5095257	11/2016	S82-PMC5095257	['this HYPOTHESIS is PARTICULARLY PLAUSIBLE in the case of aad because of the KNOWN ASSOCIATION of the disease with polymorphisms in both the Vitamin D Receptor ( Vdr ) Gene and the Cyp27B1 Gene encoding 1-α-hydroxylase converting 25-Hydroxyvitamin D into its active form 1,25-Dihydroxyvitamin D (8,27,33).']	[('INCOMPLETE_EVIDENCE', 5), ('ANOMALY_CURIOUS_FINDING', 19), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 82)]	5	[('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 140, 'vitamin D receptor'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 161, 'VDR'), ('SO_0000704', 'gene', 167, 'gene'), ('PR_000006101', 'cytochrome P450 1A1', 180, 'CYP27B1'), ('SO_0000704', 'gene', 188, 'gene'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 229, '25-hydroxyvitamin D'), ('CHEBI_67472', '15-epi-lupulin B', 270, '1,25-dihydroxyvitamin D')]	0	['aad disease polymorphisms  receptor vdr  cyp27b1  encoding 1-α-hydroxylase converting 25-hydroxyvitamin form 1,25-dihydroxyvitamin (8,27,33).']
S138-PMC5137891	PMC5137891	12/2016	S138-PMC5137891	['other key FACTORS that MAY CONTRIBUTE to anemia include: OTHER Nutrient deficiencies (Folate, Vitamin B12, and Vitamin A), Genetic traits (including Sickle-Cell anemia and thalassaemia), malaria, schistosomiasis, hookworm and Trichuris infection, and hiv and some non-communicable diseases [1].']	[('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 57)]	4	[('CHEBI_33284', 'nutrient', 63, 'nutrient'), ('CHEBI_30863', '5-azaorotic acid', 86, 'folate'), ('CHEBI_33279', 'vitamin D5', 94, 'vitamin B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 102, 'B12'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin A'), ('SO_0000704', 'gene', 123, 'genetic'), ('CL_0000429', 'imaginal disc cell', 149, 'sickle-cell'), ('NCBITaxon_10088', 'Mus <genus>', 226, 'trichuris')]	0	['anemia include: nutrient (folate, vitamin b12, ),  traits (including sickle-cell anemia thalassaemia), malaria, schistosomiasis, hookworm trichuris infection, hiv non-communicable diseases [1].']
S131-PMC5155676	PMC5155676	12/2016	S131-PMC5155676	['thirdly, we DID NOT examine Genetic determinants of the response to Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 12)]	1	[('SO_0000704', 'gene', 28, 'genetic'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]	0	['thirdly,  response  supplementation.']
S132-PMC5155676	PMC5155676	12/2016	S132-PMC5155676	['it HAS BEEN demonstrated PREVIOUSLY that the incremental rise in 25(Oh)D after supplementation DIFFERS by Single Nucleotide Polymorphisms in Vitamin D Binding Protein (33,34) and 25-hydroxylase Genes (33).']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95)]	3	[('CHEBI_71657', 'versiconol acetate', 65, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 65, '25(OH ... D'), ('SO_0000694', 'SNP', 106, 'single nucleotide polymorphisms'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 141, 'vitamin D binding protein'), ('SO_0000704', 'gene', 194, 'genes')]	0	['incremental rise 25(oh)d supplementation single nucleotide polymorphisms  binding protein (33,34) 25-hydroxylase  (33).']
S133-PMC5155676	PMC5155676	12/2016	S133-PMC5155676	['ALTHOUGH this Genetic information CAN enable a more COMPREHENSIVE understanding of the biochemical response to Vitamin D supplementation, the current inability to undertake genotyping on a widespread population basis means this additional information WOULD NOT ALLOW for alterations to current clinical PRACTICE regarding Vitamin D supplementation in Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 34), ('PROBABLE_UNDERSTANDING', 52), ('DIFFICULT_TASK', 251), ('INCOMPLETE_EVIDENCE', 303)]	6	[('SO_0000704', 'gene', 14, 'genetic'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 322, 'vitamin D'), ('GO_0007565', 'female pregnancy', 351, 'pregnancy')]	0	['although  biochemical response  supplementation, genotyping population alterations regarding  supplementation pregnancy.']
S50-PMC5310660	PMC5310660	1/2017	S50-PMC5310660	['Genes ASSOCIATED with many Autoimmune diseases are enriched for Vitamin D receptor-Binding Sites [19-21], SUGGESTING that the combined EFFECT of Vitamin D deficiency, Genetic variation, and exposure to other environmental agents MAY concur in the pathogenesis.']	[('SUPERFICIAL_RELATIONSHIP', 6), ('INCOMPLETE_EVIDENCE', 106), ('SUPERFICIAL_RELATIONSHIP', 135), ('INCOMPLETE_EVIDENCE', 229)]	4	[('SO_0000704', 'gene', 0, 'Genes'), ('UBERON_0001442', 'skeleton of manus', 27, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('SO_0000409', 'binding_site', 83, 'binding sites'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('SO_0000704', 'gene', 167, 'genetic')]	0	[' autoimmune diseases enriched  receptor-binding sites [19-21], combined  deficiency,  variation, exposure environmental agents pathogenesis.']
S3-PMC5372327	PMC5372327	3/2017	S3-PMC5372327	['it REMAINS UNCLEAR WHETHER the RECOMMENDED doses are sufficient for the wide array of OTHER EFFECTS of Vitamin D. the vidi trial performed in finland is the FIRST large randomised controlled study for evaluation of the EFFECTS of different Vitamin D supplemental doses in infancy on:\nbone strength\ninfections and immunity\nallergy, atopy and asthma\nCognitive development\nGenetic Regulation Of Mineral Homeostasis\n\nmethods/design\nvidi, a randomised controlled double-blinded single-centre intervention study is conducted in infants from the age of 2\xa0weeks to 24\xa0months.']	[('FULL_UNKNOWN', 3), ('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('FUTURE_WORK', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 157), ('SUPERFICIAL_RELATIONSHIP', 219)]	8	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D'), ('GO_0050890', 'cognition', 348, 'cognitive'), ('SO_0000704', 'gene', 370, 'genetic'), ('GO_1900046', 'regulation of hemostasis', 378, 'regulation of ... homeostasis'), ('CHEBI_46662', 'mineral', 392, 'mineral')]	0	['doses array . vidi finland randomised  supplemental doses infancy on:\nbone strength\ninfections immunity\nallergy, atopy asthma\ncognitive development\n mineral homeostasis\n\nmethods/design\nvidi, randomised double-blinded single-centre infants age 2\xa0weeks 24\xa0months.']
S6-PMC5372327	PMC5372327	3/2017	S6-PMC5372327	['discussion\nthe study ENABLES evaluation of short and long term EFFECTS of supplemental Vitamin D on growth, Immune functions and Skeletal and developmental parameters in infants, and the EFFECTS of Genetic FACTORS therein.']	[('PROBABLE_UNDERSTANDING', 21), ('SUPERFICIAL_RELATIONSHIP', 63), ('SUPERFICIAL_RELATIONSHIP', 187), ('SUPERFICIAL_RELATIONSHIP', 206)]	4	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0002405', 'immune system', 108, 'immune'), ('UBERON_0004288', 'skeleton', 129, 'skeletal'), ('SO_0000704', 'gene', 198, 'genetic')]	0	['discussion\nthe term supplemental  growth, immune functions skeletal developmental parameters infants,  therein.']
S58-PMC5372327	PMC5372327	3/2017	S58-PMC5372327	['Genetic Regulation Of Mineral Homeostasis\nS-25-Ohd concentration has high heritability (28–80%), which EXPLAINS differences in responses to Vitamin D supplementation [53].']	[('PROBABLE_UNDERSTANDING', 103)]	1	[('SO_0000704', 'gene', 0, 'Genetic'), ('GO_1900046', 'regulation of hemostasis', 8, 'regulation of ... homeostasis'), ('CHEBI_46662', 'mineral', 22, 'mineral'), ('CHEBI_86929', 'S b G-5,5-G b S A CH2', 42, 'S-25-OHD'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D')]	0	[' mineral homeostasis\ns-25-ohd concentration heritability (28–80%), responses  supplementation [53].']
S59-PMC5372327	PMC5372327	3/2017	S59-PMC5372327	['Genome-wide association studies on Vitamin D insufficiency IDENTIFIED a number OF common Genetic variants that INFLUENCE 25-Ohd concentrations and the risk of insufficiency [54].']	[('INCOMPLETE_EVIDENCE', 59), ('ANOMALY_CURIOUS_FINDING', 79), ('SUPERFICIAL_RELATIONSHIP', 111)]	3	[('SO_0001026', 'genome', 0, 'Genome'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('SO_0000704', 'gene', 89, 'genetic'), ('CHEBI_72765', 'verruculogen', 121, '25-OHD')]	0	['genome-wide   variants 25-ohd concentrations [54].']
S60-PMC5372327	PMC5372327	3/2017	S60-PMC5372327	['these included Single Nucleotide Polymorphisms in the gc Gene encoding Vitamin D Binding Protein, locus near the 7-Dehydrocholesterol reductase INVOLVED in Vitamin D Synthesis in the skin, and Cyp2R1 coding Cytochrome P450 responsible for 25-Hydroxylation.']	[('SUPERFICIAL_RELATIONSHIP', 144)]	1	[('SO_0000694', 'SNP', 15, 'single nucleotide polymorphisms'), ('SO_0000704', 'gene', 57, 'gene'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 71, 'vitamin D binding protein'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 113, '7-dehydrocholesterol'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 156, 'vitamin D synthesis'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 193, 'CYP2R1'), ('CHEBI_38557', 'cytochrome c2', 207, 'cytochrome P450'), ('PR_000006100', 'aromatase', 207, 'cytochrome P450'), ('CHEBI_52846', 'cycloalkane ring', 239, '25-hydroxylation')]	0	['single nucleotide polymorphisms gc  encoding  binding protein, locus 7-dehydrocholesterol reductase  synthesis skin, cyp2r1 coding cytochrome p450 25-hydroxylation.']
S63-PMC5372327	PMC5372327	3/2017	S63-PMC5372327	['polymorphisms of the Vitamin D Receptor Gene Vdr ASSOCIATE with growth pattern in infancy [56,57] and with bone strength [58].']	[('SUPERFICIAL_RELATIONSHIP', 49)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 21, 'vitamin D receptor'), ('SO_0000704', 'gene', 40, 'gene'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 45, 'VDR')]	0	['polymorphisms  receptor  vdr infancy [56,57] bone [58].']
S128-PMC5372327	PMC5372327	3/2017	S128-PMC5372327	['by analysis of the IMPACT of Gene polymorphisms on the concentration and efficacy of the given Vitamin D substitution it MAY create the basis for individualised dosage guidelines.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('INCOMPLETE_EVIDENCE', 121)]	2	[('SO_0000704', 'gene', 29, 'gene'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]	0	[' polymorphisms concentration  substitution create individualised dosage guidelines.']
S56-PMC5385921	PMC5385921	4/2017	S56-PMC5385921	['ancestry information and Genetic relatedness derived from observed common Genetic variants\nethnicity is strongly ASSOCIATED with Vitamin D status (darker skinned Individuals are more PRONE to Vitamin D deficiency and insufficiency).19genome-wide genotype data for the children allow us to build models that are BETTER able to account for variation in ethnic background (compared with register-based or self-ascribed ethnicity) and for Genetic relatedness between cohort members that MAY inflate an association statistic when Genes AFFECT the exposure or outcome variable.']	[('SUPERFICIAL_RELATIONSHIP', 113), ('PROBABLE_UNDERSTANDING', 183), ('INCOMPLETE_EVIDENCE', 311), ('INCOMPLETE_EVIDENCE', 483), ('SUPERFICIAL_RELATIONSHIP', 531)]	5	[('SO_0000704', 'gene', 25, 'genetic'), ('SO_0000704', 'gene', 74, 'genetic'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('NCBITaxon_1', 'root', 162, 'individuals'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D'), ('SO_0000704', 'gene', 435, 'genetic'), ('SO_0000704', 'gene', 525, 'genes')]	0	['ancestry   variants\nethnicity  status (darker skinned individuals  insufficiency).19genome-wide genotype children us able ethnic background (compared register-based self-ascribed ethnicity)  members statistic  exposure outcome variable.']
S124-PMC5385921	PMC5385921	4/2017	S124-PMC5385921	['furthermore, neonatal Vitamin D deficiency HAS been PREVIOUSLY ASSOCIATED with an increased risk of schizophrenia.36asd and schizophrenia are KNOWN to share Genetic risk variants;37our findings provide ADDITIONAL EVIDENCE of the shared risk ARCHITECTURE between these two Neurodevelopmental disorders.']	[('IMPORTANT_CONSIDERATION', 43), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 63), ('INCOMPLETE_EVIDENCE', 142), ('FUTURE_WORK', 202), ('INCOMPLETE_EVIDENCE', 213), ('SUPERFICIAL_RELATIONSHIP', 241)]	7	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('SO_0000704', 'gene', 157, 'genetic'), ('GO_0007399', 'nervous system development', 272, 'neurodevelopmental')]	0	['furthermore, neonatal  schizophrenia.36asd schizophrenia  variants;37our shared neurodevelopmental disorders.']
S125-PMC5385921	PMC5385921	4/2017	S125-PMC5385921	['for example, the active form of Vitamin D (1,25Ohd) IS KNOWN to AFFECT the function of voltage-gated calcium channels.38variants in Genes coding for subunits of these same calcium channels (e.g.']	[('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 64)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_72652', '7,2*-dihydroxy-4*-methoxyisoflavan-4-ylium cation', 45, '25OHD'), ('SO_0000704', 'gene', 132, 'genes')]	0	['example, form  (1,25ohd) voltage-gated calcium channels.38variants  coding subunits calcium channels (e.g.']
S42-PMC5405075	PMC5405075	4/2017	S42-PMC5405075	['INCONSISTENCIES across studies HAVE BEEN ATTRIBUTED to a plethora of FACTORS such as diverse study designs, MISSING significant follow-up, lack OF a clear definition of vitamin d sufficiency in Pregnancy, REMARKABLE fluctuations in populations in different latitudes, Genetic heterogeneity, the diversity of assays employed (69), low repeatability of Serum 25(Oh)D values (37), variety of Vitamin D status DETERMINANTS, multifactorial nature and phenotypical diversity of asthma, as well as imprecision in diagnosing asthma in early Life.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 41), ('SUPERFICIAL_RELATIONSHIP', 69), ('PROBLEM_COMPLICATION', 108), ('ANOMALY_CURIOUS_FINDING', 144), ('ANOMALY_CURIOUS_FINDING', 205), ('SUPERFICIAL_RELATIONSHIP', 406)]	8	[('GO_0007565', 'female pregnancy', 194, 'pregnancy'), ('SO_0000704', 'gene', 268, 'genetic'), ('UBERON_0001977', 'blood serum', 351, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 360, 'OH)D'), ('CHEBI_27300', 'vitamin D', 389, 'vitamin D'), ('UBERON_0000104', 'life cycle', 533, 'life')]	0	['inconsistencies designs, follow-up, definition vitamin pregnancy, fluctuations populations latitudes,  heterogeneity, diversity assays employed (69), repeatability serum 25(oh)d values (37),  status determinants, nature phenotypical diversity asthma, diagnosing asthma life.']
S93-PMC5405075	PMC5405075	4/2017	S93-PMC5405075	['a plethora of environmental and Genetic/epigenetic FACTORS CONTRIBUTE in a COMPLEX manner to a PARTLY understood pathogenesis, WHILE the shifted Vitamin D Metabolism during Pregnancy is also NOT FULLY ELUCIDATED.']	[('SUPERFICIAL_RELATIONSHIP', 51), ('SUPERFICIAL_RELATIONSHIP', 59), ('DIFFICULT_TASK', 75), ('INCOMPLETE_EVIDENCE', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('INCOMPLETE_EVIDENCE', 191)]	6	[('SO_0000704', 'gene', 32, 'genetic'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 145, 'vitamin D metabolism'), ('GO_0007565', 'female pregnancy', 173, 'pregnancy')]	0	['environmental /epigenetic manner pathogenesis,  metabolism pregnancy elucidated.']
S64-PMC5410409	PMC5410409	4/2017	S64-PMC5410409	['the CONFLICTING results MAY reflect Genetic variability in the general population in the Metabolism and allergy preventive EFFECTS of Vitamin D supplementation in the child [67].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 123)]	3	[('SO_0000704', 'gene', 36, 'genetic'), ('GO_0008152', 'metabolic process', 89, 'metabolism'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]	0	['results  population metabolism allergy  supplementation child [67].']
S105-PMC5418719	PMC5418719	5/2017	S105-PMC5418719	['the DIFFERENT response to Vitamin D supplementation COULD BE EXPLAINED by vdr Gene polymorphism INVOLVED in Vitamin D Receptor, which results in Vitamin D deficiency at 36 pma in SOME babies after supplementation [24].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 52), ('ANOMALY_CURIOUS_FINDING', 58), ('PROBABLE_UNDERSTANDING', 61), ('SUPERFICIAL_RELATIONSHIP', 96), ('INCOMPLETE_EVIDENCE', 179)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('SO_0000704', 'gene', 78, 'gene'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 108, 'vitamin D receptor'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]	0	['response  supplementation vdr  polymorphism  receptor, results  36 pma babies supplementation [24].']
S117-PMC5418719	PMC5418719	5/2017	S117-PMC5418719	['in addition, circulating 25(Oh)D levels are INFLUENCED by ethnicity, Genetic factors and maternal FACTORS such as Prenatal Vitamin D intake and Gestational diabetes mellitus [27,28].']	[('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 98)]	2	[('CHEBI_71657', 'versiconol acetate', 25, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 31, 'D'), ('SO_0000704', 'gene', 69, 'genetic'), ('GO_0007565', 'female pregnancy', 114, 'prenatal'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('GO_0007565', 'female pregnancy', 144, 'gestational')]	0	['addition, circulating 25(oh)d levels ethnicity,  maternal prenatal  intake gestational diabetes mellitus [27,28].']
S139-PMC5485024	PMC5485024	3/2017	S139-PMC5485024	['a cumulative EFFECT of Genetic susceptibility in Glutathione S‐Transferase Mu 1 ( Gstm1 ), Gstp1 and Nad(P)H dehydrogenase, Quinone 1 ( Nqo1 ) polymorphisms and low dietary Vitamin C intake HAS BEEN ASSOCIATED with decreased Lung function in asthmatic children28.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 190), ('SUPERFICIAL_RELATIONSHIP', 199)]	3	[('SO_0000704', 'gene', 23, 'genetic'), ('CHEBI_16856', 'glutathione', 49, 'glutathione'), ('PR_000008320', 'general transcription factor IIH subunit 4', 49, 'glutathione S‐transferase mu 1'), ('PR_000008296', 'glutathione S-transferase A3', 82, 'GSTM1'), ('PR_000008294', 'glutathione S-transferase A1', 91, 'GSTP1'), ('CHEBI_13392', 'NAD(P)H', 101, 'NAD(P)H'), ('PR_000010999', 'N-acetyltransferase 14', 101, 'NAD ...'), ('3', 'A2MP1', 104, '(P'), ('PR_000004770', 'Polycomb complex protein BMI-1', 122, ', quinone 1'), ('CHEBI_36141', 'quinone', 124, 'quinone'), ('PR_000011339', 'RNA-binding protein Nova-1', 136, 'NQO1'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin C'), ('UBERON_0002048', 'lung', 225, 'lung')]	0	['cumulative  glutathione s‐transferase mu gstm1 ), gstp1 nad(p)h dehydrogenase, quinone nqo1 polymorphisms dietary  intake decreased lung asthmatic children28.']
S31-PMC5513133	PMC5513133	7/2017	S31-PMC5513133	['these include Vitamin D’s ROLE in Modulating pro-inflammatory responses and decreasing oxidative stress in pe, promoting Angiogenesis through Vegf and Gene modulation, and decreasing Blood Pressure through the Renin-angiotensin system (ras) [19–25].']	[('SUPERFICIAL_RELATIONSHIP', 26)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0065007', 'biological regulation', 34, 'modulating'), ('GO_0001525', 'angiogenesis', 121, 'angiogenesis'), ('PR_000017279', 'testis-specific basic protein Y 1', 142, 'VEGF'), ('SO_0000704', 'gene', 151, 'gene'), ('UBERON_0000178', 'blood', 183, 'blood'), ('GO_0060208', 'proestrus', 189, 'pressure'), ('PR_000014368', 'RuvB-like 1', 210, 'renin')]	0	['’s pro-inflammatory responses decreasing oxidative pe, promoting angiogenesis vegf  modulation, decreasing blood pressure renin-angiotensin system (ras) [19–25].']
S32-PMC5513133	PMC5513133	7/2017	S32-PMC5513133	['caption (table-wrap): table 1\n\nsummary of effects of increased Vitamin D on the pathogenesis of pre-eclampsia (pe)stage of pecharacteristic of pe↑ Vitamin dstage 1inflammation-linked abnormal Placental Implantation↓ predisposition to pro-inflammatory response [20]↑ Regulation of Genes associated with Placental invasion and normal Implantation [20]stage 2vascular Endothelial dysfunction↑ Vascular structure, elasticity and Intima-Media thickness↓ Blood pressure (Regulation of Renin-angiotension system) [63]↓oxidative stress [24]proteinuria mediated by Renal Vascular Endothelial Growth Factor (Vegf)↑ Vascular Smooth Muscle Cell Proliferation by increasing vegf Gene transcription [19]\n\nbiological PLAUSIBILITY of the ROLE of Vitamin D in pe\nVitamin D3, or Cholecalciferol, is formed endogenously when 7-Dehydrocholesterol in Keratinocytes is converted to a seco-Steroid pro-hormone upon irradiation by uv-b light.']	[('INCOMPLETE_EVIDENCE', 702), ('PROBABLE_UNDERSTANDING', 702), ('SUPERFICIAL_RELATIONSHIP', 722)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 147, 'Vitamin'), ('UBERON_0001987', 'placenta', 192, 'placental'), ('GO_0007566', 'embryo implantation', 202, 'implantation'), ('GO_0007567', 'parturition', 214, '↓'), ('GO_0065007', 'biological regulation', 266, 'Regulation'), ('SO_0000704', 'gene', 280, 'genes'), ('UBERON_0001987', 'placenta', 302, 'placental'), ('GO_0007566', 'embryo implantation', 332, 'implantation'), ('UBERON_0001986', 'endothelium', 365, 'Endothelial'), ('GO_0031674', 'I band', 390, 'Vascular'), ('GO_0005622', 'intracellular anatomical structure', 425, 'intima'), ('UBERON_0009472', 'axilla', 425, 'intima'), ('UBERON_0000951', 'rotator muscle of the vertebral column', 432, 'media'), ('UBERON_0000178', 'blood', 449, 'Blood'), ('GO_0065007', 'biological regulation', 465, 'regulation'), ('PR_000014368', 'RuvB-like 1', 479, 'renin'), ('UBERON_0002113', 'kidney', 556, 'renal'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 562, 'vascular endothelial growth factor'), ('UBERON_0001986', 'endothelium', 571, 'endothelial'), ('PR_000017279', 'testis-specific basic protein Y 1', 598, 'VEGF'), ('CL_0000359', 'vascular associated smooth muscle cell', 605, 'Vascular smooth muscle cell'), ('UBERON_0006849', 'scapula', 605, 'Vascular'), ('UBERON_0001135', 'smooth muscle tissue', 614, 'smooth muscle'), ('GO_0007601', 'visual perception', 621, 'muscle'), ('GO_0008283', 'cell proliferation', 628, 'cell proliferation'), ('SO_0000704', 'gene', 666, 'gene'), ('CHEBI_27300', 'vitamin D', 730, 'vitamin D'), ('CHEBI_33237', 'vitamin D4', 746, 'Vitamin D3'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 746, 'Vitamin D3'), ('CHEBI_52550', 'theopalauamide', 761, 'cholecalciferol'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 806, '7-dehydrocholesterol'), ('CL_0000312', 'keratinocyte', 830, 'keratinocytes'), ('CHEBI_35341', 'steroid', 867, 'steroid')]	0	['caption (table-wrap): table 1\n\nsummary  pathogenesis pre-eclampsia (pe)stage pecharacteristic pe↑ vitamin dstage 1inflammation-linked abnormal placental implantation↓ pro-inflammatory response [20]↑  placental invasion normal implantation [20]stage 2vascular endothelial dysfunction↑ vascular structure, elasticity intima-media thickness↓ blood pressure (regulation renin-angiotension system) [63]↓oxidative [24]proteinuria renal vascular endothelial (vegf)↑ vascular smooth muscle cell proliferation vegf  transcription [19]\n\nbiological  pe\nvitamin d3, cholecalciferol, formed endogenously 7-dehydrocholesterol keratinocytes converted seco-steroid pro-hormone irradiation uv-b light.']
S77-PMC5513133	PMC5513133	7/2017	S77-PMC5513133	['Vitamin D Metabolites MAY suppress Renin Gene transcription by a Vitamin D receptor (vdr) dependent pathway [65] or reduce Autoantibodies to the angiotensin ii type i receptor [64].']	[('INCOMPLETE_EVIDENCE', 22)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_25212', 'metabolite', 10, 'metabolites'), ('PR_000014368', 'RuvB-like 1', 35, 'renin'), ('SO_0000704', 'gene', 41, 'gene'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0044308', 'axonal spine', 123, 'autoantibodies')]	0	['vitamin metabolites suppress renin  transcription  receptor (vdr) [65] autoantibodies angiotensin ii type receptor [64].']
S265-PMC5513133	PMC5513133	7/2017	S265-PMC5513133	['DESPITE the clear ASSOCIATION of Serum deficiency with pe, a better understanding of the variable IMPACT of supplementation IS NEEDED to identify POTENTIAL of Genetic and environmental INTERACTIONS, as well as pre-Conception data TO IDENTIFY the CRITICAL time window for therapeutic potential of Vitamin D, if any.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 18), ('SUPERFICIAL_RELATIONSHIP', 98), ('FUTURE_WORK', 124), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 185), ('QUESTION_ANSWERED_BY_THIS_WORK', 230), ('IMPORTANT_CONSIDERATION', 246)]	8	[('UBERON_0001977', 'blood serum', 33, 'serum'), ('SO_0000704', 'gene', 159, 'genetic'), ('GO_0007620', 'copulation', 214, 'conception'), ('CHEBI_27300', 'vitamin D', 296, 'vitamin D')]	0	['despite serum pe, supplementation  environmental interactions, pre-conception window any.']
S11-PMC5521778	PMC5521778	7/2017	S11-PMC5521778	['taken TOGETHER, THESE FINDINGS provide the FIRST EVIDENCE that Gcs Regulate Vitamin A (Retinoid) Signaling via inhibition of bco1 Gene Expression in a Pparα-dependent manner.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 43)]	3	[('CL_0000740', 'retinal ganglion cell', 63, 'GCs'), ('GO_0065007', 'biological regulation', 67, 'regulate'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin A'), ('GO_0038094', 'Fc-gamma receptor signaling pathway', 76, 'vitamin A ... signaling'), ('CHEBI_26537', 'retinoid', 87, 'retinoid'), ('GO_0010467', 'gene expression', 130, 'gene expression'), ('SO_0000704', 'gene', 130, 'gene'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 151, 'PPARα')]	0	['taken together, gcs regulate  (retinoid) signaling via inhibition bco1  expression pparα-dependent manner.']
S0-PMC5546866	PMC5546866	8/2017	S0-PMC5546866	['response to antenatal Cholecalciferol supplementation is ASSOCIATED with common Vitamin D–related Genetic variants\n\nabstract\n\ncontext:\nSingle-Nucleotide Polymorphisms (Snps) in Genes RELATED to Vitamin D Metabolism HAVE BEEN ASSOCIATED with Serum 25-Hydroxyvitamin D [25(Oh)D] concentration, BUT these RELATIONSHIPS have NOT BEEN EXAMINED following Antenatal Cholecalciferol supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 57), ('SUPERFICIAL_RELATIONSHIP', 183), ('INCOMPLETE_EVIDENCE', 215), ('SUPERFICIAL_RELATIONSHIP', 225), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 292), ('SUPERFICIAL_RELATIONSHIP', 302), ('FULL_UNKNOWN', 321)]	7	[('CHEBI_16113', 'cholesterol', 22, 'Cholecalciferol'), ('CHEBI_28384', 'vitamin K', 80, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 80, 'Vitamin D'), ('SO_0000704', 'gene', 98, 'Genetic'), ('SO_0000694', 'SNP', 135, 'Single-nucleotide polymorphisms'), ('SO_0000694', 'SNP', 168, 'SNPs'), ('SO_0000704', 'gene', 177, 'genes'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('GO_0018977', '1,1,1-trichloro-2,2-bis-(4-chlorophenyl)ethane metabolic process', 202, 'D metabolism'), ('UBERON_0001977', 'blood serum', 241, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 247, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 268, '25(OH)D'), ('GO_0007567', 'parturition', 349, 'antenatal'), ('CHEBI_52550', 'theopalauamide', 359, 'cholecalciferol')]	0	['response antenatal cholecalciferol supplementation vitamin d–related  variants\n\nabstract\n\ncontext:\nsingle-nucleotide polymorphisms (snps)   metabolism serum 25-hydroxyvitamin [25(oh)d] concentration, following antenatal cholecalciferol supplementation.']
S11-PMC5546866	PMC5546866	8/2017	S11-PMC5546866	['conclusions:\nGenetic variation in Dhcr7 , which encodes 7-Dehyrocholesterol reductase in the Epidermal Vitamin D Biosynthesis pathway, APPEARS to modify baseline 25(Oh)D. IN CONTRAST, the response to Antenatal Cholecalciferol supplementation was ASSOCIATED with Snps in Cyp2R1 , which MAY alter 25-hydroxylase activity, and gc , which MAY AFFECT Vitamin D binding Protein Synthesis or Metabolite affinity.']	[('ANOMALY_CURIOUS_FINDING', 135), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 171), ('SUPERFICIAL_RELATIONSHIP', 246), ('INCOMPLETE_EVIDENCE', 285), ('INCOMPLETE_EVIDENCE', 335), ('SUPERFICIAL_RELATIONSHIP', 339)]	6	[('SO_0000704', 'gene', 13, 'Genetic'), ('PR_000006474', 'ATP-dependent RNA helicase A', 34, 'DHCR7'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 56, '7-dehyrocholesterol'), ('UBERON_0007376', 'outer epithelium', 93, 'epidermal'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 103, 'vitamin D biosynthesis'), ('PR_000006444', 'diacylglycerol kinase delta', 111, 'D'), ('CHEBI_71657', 'versiconol acetate', 162, '25(OH)D'), ('GO_0007567', 'parturition', 200, 'antenatal'), ('CHEBI_52550', 'theopalauamide', 210, 'cholecalciferol'), ('SO_0000694', 'SNP', 262, 'SNPs'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 270, 'CYP2R1'), ('CHEBI_27300', 'vitamin D', 346, 'vitamin D'), ('GO_0006412', 'translation', 364, 'protein synthesis'), ('CHEBI_39382', 'flufenoxuron', 385, 'metabolite')]	0	['conclusions:\n dhcr7 encodes 7-dehyrocholesterol reductase epidermal  biosynthesis pathway, baseline 25(oh)d. contrast, response antenatal cholecalciferol supplementation snps cyp2r1 alter 25-hydroxylase activity, gc  binding protein synthesis metabolite affinity.']
S19-PMC5546866	PMC5546866	8/2017	S19-PMC5546866	['in a PREVIOUS Genome-wide association study (gwas), we DEMONSTRATED that a NUMBER OF Single-Nucleotide Polymorphisms (Snps) in or near to Genes encoding KEY components of the Vitamin D Metabolism pathway are ASSOCIATED with Serum 25(Oh)D level (8).']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 55), ('INCOMPLETE_EVIDENCE', 75), ('IMPORTANT_CONSIDERATION', 153), ('SUPERFICIAL_RELATIONSHIP', 208)]	5	[('SO_0001026', 'genome', 14, 'genome'), ('SO_0000694', 'SNP', 85, 'single-nucleotide polymorphisms'), ('SO_0000694', 'SNP', 118, 'SNPs'), ('SO_0000704', 'gene', 138, 'genes'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 175, 'vitamin D metabolism'), ('UBERON_0001977', 'blood serum', 224, 'serum'), ('CHEBI_71657', 'versiconol acetate', 230, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 233, 'OH ... D')]	0	['genome-wide (gwas), single-nucleotide polymorphisms (snps)  encoding  metabolism serum 25(oh)d (8).']
S26-PMC5546866	PMC5546866	8/2017	S26-PMC5546866	['CONSIDERING this and the physiological changes to the Vitamin D pathway in Pregnancy, it is THEREFORE POSSIBLE that the Genetic variants ASSOCIATED with baseline Serum 25(Oh)d status and the response to supplementation also differ between the Pregnant and nonpregnant state.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 92), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 137)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('SO_0000704', 'gene', 120, 'genetic'), ('UBERON_0001977', 'blood serum', 162, 'serum'), ('CHEBI_30778', 'gallic acid', 168, '25(OH)'), ('GO_0007565', 'female pregnancy', 243, 'pregnant')]	0	['considering physiological changes  pregnancy,  variants baseline serum 25(oh)d status response supplementation pregnant nonpregnant state.']
S118-PMC5546866	PMC5546866	8/2017	S118-PMC5546866	['discussion\nTHIS STUDY ASSESSED the RELATIONSHIPS between common Genetic variants and the response to Vitamin D supplementation in Pregnancy; rs12785878 in dhcr7 was ASSOCIATED with 25(Oh)D status in early Pregnancy prior to Vitamin D supplementation, WHEREAS rs10741657 in Cyp2R1 and rs2282679 in gc were ASSOCIATED with both the achieved and change in 25(Oh)D concentration following supplementation with 1000 iu/d Cholecalciferol.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('SUPERFICIAL_RELATIONSHIP', 35), ('SUPERFICIAL_RELATIONSHIP', 165), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 251), ('SUPERFICIAL_RELATIONSHIP', 305)]	6	[('SO_0000704', 'gene', 64, 'genetic'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('CHEBI_30778', 'gallic acid', 181, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 187, 'D'), ('GO_0007565', 'female pregnancy', 205, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 224, 'vitamin D'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 273, 'CYP2R1'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 356, 'OH)D'), ('CHEBI_52550', 'theopalauamide', 416, 'cholecalciferol')]	0	['discussion\nthis  variants response  supplementation pregnancy; rs12785878 dhcr7 25(oh)d status pregnancy  supplementation, rs10741657 cyp2r1 rs2282679 gc achieved 25(oh)d concentration following supplementation 1000 iu/d cholecalciferol.']
S129-PMC5546866	PMC5546866	8/2017	S129-PMC5546866	['the Dhcr7 Gene encodes 7-Dhc reductase, which converts 7-Dhc back to Cholesterol, thereby reducing the availability of 7-Dhc for conversion to previtamin d. the ASSOCIATION of this Snp with only baseline 25(Oh)D is biologically CONSISTENT with the NOTION that the relative proportion of 25(Oh)D obtained from Vitamin D Biosynthesis in the skin AS OPPOSED TO dietary intake is lower following supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 161), ('INCOMPLETE_EVIDENCE', 228), ('INCOMPLETE_EVIDENCE', 248), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 344)]	4	[('PR_000006474', 'ATP-dependent RNA helicase A', 4, 'DHCR7'), ('SO_0000704', 'gene', 10, 'gene'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 23, '7-DHC'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 55, '7-DHC'), ('CHEBI_16113', 'cholesterol', 69, 'cholesterol'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 119, '7-DHC'), ('SO_0000694', 'SNP', 181, 'SNP'), ('CHEBI_71657', 'versiconol acetate', 204, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 287, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 293, 'D'), ('CHEBI_27300', 'vitamin D', 309, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 309, 'vitamin D biosynthesis')]	0	['dhcr7  encodes 7-dhc reductase, converts 7-dhc back cholesterol, reducing availability 7-dhc conversion previtamin d. snp baseline 25(oh)d biologically relative proportion 25(oh)d  biosynthesis skin dietary intake following supplementation.']
S120-PMC5634602	PMC5634602	10/2017	S120-PMC5634602	['jones has OUTLINED a mechanism by which this toxicity MAY present ARGUING that 25(Oh)D3At these concentrations displaces 1-alpha,25(Oh)2D from Vitamin D binding protein leading to increased Gene transcription [48].']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 54), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 66)]	3	[('CHEBI_35047', 'xanthomicrol', 79, '25(OH)D3at'), ('CHEBI_66212', '5,7,3*,4*-tetrahydroxy-2*-(3,3-dimethylallyl)isoflavone', 129, '25(OH)2D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('SO_0000704', 'gene', 190, 'gene')]	0	['jones toxicity 25(oh)d3at concentrations displaces 1-alpha,25(oh)2d  binding protein  transcription [48].']
S15-PMC5659607	PMC5659607	10/2017	S15-PMC5659607	['trial registration\ncopsac2010: clinicaltrials.govnct00856947; vdaart: clinicaltrials.govnct00920621\n\nintroduction\nthere are several REASONS to HYPOTHESIZE that low in utero Vitamin D exposure increases risk of childhood asthma/recurrent wheeze: (1) Genetic studies HAVE SHOWN that polymorphisms in the Vitamin D Receptor are ASSOCIATED with childhood asthma susceptibility[1].']	[('PROBABLE_UNDERSTANDING', 132), ('INCOMPLETE_EVIDENCE', 143), ('INCOMPLETE_EVIDENCE', 265), ('SUPERFICIAL_RELATIONSHIP', 325)]	4	[('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('SO_0000704', 'gene', 249, 'Genetic'), ('CHEBI_27300', 'vitamin D', 302, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 302, 'vitamin D receptor')]	0	['trial registration\ncopsac2010: clinicaltrials.govnct00856947; vdaart: clinicaltrials.govnct00920621\n\nintroduction\nthere utero  exposure childhood asthma/recurrent wheeze: (1)  polymorphisms  receptor childhood asthma susceptibility[1].']
S139-PMC5659607	PMC5659607	10/2017	S139-PMC5659607	['HOWEVER, EMERGING EVIDENCE arising from Lung Gene Expression data from our own lab have SUBSEQUENTLY SHOWN that Vitamin D already has EFFECTS at the stage of Branching Morphogenesis of the fetal Lung occurring in the first Trimester of Pregnancy prior to randomization in both these trials[2].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 134)]	4	[('UBERON_0002048', 'lung', 40, 'lung'), ('GO_0010467', 'gene expression', 45, 'gene expression'), ('SO_0000704', 'gene', 45, 'gene'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0001763', 'morphogenesis of a branching structure', 158, 'branching morphogenesis'), ('UBERON_0002048', 'lung', 195, 'lung'), ('GO_0009294', 'DNA mediated transformation', 223, 'trimester'), ('GO_0007565', 'female pregnancy', 236, 'pregnancy')]	0	['however, arising lung  expression lab  branching morphogenesis fetal lung occurring trimester pregnancy randomization trials[2].']
S1-PMC5941617	PMC5941617	5/2018	S1-PMC5941617	['besides its historical Skeletal functions, in the last years it HAS BEEN DEMONSTRATED that Vitamin D directly OR indirectly Regulates up to 1250 Genes, playing so-called Extraskeletal actions.']	[('INCOMPLETE_EVIDENCE', 64), ('INCOMPLETE_EVIDENCE', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 110)]	3	[('UBERON_0004288', 'skeleton', 23, 'skeletal'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0065007', 'biological regulation', 124, 'regulates'), ('SO_0000704', 'gene', 145, 'genes'), ('UBERON_0001431', 'distal carpal bone 2', 170, 'extraskeletal')]	0	['besides skeletal functions, last  1250 playing extraskeletal actions.']
S302-PMC5941617	PMC5941617	5/2018	S302-PMC5941617	['furthermore, SOME ROLE from vdr polymorphisms or OTHER Genetic factors MIGHT play a ROLE in determining the INFLUENCE of Vitamin D status on Respiratory morbidity [257,258].']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 49), ('INCOMPLETE_EVIDENCE', 71), ('SUPERFICIAL_RELATIONSHIP', 84), ('SUPERFICIAL_RELATIONSHIP', 108)]	6	[('SO_0000704', 'gene', 55, 'genetic'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 141, 'respiratory')]	0	['furthermore, vdr polymorphisms  play  status respiratory morbidity [257,258].']
S326-PMC5941617	PMC5941617	5/2018	S326-PMC5941617	['evaluated more than 900 infected children and OBSERVED that Vitamin D-RELATED host Genetic variants MAY alter the availability and activity of Vitamin D and are ASSOCIATED with risk of hiv disease progression in children [284].']	[('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 161)]	4	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('SO_0000704', 'gene', 83, 'genetic'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]	0	['evaluated 900 infected children -related host  variants alter availability activity  hiv disease progression children [284].']
S359-PMC5941617	PMC5941617	5/2018	S359-PMC5941617	['furthermore, PREVIOUS STUDIES focused on the ASSOCIATION between Serum 25(Oh)D levels and the Expression of Genes INVOLVED in the Proliferation and Cells Differentiation, showing an anti-proliferative activity of Vitamin D with CONSEQUENTLY remodeling inhibition [309–312].']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 45), ('SUPERFICIAL_RELATIONSHIP', 114), ('PROBABLE_UNDERSTANDING', 228)]	4	[('UBERON_0001977', 'blood serum', 65, 'serum'), ('CHEBI_71657', 'versiconol acetate', 71, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 77, 'D'), ('GO_0010467', 'gene expression', 94, 'expression'), ('SO_0000704', 'gene', 108, 'genes'), ('GO_0007565', 'female pregnancy', 130, 'proliferation ...'), ('GO_0030154', 'cell differentiation', 148, 'cells differentiation'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]	0	['furthermore, serum 25(oh)d levels expression  proliferation cells differentiation, anti-proliferative activity  remodeling inhibition [309–312].']
S394-PMC5941617	PMC5941617	5/2018	S394-PMC5941617	['a RECENT large STUDY FOUND NO EVIDENCE that Genetically determined reduction in 25(Oh)D levels conferred an increased risk for ad, SUGGESTING that EFFORTS to increase Vitamin D are UNLIKELY to reduce risks of the atopic disease [349].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 131), ('FUTURE_WORK', 147), ('PROBABLE_UNDERSTANDING', 181)]	6	[('SO_0000704', 'gene', 44, 'genetically'), ('CHEBI_71657', 'versiconol acetate', 80, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]	0	[' reduction 25(oh)d levels ad, increase  atopic disease [349].']
S419-PMC5941617	PMC5941617	5/2018	S419-PMC5941617	['data on polymorphisms of OTHER Genes INVOLVED in Vitamin D Metabolism are still CONFLICTING or RELATED to small populations [373–376].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('SUPERFICIAL_RELATIONSHIP', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 80), ('SUPERFICIAL_RELATIONSHIP', 95)]	4	[('SO_0000704', 'gene', 31, 'genes'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 49, 'vitamin D metabolism')]	0	['data polymorphisms   metabolism populations [373–376].']
S14-PMC5952272	PMC5952272	5/2018	S14-PMC5952272	['approximately 1 in 68 children aged 8\u2009years living in sites participating in the addm network surveillance areas (usa) met the asd case criteria for the 2012 surveillance year.1some HYPOTHESES were SUGGESTED to explain this increase, such as an increased awareness, improved detection, expanding definition, or an actual increase in incidence or a combination of these FACTORS.2ALTHOUGH both Genetic and multiple environmental RISK FACTORS HAVE BEEN studied extensively, many POTENTIALLY modifiable RISK factors including nutritional and Immune function–RELATED RISK FACTORS such as Vitamin D, Folic Acid, and Metabolic syndrome have NOT RECEIVED SUFFICIENT ATTENTION.3SEVERAL RECENT STUDIES have put FORWARD hypotheses to explain the mechanism of ASSOCIATION between both Folic Acid and Vitamin D and autism.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('INCOMPLETE_EVIDENCE', 198), ('SUPERFICIAL_RELATIONSHIP', 369), ('ANOMALY_CURIOUS_FINDING', 377), ('SUPERFICIAL_RELATIONSHIP', 427), ('INCOMPLETE_EVIDENCE', 440), ('INCOMPLETE_EVIDENCE', 476), ('SUPERFICIAL_RELATIONSHIP', 499), ('SUPERFICIAL_RELATIONSHIP', 554), ('SUPERFICIAL_RELATIONSHIP', 562), ('INCOMPLETE_EVIDENCE', 634), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 668), ('INCOMPLETE_EVIDENCE', 677), ('FUTURE_WORK', 701), ('SUPERFICIAL_RELATIONSHIP', 748)]	15	[('SO_0000704', 'gene', 392, 'genetic'), ('UBERON_0002405', 'immune system', 538, 'immune'), ('CHEBI_27300', 'vitamin D', 583, 'vitamin D'), ('CHEBI_30751', 'formic acid', 594, 'folic acid'), ('GO_0008152', 'metabolic process', 610, 'metabolic'), ('CHEBI_30751', 'formic acid', 773, 'folic acid'), ('CHEBI_27300', 'vitamin D', 788, 'vitamin D')]	0	['approximately 68 children aged 8\u2009years living sites participating addm (usa) met asd criteria 2012 year.1some increase, awareness, detection, definition, actual increase combination factors.2although  environmental extensively, nutritional immune function–related folic acid, metabolic syndrome received attention.3several folic acid  autism.']
S143-PMC5952272	PMC5952272	5/2018	S143-PMC5952272	['IN fact, it is the most potent Steroid Hormone in the Human body INTERACTING with 2.5% of the Human Genome or some 1000 Genes (a large NUMBER of which AFFECT Brain Development and function) and working like a master on-off switch.35\nthe LINK between Vitamin D and autism are based on 4 observational data:\nthe low concentrations of Serotonin in the Brain and its elevated concentrations in Tissues outside the Blood-Brain Barrier;\nlow Plasma concentrations of the Vitamin D hormone precursor 25-Hydroxyvitamin D (25(Oh) D3);\nhigh male incidence;\npresence of maternal Antibodies to foetal Brain Tissue.35,36\nthe level of Serotonin in the Brain DEPENDS ON the Blood levels of tryptophan, which, UNLIKE Serotonin, crosses the Blood-Brain Barrier.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 151), ('SUPERFICIAL_RELATIONSHIP', 237), ('SUPERFICIAL_RELATIONSHIP', 643), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 693)]	7	[('CHEBI_26764', 'steroid hormone', 31, 'steroid hormone'), ('NCBITaxon_9606', 'Homo sapiens', 54, 'human'), ('NCBITaxon_9606', 'Homo sapiens', 94, 'human'), ('SO_0001026', 'genome', 100, 'genome'), ('SO_0000704', 'gene', 120, 'genes'), ('GO_0007420', 'brain development', 158, 'brain development'), ('UBERON_0000955', 'brain', 158, 'brain'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin D'), ('CHEBI_28790', 'serotonin', 332, 'serotonin'), ('UBERON_0000955', 'brain', 349, 'brain'), ('UBERON_0000479', 'tissue', 390, 'tissues'), ('UBERON_0000120', 'blood brain barrier', 410, 'blood-brain barrier'), ('UBERON_0001969', 'blood plasma', 435, 'plasma'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 492, '25-hydroxyvitamin D'), ('CHEBI_62946', 'ammonium sulfate', 513, '25(OH) D3'), ('GO_0042571', 'immunoglobulin complex, circulating', 567, 'antibodies'), ('UBERON_0000955', 'brain', 588, 'brain'), ('UBERON_0000479', 'tissue', 594, 'tissue'), ('CHEBI_28790', 'serotonin', 620, 'serotonin'), ('UBERON_0000955', 'brain', 637, 'brain'), ('UBERON_0000178', 'blood', 658, 'blood'), ('CHEBI_28790', 'serotonin', 700, 'serotonin'), ('UBERON_0000178', 'blood', 723, 'blood'), ('UBERON_0000052', 'fornix of brain', 729, 'brain barrier')]	0	['fact, potent steroid hormone human 2.5% human genome 1000  (a brain function) working master on-off switch.35\nthe  autism 4 data:\nthe concentrations serotonin brain elevated concentrations tissues outside blood-brain barrier;\nlow plasma concentrations  hormone 25-hydroxyvitamin (25(oh) d3);\nhigh male incidence;\npresence maternal antibodies foetal brain tissue.35,36\nthe serotonin brain blood levels tryptophan, which, serotonin, crosses blood-brain barrier.']
S239-PMC5956785	PMC5956785	5/2018	S239-PMC5956785	['exploring elements of Vitamin D status that MAY have a ROLE in disease development such as early Life and Gestational Vitamin D status as well as Genes in the Vitamin D pathway will help TO CLARIFY the ROLE of Vitamin D.\nseason of Birth HAS BEEN SUGGESTED to have an IMPACT on the risk of developing a number of Autoimmune diseases such as multiple sclerosis, type 1 diabetes and celiac disease [78].']	[('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 55), ('FUTURE_WORK', 187), ('SUPERFICIAL_RELATIONSHIP', 202), ('INCOMPLETE_EVIDENCE', 237), ('SUPERFICIAL_RELATIONSHIP', 267)]	6	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0000104', 'life cycle', 97, 'life'), ('GO_0007565', 'female pregnancy', 106, 'gestational'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('SO_0000704', 'gene', 146, 'genes'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D'), ('GO_0007567', 'parturition', 231, 'birth'), ('UBERON_0001442', 'skeleton of manus', 312, 'autoimmune')]	0	['exploring elements  status disease life gestational  status   .\nseason birth autoimmune diseases sclerosis, type diabetes celiac disease [78].']
S250-PMC5956785	PMC5956785	5/2018	S250-PMC5956785	['certain vdr Gene polymorphisms MAY BE ASSOCIATED with different biologic response to Vitamin D. the cdx2 polymorphism of the Vdr Gene specifically the gg genotype, HAVE BEEN SUGGESTED to be more represented in patients with jia COMPARED TO healthy controls who more OFTEN have the ga genotype [82].']	[('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 164), ('INCOMPLETE_EVIDENCE', 174), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228), ('PROBABLE_UNDERSTANDING', 266)]	6	[('SO_0000704', 'gene', 12, 'gene'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 125, 'VDR'), ('SO_0000704', 'gene', 129, 'gene')]	0	['certain vdr  polymorphisms biologic response . cdx2 polymorphism vdr  gg genotype, patients jia healthy ga genotype [82].']
S251-PMC5956785	PMC5956785	5/2018	S251-PMC5956785	['RECENTLY THE IDEA of investigating epistasis (Gene-Gene interactions) amongst Genes in the inflammatory and Vitamin D pathway and HOW their INTERACTIONS CONTRIBUTE to jia risk was explored by ellis et al.']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 13), ('EXPLICIT_QUESTION', 130), ('SUPERFICIAL_RELATIONSHIP', 140), ('SUPERFICIAL_RELATIONSHIP', 153)]	6	[('SO_0000704', 'gene', 46, 'gene'), ('SO_0000704', 'gene', 51, 'gene'), ('SO_0000704', 'gene', 78, 'genes'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]	0	['recently epistasis (- interactions) amongst  inflammatory  jia ellis et al.']
S254-PMC5956785	PMC5956785	5/2018	S254-PMC5956785	['their work FOUND EVIDENCE of epistasis amongst Tyrosine-Protein Phosphatase Non-Receptor Type 2 (Ptpn2) Gene and the Vitamin D Binding Protein Gene in contributing to the risk of jia [86].']	[('INCOMPLETE_EVIDENCE', 11)]	1	[('PR_000016775', 'thiosulfate sulfurtransferase', 47, 'tyrosine-protein phosphatase non-receptor type 2'), ('PR_000013453', 'tyrosine-protein phosphatase non-receptor type 18', 97, 'PTPN2'), ('SO_0000704', 'gene', 104, 'gene'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 117, 'vitamin D binding protein'), ('SO_0000704', 'gene', 143, 'gene')]	0	['epistasis amongst tyrosine-protein phosphatase non-receptor type 2 (ptpn2)   binding protein  jia [86].']
S255-PMC5956785	PMC5956785	5/2018	S255-PMC5956785	['the ROLE of Genes in the Vitamin D pathway on both disease development and disease activity are still in the early stages of investigation.']	[('SUPERFICIAL_RELATIONSHIP', 4)]	1	[('SO_0000704', 'gene', 12, 'genes'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D')]	0	['  disease disease activity stages investigation.']
S257-PMC5956785	PMC5956785	5/2018	S257-PMC5956785	['INVESTIGATING Genetic, nutritional and environmental factors that INFLUENCE Vitamin D in jia COULD HELP inform ways in which Vitamin D status INFLUENCES the occurrence and activity of jia.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 66), ('INCOMPLETE_EVIDENCE', 93), ('FUTURE_WORK', 99), ('SUPERFICIAL_RELATIONSHIP', 142)]	5	[('SO_0000704', 'gene', 14, 'genetic'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]	0	['investigating nutritional environmental  jia  status occurrence activity jia.']
S258-PMC5956785	PMC5956785	5/2018	S258-PMC5956785	['UNDERSTANDING IF Genetic variants increase the risk of disease development will HELP tailor Vitamin D management in individual patients and CONTRIBUTE to improving Control of disease activity and improve outcomes.']	[('FUTURE_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('FUTURE_WORK', 80), ('SUPERFICIAL_RELATIONSHIP', 140)]	4	[('SO_0000704', 'gene', 17, 'genetic'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0065007', 'biological regulation', 164, 'control')]	0	['understanding  variants increase disease tailor  individual patients disease activity outcomes.']
S271-PMC5956785	PMC5956785	5/2018	S271-PMC5956785	['this review was UNABLE TO explore the RELATIONSHIP between Vitamin D status and ethnicity, Vitamin D receptor Genes or OTHER Genes that INFLUENCE Vitamin D Metabolism.']	[('DIFFICULT_TASK', 16), ('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 119), ('SUPERFICIAL_RELATIONSHIP', 136)]	4	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('SO_0000704', 'gene', 110, 'genes'), ('SO_0000704', 'gene', 125, 'genes'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 146, 'vitamin D metabolism')]	0	[' status ethnicity,  receptor    metabolism.']
S283-PMC5956785	PMC5956785	5/2018	S283-PMC5956785	['INVESTIGATING the Genetic and environmental ROLE that Vitamin D plays in the PREVENTION and Control of jia in the same children will HELP to tease out the multifaceted ROLE played by Vitamin D in this disease.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 77), ('FUTURE_WORK', 133), ('SUPERFICIAL_RELATIONSHIP', 168)]	5	[('SO_0000704', 'gene', 18, 'genetic'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0065007', 'biological regulation', 92, 'control'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D')]	0	['investigating  environmental  plays jia children tease multifaceted played  disease.']
S284-PMC5956785	PMC5956785	5/2018	S284-PMC5956785	['being able to SUGGEST specific TARGETS for Vitamin D status AS a POTENTIAL adjunct therapy in the treatment of jia and understanding HOW Genetic variants increase the RISK of disease development will enhance the quality of Life of patients and their families.']	[('INCOMPLETE_EVIDENCE', 14), ('FUTURE_WORK', 31), ('PROBABLE_UNDERSTANDING', 60), ('INCOMPLETE_EVIDENCE', 65), ('EXPLICIT_QUESTION', 133), ('IMPORTANT_CONSIDERATION', 167)]	6	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('SO_0000704', 'gene', 137, 'genetic'), ('UBERON_0000104', 'life cycle', 223, 'life')]	0	['able  status adjunct therapy treatment jia  variants increase disease life patients families.']
S163-PMC5995352	PMC5995352	6/2018	S163-PMC5995352	['ALTERNATIVE explanations MAY BE searched in the Expression of Genes encoding for the inactive c3-epimer Vitamin D, vdr, Vitamin D binding protein, etc.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 25)]	2	[('GO_0010467', 'gene expression', 48, 'expression'), ('SO_0000704', 'gene', 62, 'genes'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]	0	['alternative expression  encoding inactive c3-epimer vdr,  binding protein, etc.']
S23-PMC6039335	PMC6039335	7/2018	S23-PMC6039335	['factors AFFECTING imf deposition can be sub-categorized into Genetic (breed and sex differences, heritability), management (weaning age, castration, slaughter weight and age, and environment), and nutritional factors (Fat Metabolism, Fat Digestion and absorption, Glucose/Starch availability, roughage vs concentrate ratio, dietary energy and protein levels, Vitamins A, d, and c levels, fetal and neonatal nutritional programming, and stage-specific Feeding systems).']	[('SUPERFICIAL_RELATIONSHIP', 8)]	1	[('SO_0000704', 'gene', 61, 'genetic'), ('GO_0006631', 'fatty acid metabolic process', 218, 'fat metabolism'), ('GO_0009566', 'fertilization', 234, 'fat digestion'), ('CHEBI_17234', 'glucose', 264, 'glucose'), ('CHEBI_28017', 'starch', 272, 'starch'), ('CHEBI_27300', 'vitamin D', 359, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 368, 'A'), ('GO_0007631', 'feeding behavior', 451, 'feeding')]	0	['factors imf deposition sub-categorized  (breed sex differences, heritability), (weaning age, castration, slaughter age, environment), nutritional (fat metabolism, fat digestion absorption, glucose/starch availability, roughage ratio, dietary energy protein levels, d, c levels, fetal neonatal nutritional programming, stage-specific feeding systems).']
S275-PMC6039335	PMC6039335	7/2018	S275-PMC6039335	['they concluded that the tt genotype of adh1c c.-64t>c is RELATED to greater imf than the cc genotype when Vitamin A is restricted, and adh1c c.-64t>c COULD BE a Genetic marker for enhancing marbling in feedlot steers.']	[('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 150)]	2	[('CHEBI_27300', 'vitamin D', 106, 'vitamin A'), ('SO_0000704', 'gene', 161, 'genetic')]	0	['tt genotype adh1c c.-64t>c imf cc genotype  restricted, adh1c c.-64t>c  marbling feedlot steers.']
S69-PMC4600246	PMC4600246	10/2015	S69-PMC4600246	['the mechanisms responsible include (1) activation of growth-inhibiting proteins requiring Vitamin K2, such as prothrombin,62(2) Arylation pathways,63(3) activation of growth arrest Genes such as gas 6,64and (4) and increased C-Jun and C-Myc mrna Expression in Hepatoma Cells.57\npreventing the Recurrence of hcc is an IMPORTANT STRATEGY, ESPECIALLY CONSIDERING the fact that EVEN after patients undergo curative therapy recurrence rates REMAIN high.65while triple combination therapy with Boceprevir or Telaprevir, pegylated interferon (ifn) and Ribavirin is effective for the treatment of hepatitis c virus (Hcv), INFORMATION on preventing hcc development and/or recurrence as well as all-cause mortality is LACKING.6667moreover, this combination therapy is expensive, REQUIRES injections (ifn) and is OFTEN not well tolerated DUE TO adverse events (ie, fever and pancytopenia).']	[('IMPORTANT_CONSIDERATION', 317), ('FUTURE_WORK', 327), ('IMPORTANT_CONSIDERATION', 337), ('IMPORTANT_CONSIDERATION', 348), ('ANOMALY_CURIOUS_FINDING', 374), ('INCOMPLETE_EVIDENCE', 436), ('INCOMPLETE_EVIDENCE', 614), ('FULL_UNKNOWN', 708), ('INCOMPLETE_EVIDENCE', 708), ('IMPORTANT_CONSIDERATION', 769), ('PROBABLE_UNDERSTANDING', 802), ('PROBLEM_COMPLICATION', 827)]	12	[('CHEBI_28934', 'vitamin D2', 90, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 90, 'vitamin K2'), ('GO_0006915', 'apoptotic process', 128, 'arylation'), ('SO_0000704', 'gene', 181, 'genes'), ('PR_000004968', 'calretinin', 225, 'c-Jun'), ('PR_000000084', 'c-myc protein', 235, 'c-Myc'), ('GO_0010467', 'gene expression', 246, 'expression'), ('CL_0000632', 'hepatic stellate cell', 260, 'hepatoma cells'), ('GO_0000003', 'reproduction', 293, 'recurrence'), ('CHEBI_68621', 'boceprevir', 488, 'boceprevir'), ('CHEBI_68593', 'eurysterol B(1-)', 502, 'telaprevir'), ('CHEBI_63580', 'ribavirin', 545, 'ribavirin'), ('NCBITaxon_10088', 'Mus <genus>', 608, 'HCV')]	0	['mechanisms (1) activation growth-inhibiting proteins prothrombin,62(2) arylation pathways,63(3) activation arrest  gas 6,64and (4) c-jun c-myc mrna expression hepatoma cells.57\npreventing recurrence hcc strategy, patients undergo curative therapy recurrence rates high.65while triple combination therapy boceprevir telaprevir, pegylated interferon (ifn) ribavirin treatment hepatitis c virus (hcv), hcc and/or recurrence all-cause mortality lacking.6667moreover, combination therapy expensive, injections (ifn) tolerated events (ie, fever pancytopenia).']
